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1. Introduction 
1.1. The myeov gene 
For several years our group, using the tumorigenicity assay (section 1.2) 
and DNA from a gastric carcinoma, detected a potential oncogene. The 
DNA from a tertiary nude mice tumor (section 1.2) was cloned into EMBL-3 
phage and screened with a human specific repetitive Alu-probe. Alu-positive 
phage clones were isolated and submitted to exon-trap analysis (Auch and 
Reth, 1990). Isolated exon fragments were used to screen a cDNA library from 
RNA of a tertiary nude mice tumor and a novel putative oncogene, 
designated myeov (myeloma overexpressed gene), was isolated.  
Further analysis of this gene by fiber FISH-analysis, using the cell line 
(KMS-12) isolated from a patient suffering from a multiple myeloma (MM) with 
the t(11;14)(q13;q32), enabled the localization of this gene to chromosome 
band 11q13, 360-kb centromeric of the cyclin D1 oncogene (Janssen et al., 
2000). All breakpoints in mantle cell lymphomas (de Boer et al., 1995; 
Vaandrager et al., 1997a; Vaandrager et al., 1996) and MM cell lines (Gabrea 
et al., 1999; Raynaud et al., 1993; Ronchetti et al., 1999; Vaandrager et al., 
1997b) occur in this 360-kb region between the cyclin D1 and myeov genes. 
In addition, three out of seven MM cell lines carrying the t(11;14)(q13;32) 
showed overexpression of myeov on the mRNA level. Cyclin D1 was 
overexpressed in all of these cell lines. Mapping analysis showed, that myeov 
and cyclin D1 came under the separate control of two different IgH 
enhancers, i.e. 3`E- and 5`Eµ, respectively (Janssen et al., 2000). A similar 
activation mechanism has also been described for Follicular lymphoma 
(common type of non-Hodgkins`s lymphoma) exhibiting the reciprocal 
t(14;18)(q13;q21), in which the anti-apoptotic BCL2 gene on chromosome 18 
is juxtaposed to the IgH-Eµ enhancer on chromosome 14, and activated 
(Hockenbery et al., 1990). 
 The 11q13 region is involved in genetic rearrangements in a variety of 
human malignancies, including reciprocal translocations in B-cell neoplasms, 
unbalanced translocations or chromosomal inversions and frequent DNA 
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amplification in various carcinomas (Callanan et al., 1996; de Boer et al., 
1997; Gaudray et al., 1992). Cyclin D1 (CCND1) seemed to be a major 
candidate gene and has been described to be involved in B-cell lymphomas, 
breast tumors, and head and neck cancers (Callender et al., 1994; Dickson et 
al., 1995; Schuuring, 1995; Vaandrager et al., 1996). In breast cancer, 
amplification of the 11q13 locus has been correlated with a poor prognosis. 
The amplification is linked to lymph node metastasis and reduced survival 
(Cuny et al., 2000; Schuuring et al., 1992). 
Amplification at the chromosomal region 11q13 is also observed in 
esophageal squamous cell carcinomas (ESC) and many others types of solid 
tumors (Schuuring, 1995; Schwab, 1998; Yoshida et al., 1993). This amplification 
is suggested to be linked to the malignant phenotypes of ESC, such as 
invasiveness, metastasis, and poor prognosis (Adelaide et al., 1995; Shinozaki 
et al., 1996; Yoshida et al., 1993). Within the 11q13 amplicon, CCDN1 and 
EMS1 were the only genes known to be amplified and overexpressed; 
therefore these genes were the major candidate genes in tumors comprising 
an 11q13 amplification (Hui et al., 1997; Schuuring, 1995). As we localized the 
myeov gene in this same amplicon, our group investigated the possible 
involvement of myeov in ESC carcinogenesis, and found that the myeov was 
coamplified together with CCND1 in a great number of cell lines and primary 
tumors tested. However, myeov RNA overexpression was only detected in a 
subset of cell lines carrying myeov amplification. Aberrant methylation of the 
myeov promoter is responsible for this effect. Treatment of the cells with the  
demethylating agent 5-aza-2`-deoxycytidine restored myeov expression 
(Janssen et al., 2002).  
Zoo blot analysis of the myeov gene revealed that the myeov gene is 
present in monkeys and humans, but is not conserved in fish, frog, sheep, 
mice and rats. Northern blot analysis showed that myeov is poorly expressed 
in most human tissues. Interestingly myeov is overexpressed in pancreas tissue, 
and shows anomalous myeov transcripts.  
Transient expression of a GFP-MYEOV construct into Hela cells revealed 
expression in the endoplasmatic reticulum and in mitochondria. After 
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removing all of the myeov leucine-isoleucin tail, MYEOV proteins were 
localized in the mitochondria (unpublished data).  
Although we detected the human myeov gene in the DNA of tertiary 
tumors (section 1.2) we were never able to transform NIH/3T3 cells using 
myeov cDNA. A possibility that another human oncogene is present in these 
tertiary tumors therefore still existis. The complete cloning and sequencing of 
the human DNA present in these tertiary tumors (generally ~40 kb) should 
reveal whether this is the case. A computer search with the deduced MYEOV 
protein sequence did not detect any homology with known protein motifs or 
domains. Its possible function is therefore still enigmatic.  
 
1.2. Tumorigenicity assay  
 The NIH/3T3 focus assay (Shih et al., 1981) is a method to identify novel 
potential oncogenes. The method is based on the introduction of DNA from 
human tumors or cell lines into mouse fibroblastic cells NIH/3T3 by the calcium 
phosphate precipitation method (Graham and Eb, 1973) and screening for 
morphologically altered cells. Unfortunately there are human oncogenes 
which fail to promote changes in cells morphology. Because of this limitation, 
an in vivo assay variation of this analysis was created, named tumorigenicity 
assay (Brown et al., 1984; Fasano et al., 1984). In this assay, human tumor DNA 
is cotransfected together with plasmid DNA containing the neomycin 
selection marker into NIH/3T3 cells. Cells resistant to G418 are isolated and 
introduced subcutaneously into nude mice. The presence of an activated 
oncogene in the DNA may lead to tumor induction (primary tumor) in these 
nude mice. DNA from this primary tumor, containing the human activated 
oncogene, is isolated and the same transfection procedure is repeated 
again. A secondary tumor, now containing a small amount of human DNA 
encompassing the activated human oncogene is expected. A third 
transfection cycle may further purify the human oncogenic sequence, 
ending up with a tertiary tumor in which the human oncogene is the only 
human DNA present in these cells (Figure 1.1).  
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Figure 1.1. Two methods for identification of oncogenes. 
(A) The classical NIH/3T3 focus assay. Human tumor DNA is isolated and transfected 
into NIH/3T3 mouse fibroblastic cells by the calcium phosphate precipitation method. 
The cell which takes up an activated human oncogene, present in the human DNA, 
may change its morphology and will grow out to a focus of morphologically 
transformed cells. In this case, the focus of transformed cells is isolated and DNA is 
extracted and the cycle is repeated once more. (B) Tumorigenicity assay. Human 
tumor DNA together with plasmid DNA encoding a neomycin resistant gene are 
cotransfected into NIH/3T3 mouse fibroblastic cells by the calcium phosphate 
precipitation method. G418 resistant cells are subsequently introduced into nude 
mice by subcutaneous injection. In case an activated human oncogene is present in 
the transfected DNA, this will lead to tumor formation. Human activated oncogenic 
sequences can be further purified by repeating this procedure. Finally we end up 
with a secondary or tertiary mouse tumor in which the human activated oncogene is 
the only human DNA present in these cells.  
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DNA of this tertiary tumor can be digested with a restriction 
endonuclease, and the resulting restriction fragments are cloned into phage 
DNA, packaged, incubated with bacterial cells and plated on agar plate. 
Replica filters of the resulting phage plaques are hybridized with a 32P-labelled 
human repetitive Alu-fragment. Alu-repeat sequences are human specific, 
are present in high copy numbers (~600,000 copies dispersed in the human 
genome) and are not present in the mouse genome. Human alu-repeat 
positive plaques are picked, phage DNA is isolated and human genomic 
DNA inserts are further characterized by sequencing. The classical NIH/3T3 
assay and its variants allowed our group and others to detect several 
oncogenes (Table 1.1). 
 
Table 1.1. Detection of activated genes using the tumorigenicity assay                                  
Origin Transforming gene 
monocytic cell line Mas 
myeloproliferative disorder Ufo 
myeloproliferative disorder p85β/HUMORF8 
monocytic cell line Ret 
erythroblastic cell line Cot 
monocytic cell line Tre 
Neuroblastoma FGF4 (hst) 
chronic myelocytic leukemia Dbl 
Neuroblastoma B-raf 
stomach carcinoma Myeov 
Monocytic cell line Gef-h1 
 (Brecht et al., 2004; Janssen et al., 1999) 
 
1.3. Gene expression 
DNA is packed into chromatin, a nucleoprotein complex that includes 
both histone and non-histone proteins. Chromatin organization within 
chromosomes is not uniform, with two distinct regions: euchromatin and 
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heterochromatin. Heterochromatin domains are in general inaccessible to 
DNA binding factors and are transcriptionally silent. Euchromatic domains in 
turn are actively transcribed (Grewal and Moazed, 2003). 
 The expression of genetic information in all cells is very largely a one-
way system: DNA → RNA → Protein. DNA specifies the synthesis of RNA and 
then RNA specifies the synthesis of polypeptides, which subsequently form 
proteins. In order to express a gene, two successive steps are essential in all 
cellular organisms: transcription and translation (Strachan and Read, 2004). 
 
1.3.1. Transcription 
In the nucleus of eukaryotic cells DNA sequences are transcribed into 
RNA, in a complex mechanism called transcription. Although the transcription 
machinery of eukaryotes is much more complex than that of prokaryotes or 
archaea, the general principles of transcription and its regulation are 
conserved (Hahn, 2004). Transcription of eukaryotic and prokaryotic genes 
requires promoters and protein factors for transcription initiation (Landick, 
2001; Nickels and Hochschild, 2004; Tariverdian and Buselmaier, 2004). The key 
enzymes in this process are RNA polymerases. Bacteria and archaea have 
only one polymerease that is responsible for transcription (Hahn, 2004; Nickels 
and Hochschild, 2004). In contrast, the nucleus of eukaryotes contains three 
different RNA polymerases (Table 1.2)(Hahn, 2004; Zorio and Bentley, 2004).  
 
                  Table 1.2. Eukaryotic RNA polymerases  
Type Location Cellular transcripts 
I Nucleolus 18S, 5.8S, and 25-28S rRNA 
II Nucleoplasm mRNA precussors and snRNA 
III Nucleoplasm tRNA and 5S rRNA 
 
All these polymerases recognize distinct promoters. Promoters contain a 
group of short sequence elements that are clustered, upstream of the coding 
sequence of a gene. Promoters and other cis-acting elements are binding 
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sites for subunits of the transcriptional machinery (Hahn, 2004; Tariverdian and 
Buselmaier, 2004). The binding of a transcription factor promotes the 
recognition of the transcription start site by RNA polymerase, and in turn results 
in transcription initiation (Zorio and Bentley, 2004).                         
Besides promoters, there are other cis-acting elements that regulate 
transcription. These sequences are called operators and enhancers, and they 
are found in prokaryotes and eukaryotes, respectively. Operator sequences 
are recognized by repressor proteins which inhibit transcription that would 
otherwise occur from the promoters, and enhancer sequences are positive 
control elements recognized by activator proteins that stimulate transcription 
from the promoter. In addition, silencer sequences have been found in 
promoter regions; where binding of proteins to the sequences negatively 
influence gene expression (Smale and Kadonaga, 2003; Struhl, 1999; 
Tariverdian and Buselmaier, 2004).   
The effect of an enhancer or silencer can be blocked by the presence 
of an insulator sequence. In addition, insulators are able to establish 
independent domains of transcriptional activity within eukaryotic genomes 
(Fourel et al., 2004; Kuhn and Geyer, 2003).  
The first complementary copy of the DNA is called primary transcript or 
pre-mRNA. Primary transcripts suffer several modifications. The major changes 
in the mRNA are capping, splicing, and poly A site cleavage (McCracken et 
al., 1997a; McCracken et al., 1997b) which are briefly described below.   
 
1.3.1.1. mRNA processing 
When nascent RNA is about 22 – 40 bases long, the phosphate group of 
the triphosphate at the 5`end is hydrolyzed and the remaining diphosphate 
group attacks to the -phosphorus atom of GTP to form a 5`-5`triphosphate 
linkage. This special unusual linkage is called cap structure (Chiu et al., 2002; 
Moteki and Price, 2002; Rasmussen and Lis, 1993; Tariverdian and Buselmaier, 
2004). The cap is methylated by action of a methyltransferase, which adds a 
methyl group to the N7 position of GMP cap to form the transcript’s mature 
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m7G(5`)ppp(5`)N cap structure (Hirose and Manley, 2000). All transcripts 
derived from polymerase II are marked at their 5`ends with this cap structure 
(Zorio and Bentley, 2004), which protects the mRNA 5`end from exonucleases, 
facilitates splicing and transport to the cytoplasm, and supports binding of the 
40S subunit of ribosomes to the mRNA (Mamane et al., 2004; Moteki and Price, 
2002; Muthukrishnan et al., 1978; von der Haar et al., 2004).  
The second important modification of the pre-mRNA is splicing. Splicing 
is a process which removes the introns (sequences that usually do not code 
for protein sequence), and joins together the rest of the sequence (exons). As 
a consequence mature mRNA only contains exon sequences. The coding 
region (from the start to the stop codon) is called open reading frame, the 
rest of the exon sequences are defined 5`- and 3`UTR (Tariverdian and 
Buselmaier, 2004). Exons can be joined to each other in different 
combinations, which provide one single gene the opportunity to express 
several different transcripts, coding for different proteins.  
Splicing is mediated by a large RNA-protein complex, called 
spliceosome (Jurica and Moore, 2003; Tariverdian and Buselmaier, 2004). RNA 
splicing requires the nucleotide sequences at the exon/intron boundaries 
(splice junctions) to be recognized. In most of the cases, introns start with GU 
and end with AG (Strachan and Read, 2004; Tariverdian and Buselmaier, 
2004).   
Most mRNAs are processed at their 3`ends by cleavage and 
polyadenylation. A specific endonuclease recognizes the sequence AAUAAA 
and G/U rich sequence elements and cleaves the primary RNA at that site. 
Subsequently, a poly(A) polymerase adds 200 to 300 adenylate residues to 
the 3`end of the primary transcript (Barabino and Keller, 1999; Hirose and 
Manley, 2000; Tariverdian and Buselmaier, 2004). This terminus is called poly(A) 
tail, and is important for mRNA stability, transport of the mRNA to the 
cytoplasm and proper translation of the mRNA (Jacobson, 1996; Kaufmann et 
al., 2004). 
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1.3.2. Protein Synthesis 
Protein translation is the term given to a process where the information 
of the nucleotide sequences of the mRNA is translated into amino acid 
sequences. This special and key process takes place in the cells cytoplasm, 
and proceeds on ribosomes, where transfer RNA (tRNA) and diverse proteins 
cooperate to produce the building blocks of life – the proteins. 
 Protein synthesis in eukaryotes resembles the one found in prokaryotes, 
however, there are basic factors that will be discussed below that differ 
between these two systems. In general, protein synthesis in eukaryotes is more 
complex. 
In eukaryotes the start codon is generally an AUG (a few exceptions 
have been described where, ACG, CUG or GUG are used instead), albeit the 
methionine utilized differs from the one used in prokaryotes, since this one is 
not formylmethylated, and is called Met-tRNAi. In contrast to prokaryotic, 
eukaryotic mRNA is usually monocistronic. However, many plants and animal 
viruses produce dicistronic or polycistronic mRNAs, but still only the 5`cistron is 
translated. To enable viruses to translate these 3`cistrons, additional forms of 
mRNA are produced in which the downstream cistron is repositioned closer to 
the 5`end via splicing (Kozak, 2002b). 
In eukaryotes no Shine-Dalgarno like sequences have been identified, 
but eukaryotic mRNAs posses a cap structure at their 5`end, which is 
extremely important for initiation of ribosome scanning, and it will be 
discussed later in further detail.  
Eukaryotic ribosomes are larger than prokaryotic ribosomes, exhibiting a 
mass of 4200 kDa. They also consist of two subunits: one large (60S) and one 
smaller (40S). The large subunit contains three RNAs: 5S, 25-28S and 5.8S 
(Granneman and Baserga, 2004; Nissan et al., 2002). The first two are 
counterparts of the prokaryotic ribosomal RNAs 5S and 23S, and the last one 
(5.8S) is exclusively present in eukaryotic ribosomes. The small subunit contains 
an 18S RNA that is homologous to the prokaryotic 16S RNA. There are three 
binding sites for tRNA on the ribosome: an A site, to which aminoacyl tRNAs 
are delivered in an mRNA-directed fashion, a P site where petidyl tRNAs 
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reside, and an E site through which deacylated tRNAs pass as they are 
released from the ribosome (Moore and Steitz, 2003; Roll-Mecak et al., 2001). 
For a more extensive description of the ribosome structure and its biogenesis 
see: (Dahlberg, 2001; Granneman and Baserga, 2004; Moore and Steitz, 2003; 
Nissan et al., 2002). 
In contrast to prokaryotes where translation initiates immediately after 
transcription, eukaryotic mRNAs are first processed and specific modifications 
are made (section 1.3.1.1) before the mRNA can be transported to the cell’s 
cytoplasm, where ribosomes will have access to the mRNA in order to start 
protein synthesis.  
The most important checkpoint in protein translation is considered to be 
the initiation step, which is facilitated by proteins called eukaryotic initiation 
factors (eIFs). In eukaryotic system, there are more than ten eIFs involved in 
translation initiation (Preiss and Hentze, 2003). The factors that are involved in 
translation initiation are known and they are used to describe the model of 
protein translation called cap-dependent translation (Merrick and Hershey, 
1996). According to this model (Figure 1.2), the 5`cap structure attracts the 
initiation factor eIF4E, which in turn recruits the cap-binding complex eIF4F. 
This complex consists of the DEAD-box RNA helicase eIF4A, eIF4G and even 
eIF4E itself. The factor eIF4E binds to the N terminus of eIF4G, which acts as an 
adaptor because it contains also a binding sites for eIF4A, poly(A) binding 
protein (PABP) and eIF3. The factor eIF4A, together with the RNA-binding 
protein eIF4B or eIF4H (not shown in the Figure), is believed to melt the RNA 
secondary structures near to its 5`end (Dever, 2002; Svitkin et al., 2001). In 
summary, binding of the cap-structure to the eIF4F complex recruits the 43S 
complex.  
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Figure 1.2. The translation initiation pathway (Preiss and Hentze, 2003) 
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The eIF2 has the important responsibility to bind to Met-tRNAi. Since the 
GDP-bound form of eIF2 generated by each initiation cycle cannot bind 
MetRNAi, it requires the action of the guanine nucleotide exchange factor 
(GEF) eIF2B. The eIF2 with GTP bind to MetRNAi creating a ternary complex 
(Preiss and Hentze, 2003). The factors eIF1, eIF3 and eIF5 interact with the 
ternary complex forming a so called in yeast multi factor complex (MFC).  
Binding of the ternary complex to the 40S ribosomal subunit is aided by eIF1, 
eIF1A, and the multisubunit factor eIF3, creating a 43S complex (Dever, 2002; 
Preiss and Hentze, 2003).  
Finally, the 43S complex binds to the 5`end of the mRNA through 
interactions of eIF3 with the central part of eIF4G (Macdonald, 2001) and 
starts to scan the mRNA to the 3`end direction “searching” for an AUG start 
codon in an optimal context (Kozak, 1989). This scanning process requires ATP 
hydrolysis. Once the AUG codon is recognized, the GTP associated with eIF2 is 
hydrolyzed to GDP in a reaction that requires factor eIF5. Next, many of the 
initiation factors are believed to dissociate from the 40S subunit, leaving only 
the Met-tRNAi in the P site already base-paired to the AUG codon of the 
mRNA, completing the initiation phase of protein synthesis. Next, the factor 
eIF5B facilitates the joining of the 60S ribosomal subunit. Once the 60S subunit 
binds the 40S subunit, a complete 80S ribosome is formed, and translation 
elongation begins (Nielsen et al., 2004). The factor eIF5B in turn hydrolyses its 
GTP and is released from the 80S ribosome. The 80S ribosome carrying the 
tRNAs has the important task to scan the mRNA adding the corresponding 
anticodons until it reaches a stop codon and protein synthesis is terminated 
(Figure 1.2) (Preiss and Hentze, 2003). 
 
1.4. Perfect start codon 
 Specific sequences modulate the efficiency of a ribosome to recognize 
an AUG start codon during the scanning process. In vertebrate mRNAs, the 
initiation site usually compromises all or part of the sequence GCCRCCAUGG. 
The most highly conserved base in this sequence is the purine, usually A, at 
Introduction 
 
 20
position -3. The counting starts at AUG, where the adenosine in the AUG 
(bold) is designed +1 (Kozak, 1986; Kozak, 1989; Kozak, 1991c). The G in 
position +4 is highly conserved especially in the absence of A in the position -3 
(Kozak, 1997). As long as positions -3 and +4 follow the so called Kozak rule, 
the rest of the motif (GCC) seems to be less important. However, in the 
absence of the important bases in positions -3 and +4, the upstream GCC 
motif strongly contributes to the efficiency of a ribosome to recognize the 
start codon (Kozak, 1987b).  
 
1.5. Cap-Independent Translation 
As mentioned previously, the cap structure located at the 5`end of the 
mRNA has an important role recruiting the 40S ribosomal subunit through 
interactions with initiation factors. Consequently the mechanism of translation 
is dependent on the cap structure, and therefore, is called cap-dependent 
mechanism. Cap-dependent translation is not the only way to translate 
mRNAs. Translation initiation by internal ribosome entry is an alternative 
mechanism whereby the 40S ribosomal subunit binds to the mRNA at or near 
the authentic AUG codon, independent of the cap structure, and therefore 
enables these mRNAs to be translated by a so called cap-independent 
translation.  
The best understood example of cap-independent translation occurs 
by certain picornaviruses. The picornavirus family includes several pathogens 
of both humans (e.g., poliovirus, coxsackievirus, and hepatitis A viruses) and 
animals (e.g., foot-and-mouth disease virus and encephalomyocarditis virus) 
(Hellen and Sarnow, 2001; Zamora et al., 2002). Recently, it has been 
demonstrated that also cellular mRNAs can be translated by a cap-
independent mechanism. This mechanism could be advantageous in 
situations where cap-dependent translation is inhibited, e.g. during apoptosis 
or hypoxia. During apoptosis activated caspases cleave several initiation 
factors, including eIF4G, inhibiting in this way the cellular cap-dependent 
translation (Marissen and Lloyd, 1998). In this situation it could be imagined 
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that some mRNAs encoding important proteins for these processes would be 
translated by a cap-independent mechanism.  
The initiation factors involved in translation of mRNAs mediated by 
internal ribosome entry are still not well characterized. The 5`end of 
picornavirus family mRNAs have a 5`-pUp terminus, instead of the common 5`-
cap structure (Nomoto et al., 1977). This peculiar feature suggests that 
translation of this mRNA does not require the eIF4E, because the function of 
this initiation factor is to bind to the cap-structure and together with eIF4F 
complex recruit the ribosome to the cap structure. Indeed inhibition of eIF4E 
did not alter IRES-dependent translation and thus confirmed this hypothesis 
(Canaani et al., 1976; Pause et al., 1994). The fact that picornavirus rapidly 
inhibits translation of capped cellular mRNAs in infected cells support this 
finding (Macejak and Sarnow, 1991; Sarnow, 1989; Yang and Sarnow, 1997). 
When mammalian cells are infected by picornavirus, the factor eIF4G is 
cleaved by action of virus-encoded proteinases 2Apro (entero- and rhinovirus) 
or Lpro (aphthovirus) (Haghighat et al., 1996; Lamphear and Rhoads, 1996; 
Ventoso et al., 1998). Cleavage of eIF4G preclude infected cells from using 
the cap-dependent initiation mechanisms, instead of that, viral translation 
proceeds via cap-independent mechanism that require a cis-acting internal 
ribosome entry site (IRES) on the mRNA (Gan et al., 1998). In this way, eIF4G 
mediated the shut down of cap-dependent mechanisms and in turn 
activated cap-independent mechanisms (Gan et al., 1998). 
In order to confirm that translation of RNAs from these viruses occur in a 
cap-independent manner, the 5`UTR of EMCV and poliovirus were placed 
into the intercistronic spacer region of a bicistronic mRNA. These sequences 
were able to support translation of the second cistron independent of 
translation of the fist cistron. This discovery demonstrated that these virus 
5`UTRs contain an IRES and can be translated independently of the cap-
structure (Jang et al., 1988; Jang et al., 1990; Jang and Wimmer, 1990; 
Pelletier and Sonenberg, 1988). BiP, the gene that codes for the 
immunoglobulin heavy chain binding protein, was the first cellular mRNA 
described to contain an IRES, and was found in cells infected by poliovirus, 
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where translation of the host mRNA was inhibited (Macejak and Sarnow, 1991; 
Sarnow, 1989; Yang and Sarnow, 1997). After this discovery, several other 
cellular mRNAs have been reported to contain an IRES by application of the 
bicistronic assay, e.g., antennapedia (Ye et al., 1997), fibroblast growth factor 
2 (Vagner et al., 1995), platelet-derived growth factor B (PDGF2/c-sis) 
(Bernstein et al., 1997), vascular endothelial growth factor (Miller et al., 1998; 
Stein et al., 1998), insulin like growth factor II (Teerink et al., 1995), the 
transcription repressor Mnt (Stoneley et al., 2001), the X-chromosome linked 
inhibitor of apoptosis XIAP and c-myc (Nanbru et al., 1997). Interestingly, many 
translation products of cellular mRNAs described to contain an IRES play a 
role in growth control. 
Although IRES mediated translation is independent from some initiation 
factors, including eIF4E, footprinting and mutagenesis analysis have recently 
demonstrated that the eukaryotic factors 4G and 4A mediate conformational 
changes downstream of the initiation codon of the EMCV IRES. This process is 
ATP-independent and is used to prepare a site on the IRES to which the 
ribosome can bind efficiently (Kolupaeva et al., 2003). In fact, it has been 
suggested that internal initiation in picornavirus translation requires all 
canonical eukaryotic initiation factors that are also used for a cap-
dependent translation mechanism, except for eIF4E (Lomakin et al., 2000; 
Pestova et al., 1996; Pilipenko et al., 2000). In addition, five cellular trans-
acting factors (ITAFs) specific for picornavirus IRES mediated translation have 
also been identified, four of them are RNA-binding proteins:  
 
(a) The polypyrimidine tract-binding protein (PTB)(Kolupaeva et al., 
1996; Niepmann et al., 1997). 
(b) The poly (rC)-binding protein 2 (PCBP2)(Blyn et al., 1996; Gamarnik 
and Andino, 2000; Walter et al., 1999). 
(c) The autoantigen La (Costa-Mattioli et al., 2004; Holcik and Korneluk, 
2000; Kim et al., 2001; Ray and Das, 2002).  
(d) The RNA binding  protein Unr (Boussadia et al., 2003; Brown and 
Jackson, 2004; Hunt et al., 1999; Mitchell et al., 2003). 
(e) The cell cycle dependent protein ITAF45  (Pilipenko et al., 2000). 
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Functional in vitro assays showed that a combination of two or three of 
these ITAFs are required for a cap-independent IRES mediated translation 
initiation (Pilipenko et al., 2000). In XIAP mRNA, for example, analysis by UV 
cross-linking experiments demonstrated that the autoantigen La is an essential 
part of the XIAP IRES ribonucleoprotein (RNP) complex. However PTB and 
PCBP do not bind to this complex (Holcik and Korneluk, 2000). In addition, 
other ITAFs were identified that bind to the XIAP IRES, i.e. two heterogeneous 
nuclear ribonucleoproteins (hnRNPC1 and C2) (Holcik et al., 2003). These 
ribonucleoproteins are known to be involved in different steps of RNA 
biogenesis, including splicing (Choi et al., 1986), RNA turnover (Hamilton et al., 
1993) and polyadenylation (Wilusz and Shenk, 1990). It has been reported that 
the hnRNPC1 and hnRNPC2 do not only mediate IRES-dependent XIAP 
translation, but has also been shown to bind to the IRESes of PDGF/c-sis (Sella 
et al., 1999) and p27 mRNAs (Kullmann et al., 2002; Millard et al., 2000). Further 
evidence for additional cellular proteins being important for IRES utilization is 
provided by the observation that IRES containing cellular mRNAs do not 
function properly in a cell-free translation system or in RNA transfection assays, 
suggesting that these identified IRESes need a nuclear event (Iizuka et al., 
1995; Stoneley et al., 2000). 
 Interestingly the 5` UTR of the identified mRNAs that are translated by a 
cap-independent mechanism, are long, contain uAUG codons, and are G-C 
rich forming stable secondary structures that may block ribosome scanning 
during cap-dependent translation.  
 
1.6. Assays used to determine IRES activity 
 Several types of assays are widely used to analyze whether a specific 
sequence harbors an IRES. The bicistronic assay is considered to be the gold 
standard (Figure 1.3). In this assay, the sequence under scrutiny is placed in 
an intercistronic region between two reporter genes, and transiently 
transfected into cells. The DNA is transcribed into RNA using a promoter 
located upstream of the first cistron. If the sequence does not contain an IRES, 
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the ribosome will leave the mRNA after translation of the first reporter gene 
(Figure 1.4 pathway 1). However, if the inserted sequence contains an IRES, 
translation of the second cistron will be mediated by the IRES, and activities of 
both reporter genes will be measured. The critical question in this kind of assay 
is whether the inserted sequence stimulates the expression of the second 
cistron to a level comparable to that of the first cistron. Cases where the 
downstream cistron is translated at a level less than 10% of the expression of 
the first cistron should be considered with some suspicion (Jackson et al., 
1995).  
 
 
Figure 1.3. Cap dependent and IRES-dependent translation. 
The vector contains two open reading frames: Renilla luciferase (RL) and Firefly luciferase (FL), 
respectivly. The transcription is driven by the promoter located upstream the RL cistron. The 
transcribed RNA contains a cap-structure and a poly (A) tail. In order to start protein synthesis, 
the 40S ribosomal subunit associates with transcription factors, recognizes the cap-structure 
and scans the mRNA until the AUG codon of the RL cistron is encountered. After translation of 
RL, the ribosome dissociates from the mRNA. The FL cistron is not translated. (B) The DNA 
contains an IRES sequence upstream the FL cistron. Transcription is still driven by the promoter 
encountered upstream the RL cistron. In this situation, two proteins are produced from only 
one mRNA. This is possible because the ribosome still can bind to the cap-structure and 
translate the RL cistron (pathway 1). In addition, the ribosome can also bind to the IRES 
sequence, and start translation of the FL cistron (pathway 2). The complete 80S ribosome is 
depicted in red. AUG and UGA corresponds to start and stop codon, respectively.  
 
It is also common to place an inverted sequence upstream of the first 
cistron. This sequence which forms a stable hairpin when transcribed has the 
power to block ribosome scanning, and therefore abolishes expression of the 
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first cistron (Bernstein et al., 1997; Blaschke et al., 2003). In contrast, expression 
of the second cistron should not be severely altered if the intercistronic  
sequence contains an IRES. The addition of a hairpin without careful analysis 
of the mRNA can still fail to prove that an inserted sequence contains IRES 
activity, because the presence of cryptic promoter or splice sites in the 
sequence under investigation may interfere with this assay. For that reason, 
the sequence under scrutiny should pass other control assays. For example, 
one should verify whether the putative IRES can function in an in vitro assay. In 
this assay, the DNA is transcribed using a T3 or T7 promoter in vitro followed by 
translation using a rabbit reticulocyte lysate. If the sequence analyzed 
contains an IRES, the second cistron should be translated. Unfortunately the 
interpretation of the results may be hampered by two different observations. 
1) It has been described that the reticulocyte lysate system may initiate 
translation at a number of incorrect sites on some mRNAs (Borman and 
Jackson, 1993; Dorner et al., 1984). 2) It is also possible that ITAFs that are 
required for a perfect IRES function are not present in the rabbit reticulocyte 
lysate. This possibility was described for poliovirus and rhinovirus IRESes which 
were not active in an vitro assay unless the lysate was supplemented by HeLa 
cell extracts (Borman et al., 1993; Brown and Ehrenfeld, 1979; Dorner et al., 
1984). 
Another assay should be performed to verify whether the putative IRES 
encompass a cryptic promoter. For this purpose, one should simply remove 
the promoter of the construct and look for reporter gene activity. If the 
sequence does not contain a cryptic promoter, no transcription should occur 
and no translation of the reporter gene should be measured. If the sequence 
under investigation encloses a promoter sequence, transcription and 
subsequently translation will occur. In this case the presence of the promoter 
may be detected by Northern Blot analysis. However, the promoter has to be 
strong enough to be detected by this kind of analysis. It has been reported 
that the level of translation of the second cistron should be at least 5% of that 
of the first cistron, in order to be able to observe the transcript by Northern 
blot analysis (Kozak, 2003).  
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Transfection of the bicistronic mRNA directly into the cells has also been 
performed to confirm the presence of an IRES in the sequence investigated. 
In this assay, the RNA is transcribed in vitro and directly used for transient 
transfection into cells. Expression of the second cistron should occur.  
 
1.7. Leaky scanning  
 Translation initiation usually starts at an AUG codon that is near the 
mRNA 5` end, and is embedded in an optimal “environment” represented by 
the nucleotide sequence GCCRCCAUGG (section 1.4). In this situation all or 
almost all ribosomes stop scanning and initiate protein synthesis on that AUG. 
However, when the AUG resides in a very weak context, lacking both, R in 
position -3 and G in position +4, some ribosomes may initiate at that point but 
most continue scanning and initiate farther downstream. This process is called 
leaky scanning and allows producing two proteins from only one mRNA 
(Kozak, 2002b). A list of examples can be found in Table 3 of Kozak, M (Kozak, 
2002b). There are also rare cases of leaky scanning where the first AUG resides 
in a good context (R-3 and G+4) that is bypassed by the ribosome which starts 
at a downstream AUG. This may occur when the first AUG codon is too close 
to the 5`end to be recognized efficiently (Kaneda et al., 2000; Kozak, 1991b; 
Slusher et al., 1991; Spiropoulou and Nichol, 1993; Werten et al., 1999) or when 
the positive effect of the G in position +4 is counteracted by an U in position 
+5 (Kozak, 1997; Sloan et al., 1999; Stallmeyer et al., 1999). There are 
mammalian mRNAs however that completely lack a start codon in an 
optimal context (Arai et al., 1991; Hickey and Roth, 1993; Leslie et al., 1992; 
McNeil et al., 1992; Plowman et al., 1990; Wu et al., 1993). A good example of 
leaky scanning is the c-myc gene. The c-myc gene produces three proteins 
from only one mRNA. The first start codon has the sequence AGGCUGG, 
producing a 68 kDa long protein. The second start codon has the sequence 
ACGAUGC, leading to a protein of 65 kDa, which is the predominant form of 
the C-MYC protein. The last start codon has the sequence GAGAUGA, 
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leading to a protein of 50 kDa. Only a small amount of long protein is 
translated (68 kDa), because its start codon is not an AUG. The second start 
codon contains an AUG and even an A in position -3, however still some 
ribosomes bypass that site and initiate at the next AUG. This can happen 
because the first AUG is in a good but still not perfect context. This was 
confirmed by mutagenesis analysis, where the first AUG was changed into a 
perfect start codon. In this case the small protein was not detectable (Spotts 
et al., 1997). When discussing leaky scanning, one should also mention the 
process of ribosome reinitiation in which the ribosome may resume scanning 
of the mRNA after translation of a small peptide. This matter will be discussed 
in more details in the section about upstream open reading frames (section 
1.9). 
 
1.8. Ribosome shunting 
Ribosome shunting is the mechanism in which ribosomal subunits bind to 
the mRNA in a 5`cap-dependent manner and scan downstream until a stable 
RNA structure is encountered that may arrest the scanning ribosome or cause 
its dissociation from the mRNA. This arrest is followed by intramolecular 
shunting of the ribosomal subunit to a downstream site, bypassing in this way 
some of the RNA structure, and the ribosome resumes scanning until the next 
appropriate start codon is reached (Hellen and Sarnow, 2001).    
 
1.9. Upstream open reading frame 
 Usually the 5`UTR sequence of the mRNA is short and the mRNA itself 
contains only one open reading frame. In fact, less than 10% of cellular 
mRNAs have a long 5` UTR and contain one or more upstream AUG (uAUG) 
codons. The uAUG codons often create small open reading frames (uORFs). 
(Kozak, 1987a). Although uORFs are rare they represent a common feature of 
genes involved in the control of cellular growth and differentiation (Kozak, 
1987a; Kozak, 1991a; Morris, 1995), including two-third of the oncogenes.  
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uORFs usually exhibit three potential configurations following uAUG 
codons (Figure 1.4) (Geballe and Sachs, 2000):  
 
1) Nonoverlapping – a nonoverlapping uORF is the one which has the 
termination codon located in the 5`UTR. 
2) Overlapping – an overlapping uORF has its termination codon 
located somewhere in the main ORF. 
3) In frame – in frame is the uORF that is in frame with the main ORF and 
ends at the same termination codon.   
 
 
Figure 1.4. Three possible configurations of ORFs following upstream AUG codons.  
 
Features that regulate protein synthesis of any uORF, seems to be 
identical to those described for major ORFs, e.g. the context of its start codon  
(R-3 and G+4)(section 1.4); its secondary structure and the proximity of the AUG 
codon to the cap structure (Cao and Geballe, 1995; Kozak, 1999; Ruan et al., 
1994; Wang and Sachs, 1997; Werner et al., 1987). 
Unfortunately, the signals that are responsible for the mechanisms 
involved in reinitiation or continued scanning after translation of the uORF are 
not completely understood. Some possibilities for the ribosome after 
translation of the uORF are described below: 
 
1) The ribosome dissociates from the mRNA – one possibility is that the 
ribosome may encounter structures that facilitate the dissociation from the 
mRNA, or the ribosome may leave the mRNA just because the ribosome has 
finished already its function in translating an uORF. In this case, translation of 
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the downstream AUG would not occur, and this uORF would have the 
function of blocking protein translation of the downstream ORF.  
 
2) The ribosome remains associated with the mRNA – another possibility 
is that the ribosome remains associated with the mRNA, continues scanning, 
and reinitiates at either a proximal or distal AUG codon (Cao and Geballe, 
1995; Mize et al., 1998). The problem in this situation is that the ribosome may 
need to reacquire some initiation factors, especially eIF2-GTP which carries 
the Met-tRNAi in order to reinitiate at a downstream AUG codon (Hinnebusch, 
1996). In agreement with that, a longer “spacing region” between the stop 
codon of the uORF and the following start codon would result in a higher 
probability of the ribosome to reacquire the necessary initiation factors 
(Kozak, 1998). This mechanism has been confirmed for translation of the GCN4 
mRNA by demonstrating that an increase of the intercistronic space to up ~80 
nucleotides  reduces or eliminates the inhibitory effect of the uORF in some 
cases (Child et al., 1999; Kozak, 1987c).   
 
3) The ribosome stalls – the ribosome may also stall after translation of 
the uORF, or even during elongation, thereby blocking protein translation by 
prohibiting the following ribosome from continued scanning. This has been 
observed in S. cerevisiae CPA1 and Neurospora crassa arg-2 uORFs (Wang et 
al., 1998; Wang et al., 1999). Interestingly, ribosome stalling after translation of 
the arg-2 and CPA1 uORF even after removal of the termination codons of 
the respective uORFS was observed (Wang et al., 1998; Wang et al., 1999).  
 
 4) mRNA stability – mRNAs harboring imperfect messages containing  
premature translational stop codons are recognized and degraded by a 
process called nonsense-mediated decay (Belgrader et al., 1994; Cheng and 
Maquat, 1993; Whitfield et al., 1994). Transcripts containing uORFs as a result 
of mutations are sensitive to NMD. However, most described wild type uORF 
transcripts are not degraded by this pathway  (Ruiz-Echevarria et al., 1998; 
Vilela et al., 1998), because they have  stabilizer elements (STEs) that are able 
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to inactivate the NMD pathway (Ruiz-Echevarria and Peltz, 2000). However, 
the yeast CPA1 uORF mRNA is degraded via the NMD (Ruiz-Echevarria and 
Peltz, 2000). The NMD machinery is conserved from yeast to humans (Couttet 
and Grange, 2004). However, the premature termination codon transcripts 
found in Drosophila are degraded by a mechanism that differs from the 
degradation mechanism found in yeast and mammals (Cao and Parker, 
2003; Lejeune et al., 2003; Mitchell and Tollervey, 2003). 
 
 In summary, the examples mentioned above clearly demonstrate that 
upstream open reading frames regulate biosynthesis by interference and/or 
regulation of translation efficiency. Some examples concerning the relation 
between uORFs and diseases are find in the discussion section.  
 
1.10. Objective of this work  
Overexpression of the myeov gene in a subset of t(11;14) positive 
multiple myeloma cell lines and esophageal squamous cell carcinomas, and 
its localization in a critical chromosomal region suggest that myeov may play 
a role in carcinogenesis. At the same time we observed myeov amplification 
and overexpression on an mRNA level in different cells without being able to 
detect any MYEOV protein. Special features of the myeov 5`UTR, like its length 
of ~450 nucleotides, the presence of four uAUGs encoding four uORFs and its 
high GC content enabling it to form a highly stable secondary structure, 
might be an explanation for this phenomenon. We therefore conducted 
further studies to characterize the myeov gene with the following objectives: 
1) a search for MYEOV interaction partners in order to be able to elucidate 
the biological function of the MYEOV protein, 2) characterization of its 5`UTR 
sequence in order to delineate the mechanisms involved in the regulation of 
MYEOV biosynthesis.  
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2. Materials and Methods 
2.1. Materials 
2.1.1. Equipment 
Bio-freezer (-80ºC)  Forma Scientific 
Biofuge pico  Heraeus 
Certoclav (autoclave)  LGA 
Contact thermomether MR 3002  Heidolph 
Digital graphic printer  Sony 
DNA sequencer long read 4200 and 4300  Li-cor 
E. coli pulser DNA electroporator  Bio-Rad 
Easy cast electrophoresis  Angewandte Gentechnologie 
Electophoresis camera  Bethesda Research 
Epichemi II darkroom  UVP 
Galaxy mini centrifuge (for PCR tubes)  Merck 
Icemaker B-3905  Scotsman 
Incubator (cell culture)  Heraeus 
Incubator shaker model G25  New Brunswick Scientific 
Lucy 2 (Luciferase assay)  Rosys Anthos 
Mettler delta 320 (pH meter)  Mettler Toledo 
Microflow biological safety cabinet  Intermed Nunc 
Microscope 090-131-001  Leica 
Microwave oven 9023  Privileg 
Mini centrifuge  National Labnet Co. 
Optimax X-ray film processor 1170-1-0000  Protec Medizintechnik 
Orbital shaker  Forma Scientific 
Peltier thermal cycler PTC-200  MJ Research 
Power pac 3000 (power supply)  Bio-Rad 
Precision weigher FA 3100-2iCE Faust 
Reax 2000 (vortex)  Heidolph 
Refrigared centrifuge RC-5B  Sorvall 
Refrigared centrifuge RC-5B plus  Sorvall 
Refrigerated centrifuge 5417  Eppendorf 
Sealboy 235  Audion Elektro 
Speed vac  Savant 
Superspeed centrifuge  Du Pont Instruments 
Thermomixer 5436  Eppendorf 
Ultrospec 2000 (spectrophotometer)  Pharmacia Biothech 
UV stratalinker 2400  Stratagene 
UV table foto prep I Fotodyne 
Varifuge 3.9 R  Heraeus 
Vortexer reax 2000  Heidolph 
Water bath type 1012  Faust 
Wide mini sub cell  Bio-Rad 
X-cell sure lock  Invitrogen 
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2.1.2. Chemicals 
2- Mercapto-ethanol Roth 
3-Aminophthalhydrazide; Luminol Sigma 
Ammonium acetate Applichen  
Ammonium chloride Merck 
Ammonium persulfate Sigma 
Ammonium sulfate Sigma 
Ampicillin Sigma 
Aqua ad injectabila Braun 
Bacto® trypton BD 
Bacto® yeast extract Difco   
Bromophenol blue Schmid  
Calf intestine phosphatase  Roche 
Coomasie blue R250 Merck  
Diethylpyrocarbonat (DEPC) Roth 
DMEM high glucose PAA 
DMEM/Ham´s F-12 (1x) PAA 
DMSO J.T. Baker 
dNTPs MBI 
DTT Sigma 
ECL® Amersham 
Ethanol absolut Riederl-de-Haen 
Ethidium bromid Merck 
Ethylenediamine-tetraaceticacid Roth 
Ficoll 400 Pharmacia 
Fetal calf serum  PAA   
Formaldehyde solution J.T. Baker 
Formamide solution J.T. Baker 
GenRuler® 100 bp and 1 Kb DNA ladder MBI 
Glycerol Roth 
Glycogen Roche 
HEPES Roth 
Imidazol Serva 
IPTG (isopropyl-β-D-1-thiogalactopyranosid) Sigma 
Long ranger® gel solution BMA 
Methanol  Merck 
Nonfat dry milk Nestlé 
NZY broth Gibco BRL 
Orange G Sigma 
PBS PAA 
Phenol/chloroform/isoamylalcohol 25:24:1 Roth 
Ponceau S solution Sigma   
Potassium acetate Gerbu   
Potassium chloride Riedel-de-Haen 
Propanol Merck 
Proteinase K Sigma 
Rothiphorese® gel 40 (29:1) Roth 
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SDS Roth 
SeeBlue® Plus2 prestained standard Invitrogen 
Select agar Invitrogen 
Spermidin Sigma 
TEMED Pharmacia 
Tetracycliin Sigma 
Tris Sigma 
Triton X-100 Fluka 
Trypsin/EDTA (1x) PAA   
Tween 20 Roth 
Urea Pharmacia 
X-Gal Roth 
Yeast extract Difco 
 
2.1.3. Buffers 
BBS 50 mM BES/HCl, pH 6.95 
 280 mM NaCl 
 1.5 mM Na2HPO4 
    
Bloting (10 x) 47.9 mM Tris/HCl, pH 6.8 
 38.6 mM Glycine 
 0.037 % SDS 
    
CIP (10 x) 100 mM Tris/HCl, pH 8.0 
 10 mM MgCl2 
 10 mM ZnCl2 
    
Denaturation buffer 0.5 M NaOH 
 1.5 M NaCl 
    
Denhardt´s (100 x) 2 % Ficoll 
 2 % BSA Fraktion V 
 2 % Polyvinylprolidon type 360 
    
Electroporation (5 x) 125 mM Tris/HCl, pH 6.8 
 1.25 mM Glycine 
 0. 5 % SDS 
 20 mM EDTA 
    
Hybridization mix 10 X Denhardt´s 
 10 % Dextran sulfate 
 1 % SDS 
 3 X SSC 
 50 mg/l Salm DNA 
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SSC (20 x) 3 M NaCl 
 0.3 M Sodium citrate, pH 7.0 
    
SSC wash mix (3 x) 3 X SSC 
 0.1 % SDS 
    
SSC wash mix (0.3 x) 0.3 X SSC 
 0.1 % SDS 
    
TBE (10 x) 0.9 M Tris 
 0.9 M Boric acid 
 20 mM Na2EDTA, pH 8,3 
    
TBS 10 mM Tris/HCl, pH 7,4 
 150 mM NaCl 
    
TBS-T TBS + 0.05% Tween 20 
    
TE 10 mM Tris/HCl, pH 7.5 
 1 mM EDTA 
    
10 x Ligase 500 mM Tris/HCl, pH 7.8 
 100 mM MgCl2 
 100 mM DTT 
 10 mM ATP 
 500 µg/ml BSA 
    
Neutralization 0.5 M Tris/HCl, pH 7.5 
 3 M NaCl 
    
Ponceau S 0.2 % Ponceau S 
 3 % Tri-Cl-acetic acid in water 
 
2.1.4. Enzymes 
Calf intestine phosphatase  Roche 
Pfu DNA polymerase  Promega 
RNase A   Roche  
T4 DNA ligase  Promega 
Taq DNA polymerase  Gibco 
 
All restriction endonucleases inclusive the respective buffers were purchased 
from New England Biolabs, Roche and MBI Fermentas. 
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2.1.5. Special materials 
96-well plate (for luciferases measurements) Nunc 
BioMax MS film Kodak 
BioMax MS intensifying Kodak 
BioMax XAR film Kodak 
Cell culture flasks and plates Greiner 
Disposable filters unit: 0.2 and 0.45 µm Schleicher & Schuell BioScience  
Electroporation cuvette 1.0 mm Equibio and Bioenzym 
Falcon tube 2059  Becton Dickinsons  
Folded filters 240 mm Schleicher & Schuell BioScience 
Hematocytometer 0.0025 mm2 Brand 
Hybond™-N Amersham Biosciences 
Hypercassete Amerscham Biosciences 
Precision quartz cuvette  Hellma 
Precision wipe tissue Kimberly-Clark 
Protein gel cassette 1.0 mm Invitrogen  
Protran® nitrocellulose membrane Schleicher & Schuell BioScience 
 
2.1.6. Special reagents and kits 
Cycle Reader™ Auto DNA Sequencing Kit MBI Fermentas 
DNA Gel Extraction Kit  Montage 
Dual Luciferase Reporter Assay System Kit Promega 
ECL Kit   Amerscham Biosciences 
Fugene  Roche 
Gene Juice® Transfection Reagent Novagen 
Genelute™ Direct Mrna Miniprep Kit  Sigma 
Genelute™ HP Plasmid Maxiprep Kit  Sigma 
Hexalabel™ DNA Labeling Kit  MBI Fermentas 
High Pure RNA Isolation Kit  Roche 
Mmessage Mmachine™   Ambion 
Mrna Isolation Kit  Roche 
PCR Polishing  Stratagene 
Pgem® - T Easy Vector System I  Promega 
QIAEX® II Gel Extraction Kit  Qiagen 
Qiafilter™Plasmid Maxi Kit Qiagen 
Quikchange® Multi Site-Direct Mutagenesis Stratagene 
Rneasy Minelute Cleanup Kit  Qiagen 
TNT® Coupled Reticulocyte Lysate Systems Promega 
Transmesseger™Transfection Reagent  Qiagen   
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2.1.7. Bacterial strains 
Strain Genotype 
DH10B F- mcrA ∆(mrr-hsdRMS-mcrBC) 80lacZ∆M15 ∆lacX74 recA1 
endA1 ara∆139 ∆(ara, leu)7697 galU galK λ- rpsL (StrR) nupG 
  
DH5 F- 80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, 
mk+) phoA supE44 λ-thi-1 gyrA96 relA1  
  
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) 80lacZ∆M15 ∆lacX74 recA1 
ara∆139 ∆(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
  
XL10 – Gold Tetr∆ (mcrA) 183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac Hte (F`proAB laclqZ∆M15Tn10 (Tetr) Amy 
Camr)a  
  
XL-2 Blue 
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac (F`proAB 
laclqZ∆M15Tn10 (Tetr) Amy Camr)a 
 
2.1.8. Cultivation 
 E. coli was cultivated overnight in Luria Bertani medium (LB-medium) at 
37ºC under vigorous shaking. When required, antibiotic was added to the 
medium in order to make selection (Table 2.1). 
 
Table 2.1. Stock and working solution of antibiotic 
Antibiotic Stock solution concentration Working concentration 
Ampicillin 50 mg/ml in water 100 µg/ml 
Chloramphenicol 34 mg/ml in ethanol 34 µg/ml 
Kanamycin 10 mg/ml in water 50 µg/ml 
Tetracyclin 15 mg/ml in ethanol 15 µg/ml 
 
LB medium was prepared by dissolving 10 g tryptone, 5 g yeast extract, 
and 10 g NaCl in 800 ml distilled water. The pH was adjusted to 7.5 with NaOH 
and distilled water was added to a final volume of one liter. The LB medium 
was sterilized by autoclaving at 120°C for 15 minutes, and stored at room 
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temperature. In order to make selection media, antibiotic was added to the 
LB medium according to the concentration described in Table 2.1, and the 
antibiotic containing LB was stored at 4ºC. 
 
LB-agar plate was prepared by adding 15 g/l of select agar to LB 
medium and sterilized by autoclaving as described above. 
 
NZY broth was prepared by dissolving 10 g NZ amine (casein 
hydrolysate), 5 g yeast extract and 5 g NaCl in 800 ml distilled water, pH was 
adjusted to 7.5 with NaOH, and water was added to a final volume of 1 liter.  
Prior to use 12.5 ml/l 1 M MgCl2, 12.5 ml/l MgSO4 and 10 ml/l of filter-sterilized 2 
M glucose were added.  
 
Freezing - Bacteria grown on LB-media were frozen by adding one 
tenth volume of 10 x Hogness Freezing Medium (Werner et al., 1997) to 0.9 ml 
aliquot of bacteria and stored at -80ºC. 
 
10x Hogness Freezing Medium 
K2HPO4 360 mM 
KH2PO4 132 mM 
MgSO4 x 7 H20 4 mM 
Na3-citrate x 2 H20 17 mM 
(NH4)2SO4 68 mM 
Glycerol (v/v) 44 % 
(autoclaved)   
 
2.1.9. Oligonucleotides primers 
2.1.9.1. To study an Internal Ribosome Entry Site (IRES) 
myeovEcoRIUTRfor 5`- CGGAATTCGAACCCACATCCCTACAAAGCAG -3` 
myeov14NcoIUTRrev 5`- CATGCCATGGGCCGAGGGAAGGAGCCAG -3` 
myeov14NcoIUTRrevA 5`- CATGCCATGGTCCGAGGGAAGGAGCCAG -3` 
myeovUTREcoRVrev 5`- GGTTCCGATATCGAGCCGAGGGAAGGAGCC -3` 
myeovUTRHindIIIfor 5`- CAGCCCAAGCTTCGGACCGCGAACCCACATC -3` 
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2.1.9.2. To study uORFs  
myeovATG1* 5`- CAAAGCAGGAAAGTAAGCTTGGGAGAGGCC -3` 
myeovATG2* 5`- CAGAGGGCGGGAGAAGCCATCCCCACTG -3` 
myeovATG3* 5`- GGGCCGGGGCGTGCAAGGCCTCAGGG -3` 
myeovATG4* 5`- GGCCTCAGGGAAGGCCTGTTCAGCTGC -3` 
HRVirusIRESHindIII* 5`- AAGCGCCTACACAAAGTTTAGTAGCATCTCCG -3` 
EMCVirusIRESHindIII* 5`- GCAGTTCCTCTGGAAGTTTCTTGAAGACAAGC -3` 
myeovUTRHindIIIfor 5`- CAGCCCAAGCTTCGGACCGCGAACCCACATC -3` 
myeovEcoRVrev 5`- GGTTCCGATATCGAGCCGAGGGAAGGAGCC -3` 
 
* Oligonucleotides primers modified in their 5`phosphate group to be used in a mutagenesis assay. 
 
2.1.9.3. Construction of myeov cDNA into the vector pMT2SM to 
study its 5`and 3`UTR  
myeovKpnKozaklong-14 5`- GGGGTACCGCCACCATGGCCCTCAGAATCTGCG -3` 
myeovKpnownlong14 5`- GGGGTACCTTCCCTCGGCTCATGGCC -3` 
myeovKpnKozakshort2 5`- GGGGTACCGCCACCATGGTCACCCGGCAGGCTGGAC -3` 
myeovKpnATGown2short 5`- GGGGTACCGGGACTCGTTGCTCATGTTC -3` 
myeov-Xba-end 5`- GCTCTAGATCAACAAGTGAGGATGATGATG -3` 
myeov-Xba-L-end 5`- GCTCTAGATCAAGGAGAAGCACCTGACACTG -3` 
 
2.1.9.4. Promoter characterization 
EcoRImyeov5UTRdel1for 5`- CGGAATTCCTTTTTCCCCACCTTGGACAG -3` 
EcoRImyeov5UTRdel2for 5`- CGGAATTCCACCTGCAGGGCCGGGG -3` 
EcoRImyeov5UTRdel3for 5`- CGGAATTCCTGCTCGTTGCCTTTGGGC -3` 
myeov14NcoIUTRrev 5`- CATGCCATGGGCCGAGGGAAGGAGCCAG -3` 
 
2.1.9.5. Transcription factor 
myeovBampBindfor 5`- CGCGGATCCTGGCCCTCAGAATCTGCGTCAC -3` 
myeovXbaEnde 5`- GCTCTAGATCAACAAGTGAGGATGATGATG -3` 
BamVP16for 5`- CGCGGATCCTGTCGACGGCCCCCCCGAC -3` 
XbaVP16rev 5`- GCTCTAGATCATCCCGGACCCGGGGAATCCC -3` 
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2.1.9.6. Northern Blotting probes 
GAPDHfor 5`- TTAGCACCCCTGGCCAAGG -3` 
GAPDHrev 5`- CTTACTCCTTGGAGGCCATG -3` 
Luiferase for 5`- GGAGAGCAACTGCATAAGGC -3` 
Luciferase rev  5`- CATCGACTGAAATCCCTGGT -3`  
Renilla luciferase for 5`- ATGTTGTGCCACATATTGAGCCAGT -3` 
Renilla luciferase rev 5`- GATTTCACGAGGCCATGATAATGA -3` 
 
2.1.9.7. Sequencing primers 
M13for (700) 5`-GTAAAACGACGGCCAGT-3` 
M13rev (800) 5`-CAGGAAACAGCTATGAC-3` 
Fireluc (700) 5´-CTTCTGCCAACCGAACGGAC-3` 
RenillaLucRev (700) 5´-ACACCGCGCTACTGGCTC-3` 
pMT2Smrev (700) 5´-GCGACGATGCAGTTCAATGG-3 
pMT2Smfor (800) 5`-GGTGATGCCTTTGAGGGTGG-3` 
myeovseq1098rev (700) 5`- CCACCGCCCTTGCAGAC-3 
myeovseq882forw (800) 5`-GCGGTGAGAGGAGCATTTG-3` 
 
2.1.10. Plasmids 
2.1.10.1. Establishment of the mono- and bicistronic constructs.  
The luciferase plasmids: pGL3, phpL, pRF, phpRF and pRF+EMCV have 
been described previously and were kindly provided by Dr. A. Willis (Stoneley 
et al., 2000). Pfu DNA polymerase (Promega) was used to amplify the 
complete myeov 5`UTR using a cloned cDNA 11SMNp14m81 encoding the 
large ORF and the following primers: myeovEcoRIUTRfor and 
myeov14NcoIUTRrev or myeov14NcoIUTRrevA (used to keep the perfect 
Kozak start codon of the Firefly luciferase gene). A`s were added by the 
addition of dATP (Pharmacia) and Taq DNA polymerase and incubation at 
70ºC for 30 minutes. The fragment was purified after gel electrophoresis using 
a gel extraction kit from Qiagen or Montage, and inserted into a T-vector, 
pGEM-T easy plasmid (Promega) originating pGEM-T+myeov5`UTR and pGEM-
T+myeov5`UTR(K). The identities of the inserts were verified by DNA 
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sequencing using M13-forward and reverse primers (M13for and M13rev). The 
fragment was digested with EcoRI and NcoI restriction endonucleases and 
cloned into pGL3, phpL, pRF and phpRF between EcoRI and NcoI sites thus 
creating pGL3+UTR, pGL3+UTR(K), phpL+UTR, phpL+UTR(K), pRF+UTR, 
pRF+UTR(K), phpRF+UTR and phpRF+UTR(K). The correct insertion was verified 
by DNA sequencing using a specifically labelled Firefly luciferase reverse 
primer (Fireluc) on a Li-Cor 4200 DNA Analyser.  
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2.1.10.2. Promoterless construction 
Construction of the mono and bicistronic promoterless constructs were 
performed by deleting the SV40 promoter sequence between the HindIII and 
XhoI sites from pGL3 and pGL3+UTR; and the SmaI and EcoRV sites from pRF, 
pRF+UTR and pRF+EMCV by restriction digestion, agarose gel electrophoresis, 
purification and religation and thus creating pGL3-P, pGL3-P+UTR, pRF-P, pRF-
P+UTR and pRF-P+EMCV, respectively. The pGL3-P+EMCV was construct by 
digesting the construct pRF+EMCV with SpeI and NcoI restriction 
endonucleases. The purified fragment (5`UTR of EMCV) was inserted upstream 
of the Firefly luciferase cistron via SpeI and NcoI sites in the vector pGL3-P. All 
constructs were checked by sequencing using a specifically labeled Firefly 
luciferase reverse primer (Fireluc).  
 
2.1.10.3. Promoter characterization 
In order to map the cryptic promoter in the myeov 5`UTR, nested 
deletions of the myeov 5`UTR were generated. Pfu DNA polymerase was used 
to amplify the complete myeov 5`UTR using a cloned cDNA 11SMNp14m81 
and the following primers: EcoRImyeov5UTRdel1for, EcoRImyeov5UTRdel2for, 
EcoRImyeov5UTRdel3for and myeov14NcoIUTRrev. A´s were added and the 
purified fragment was inserted into pGEM-T easy vector, creating pGEM-
T+UTRdel1, pGEM-T+UTRdel2 and pGEM-T+UTRdel3. Correct insertion was 
checked by sequencing using M13for and M13rev primers. The fragments 
were digested with EcoRI and NcoI restriction endonucleases and the gel 
purified fragment was inserted into the pRF vector via EcoRI and NcoI sites, 
creating pRF+UTRdel1, pRF+UTRdel2 and pRF+UTRdel3. 
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2.1.10.4. Characterization of the upstream open reading frame  
To analyze the effect of the upstream open reading frame in the 
myeov 5`UTR on protein translation, Pfu DNA polymerase was used to amplify 
the complete myeov 5`UTR using a cloned cDNA 11SMNp14m81 as template 
and the primers myeovUTRHindIIIfor and myeovEcoRVrev. A´s were added to 
the PCR fragments with Taq polymerase, gel purified and inserted into pGEM-
T easy vector, creating the construct pGEM-T+myeov5`UTRHindIII/EcoRV. 
Correct cloning was checked by sequencing using M13for and M13rev 
primers. In order to mutate the uAUGs within the myeov 5`UTR, pGEM-
T+myeov5`UTRHindIII/EcoRV was used as template and the 
QuikChange®Multi Site-Directed Mutagenesis Kit (Stratagene) with the 
mutagenesis primers myeovATG1, myeovATG2, myeovATG3 and myeovATG4. 
Introduced mutations were verified by DNA sequencing using M13for and 
M13rev primers, and the inserts, myeov5`UTRmut (containing different 
mutation combination) as well the myeov 5`UTR wild type were subcloned 
into pRF+EMCV upstream of the Renilla luciferase cistron via HindIII and EcoRV 
sites. The cloned fragments were verified by DNA sequencing using a specific 
labelled Renilla luciferase reverse primer (RenillaLucRev). 
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2.1.10.5. In vitro transcription for RNA transfection 
For in vitro transcription experiments using the T3 polymerase, we used a 
bluescript based plasmid (Stratagene) containing the SHOX 5`UTR upstream 
of the Firefly luciferase cistron with the SV40 polyA adenylation site and SV40 
enhancer (Blaschke et al., 2003). For this purpose the SHOX 5`UTR was 
replaced by either the wild type or the mutated myeov 5`UTR using the 
SpeI/NcoI restriction sites, originating pBSK+UTR and pBSK+UTRmut1,2,3,4 
respectively.  
               
 
 
2.1.10.6. Cloning of myeov cDNA fragments into the eukaryotic 
expression vector pMT2SM 
 
 
 
The complete myeov cDNAs encoding the long (11SMNp14m82) and 
the short ORF (11SMNp2m69) were digested with NotI from the lambda gt10 
cloning vector and ligated into pMT2SM via NotI restriction site, thus creating 
pMT2SM+5`UTR+longORF+3`UTR and pMT2SM+5`UTR+shortORF+3`UTR, 
respectively.  
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To create the construct pMT2SM+5`UTRmut+ORF+3`UTR a double 
ligation was performed. For that, the myeov 5`UTR containing the 4 mutations 
in the uAUGs was obtained from pGEM-T+UTR1,2,3,4mut and digested with NotI 
and PflfI restriction endonucleases. The myeov cDNA encoding the long ORF 
together with the 3`UTR was obtained from the plasmid 11SMNp14m81 using 
the same restriction endonucleases and both fragments were ligated into the 
NotI site of pMT2SM.  
 
 
  
To generate a construct that lacks the 3`UTR (pMT2SM+5`UTR+ORF), the 
plasmid 11SMNp14m81 was digested with AatII, polished and subsequently 
digested with the restriction enzyme NotI. The purified fragment was ligated 
into the vector pMT2SM that was digested with EcoRI, polished and 
subsequently digested with NotI.  
 
 
 
To construct the plasmid lacking the 5`UTR (pMT2SM+ORF+3`UTR) the 
plasmid 11SMNp14m81 was digested with PflFI, polished and then digested 
with the restriction enzyme NotI. The purified fragment was ligated into 
pMT2SM which was digested with PstI, polished and digested with NotI.  
 
 
 
To create constructs of myeov ORF without 5` and 3`UTR sequences in 
the eukaryotic expression vector pMT2SM several amplifications were 
performed. The myeov encoding the long ORF containing the start codon in 
a perfect Kozak context was created by amplification using the plasmid 
11SMNp14m81 as template and the primers myeov-Kpn-Kozak-long-14 and 
myeov-Xba-end, thus creating pMT2SM+longORF(K). To create a construct of 
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myeov long ORF containing its own ATG (suboptimal Kozak context), the 
same procedure was performed, except that the forward primer used was 
myeov-Kpn-own-long-14, creating in this way pMT2SM+longORF. In order to 
construct pMT2SM-longORF-L(K) the 11SMNp14m81 was used as template and 
the primers myeov-Kpn-Kozak-long-14 and myeov-Xba-minusL-end. This 
construct encodes the myeov long ORF without the leucine/isoleucin tail 
(Figure 3.1). 
 
 
 
Constructs of myeov cDNA encoding the short ORF containing the start 
codon in a optimal Kozak context was created by amplification using the 
plasmid 11SMNP2m69 as template and the primers myeov-Kpn-Kozak-short-2 
and myeov-Xba-L-end thus creating pMT2SM+shortORF(K). To create a 
construct of myeov short ORF containing its own ATG (suboptimal Kozak 
context), the same procedure was performed, except that the forward primer 
used was myeov-Kpn-own-2-short, creating in this way pMT2SM+shortORF. The 
construct pMT2SM-shortORF-L(K) was created using the same DNA template 
and the primers myeov-Kpn-Kozak-short-2 and myeov-Xba-end. This construct 
does not contain the leucine/isoleucin tail of myeov ORF (Figure 3.1).  
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All inserts were verified by sequencing using the pMT2SMfor and 
pMT2SMrev primers. 
 
2.1.10.7. Transcription factor 
To check whether myeov ORF codes for a transcription factor, the 
myeov long ORF was amplified with Pfu polymerase using the plasmid 
11SMNp14m81 as template and the primers MyeovBampINDfor and 
myeovXbaEnde. A`s were added to the PCR fragment and inserted into 
pGEM-T easy vector, originating pGEM-T-myeovORFBamXbaI. The insert was 
checked by sequencing using M13for and M13rev primers. The purified 
fragment was subcloned in frame with Gal4-BD into the vector pBIND 
(Promega), thus creating pBIND+myeov. The same procedure was performed 
to create the construct pBIND+VP16, however, using the vector pACT as 
template and the primers BamVP16for and XbaVP16rev. All constructs were 
verified by sequencing using the specifically labelled Renilla luciferase primer 
(RenillaLucRev). The pG5luc was also purchased from Promega.  
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2.2. Methods 
2.2.1. Cell Culture   
 All the human cell lines described here were maintained in a humidified 
atmosphere at 37°C containing 5% CO2. The semiadherent cells were 
cultivated in 24 ml of medium using 175 cm2 cell culture flasks (Greiner). Cells 
were splitted twice a week as follow: the cell monolayer was washed with 
prewarmed PBS. To detach the cells from the plastic surface, 2 ml of 
prewarmed trypsin/EDTA was added and incubated until the cells detached 
(usually 1-5 min depending on the cell line used). To stop trypsinization, 
medium with serum was added, and cells were cultured as described above. 
When necessary cells were counted using a hematocytometer and the 
numbers of required cells were transferred to a specific cell culture flask.  
 
2.2.1.1. HEK 293 cell line  
 Human fibroblast embryonic kidney cells (HEK-293) were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM)/HAM`S F-12 supplemented with 
10% fetal bovine serum (FBS) and 100 U/ml penicillin/streptomycin. 
  
2.2.1.2. Met-5A cell line 
 Mesothelial cells (Met-5A) were isolated from pleural fluids obtained 
from non-cancerous individuals. This cell line stains positively for vimentin, 
keratins and SV40 T antigen. The SV40 large T antigen promotes replication 
from the SV40 origin, which is found in all luciferase plasmid vectors used in this 
study. The combination of large T antigen and SV40 origin may result in a 
higher copy number of these vectors, which in turn may result in increased 
expression of the reporter gene compared to other cell lines and vector 
combinations. Met-5A cells were kindly donated by Dr. Ling Chen (Heidelberg 
University Pediatric Hospital). The recommended medium for this cell line was 
Medium 199 with Earle’s BSS, 75 mM L-glutamine and 1.25 g/L sodium 
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bicarbonate supplemented with 3.3 nM human epidermal growth factor 
(EGF), 400 nM hydrocortisone, 870 nM insulin, 20 mM HEPES and 10% FBS and 
100 U/ml penicillin/streptomycin. 
  
2.2.1.3. Capan-1 cell line 
 Capan-1 is a human pancreas adenocarcioma established from the 
liver metastasis of a pancreatic ductal adenocarcinoma from a 40-year-old 
Caucasian man in 1974. This cell line was described to grow in nude mice, 
induce metastases and was resistant to 5-FU (Fogh et al., 1977; Kyriazis et al., 
1986). The cell medium recommended was RPMI 1640 + 20% FBS and 100 U/ml 
penicillin/streptomycin. Capan-1 was obtained from the DKFZ Tumorbank. 
Deutsche Sammlung von Mikroorganismen und Zelkulturen GmbH (DSMZ nº 
ACC 244).  
 
2.2.1.4. Capan-2 cell line 
 Capan-2 is a human pancreas adenocarcinoma established from the 
tumor of a 56-year-old Caucasian man with pancreas adenocarcinoma in 
1975 (Kyriazis et al., 1986). The recommended medium was RPMI 1640 + 15% 
FBS and 100 U/ml penicillin/streptomycin (DSMZ nº ACC 245). 
 
2.2.1.5. DAN-G cell line 
 DAN-G is a human carcinoma cell line established from a human 
individual with pancreas carcinoma in 1985. The recommended medium was 
RPMI 1640 + 10% FBS and 100 U/ml penicillin/streptomycin (DSMZ nº 249). 
 
2.2.2. Freezing of cells 
The cells to be stored were briefly washed with prewarmed PBS, 
harvested by trypsinization and media containing serum was added to stop 
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the trypsin action. Cells were pelleted by centrifugation at 300 g for 5 min and 
resuspended in freezing media, aliquoted in 1 ml cryogenic vials and stored 
at – 80ºC overnight in a temperature controlled box (Mr. Frosty, Sigma). Next 
day the cells were transferred to liquid nitrogen. 
 
Freezing media 
DMEM 70 % 
DMSO 10 % 
FBS 20 % 
(autoclaved) 
 
2.2.3. Thawing of cells 
Thawing of stored cells was achieved by incubating the vials in a 37ºC 
water bath. Cells were removed from the vial and placed in a 15 ml sterile 
falcon tube to which slowly (dropwise) prewarmed medium was added. Cells 
were pelleted by centrifugation for 5 min at 300 x g. The cells were then 
transferred into a 75 cm2 flask and cultivated by conventional methods. The 
next day cells were briefly washed with prewarmed PBS to remove dead cells, 
and fresh medium was added. 
 
2.2.4. Polymerase Chain Reaction 
Polymerase Chain Reaction (PCR) designed by Karry Mullis (Mullis et al., 
1986) has been and is extensively used in molecular biological research, 
medical diagnostics and forensic sciences. This technique is used to amplify 
exponentially a specific DNA sequence. For a PCR reaction the following 
ingredients are necessary: DNA template, buffer, oligonucleotide primers, 
dNTPs (mix containing the four deoxyribonucleoside triphosphates), and a 
heat stable DNA polymerase. The PCR reaction comprises different 
temperature cycles which correspond to basically three steps:  
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1. DNA Denaturation. The DNA strands are separated by setting the 
temperature at 95ºC for 15 seconds, forming two single DNA strands 
that allow hybridization with oligonucleotide primers. 
2. Annealing of primers. The temperature is lowered to 56ºC to allow the 
primers to hybridize to the target sequence. The primers are designed in 
such a way that one primer hybridizes to the 5`-end and the other 
primer to the complementary strand at the 3`-end of the target 
sequence. Since there is excess of primers, the parental DNA does not 
reanneal. 
3. DNA synthesis. The temperature is raised to 72ºC, which is the optimal 
temperature for a Taq DNA polymerase to synthesize target DNA. 
Starting from the 5`- and 3`- primer, a copy of both strands of parental 
DNA is synthesized.  
 
By repeating these cycles, the target DNA between the two primers can 
be exponentially amplified. The PCR reaction was pipetted using filter tips and 
was performed in a clean area, the following components were pipetted into 
a sterile PCR tube. 
 
PCR reaction   
Template DNA ~100 ng 
Oligonucleotide primer (each) 0.3 pmol 
dNTPs 0.2 mM 
Buffer  1 x 
Magnesium 0.2 mM 
DNA Polymerase 2.5 U 
Water to 100 µl 
        
The enzyme Pfu polymerase was used preferable because this enzyme 
has a 3`→ 5`exonuclease (proofreading) activity and thus a lower error rate 
compared to other thermostable polymerases (Lundberg et al., 1991). As 
control, an additional reaction was performed without template DNA. The 
protocol described above is a standard protocol. However, the melting 
temperature (Tm) was calculated individually for each set of primers used. To 
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calculate the optimal melting temperature, the following formula has been 
used: 
 
Tm = 69.3ºC + 0.41x (GC-Percent) – 650/Primer Length 
 
 The annealing temperature was mostly set 3-5ºC bellow the calculated 
melting temperature.  
 
2.2.5. PCR Polishing 
The PCR Polishing Kit (Stratagene) was used to polish the ends of 3`-
overhang extensions of polymerase-generated DNA fragments or to fill-in 5` 
overhangs to generate blunt-ends. The following components were added 
into a sterile 0.5 ml microcentrifuge tube: 
 
Polishing reaction   
Digested DNA or PCR product ~500 ng 
10 x Pfu buffer (containing magnesium) 2 µl 
2.5 M dNTP 2 µl 
Pfu polymerase 5 U 
Water to  20 µl 
 
The contents were gently mixed and incubated in a thermal cycle at 
72ºC for 30 minutes. The mixture was phenol-chlorophorm-isoamylalchohol 
extracted and ethanol precipitated (section 2.2.16 and 2.2.17, respectively). 
 
2.2.6. A-tailing reaction 
  PCR products obtained with Pfu polymerase do not contain an 
adenosine nucleotide at its 3`- terminal and therefore are not compatible for 
direct ligation into pGEM®-T easy vector (Promega), which contains a 3`- 
terminal thymidine at both ends. However, an A-tailing reaction can be 
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performed to add adenosine nucleotides to the PCR fragment ends, making 
it possible to ligate the fragment into the pGEM-T easy vector.  
 To perform the A-tailing reaction for blunt-ended DNA or PCR fragments 
generated by Pfu Polymerase, the DNA was ethanol precipitated and 
resuspended in 20 µl water. The contents described below were mixed into a 
sterile PCR tube and incubated in a thermal block for 30 min at 70ºC.  
 
A-tailing procedure   
Purified PCR fragment 10 µl 
10 x Buffer  5 µl 
MgCl2 (end concentration) 2 mM 
dATP (end concentration) 0.2 mM 
Taq DNA polymerase 1 U 
Water to  50 µl 
 
2.2.7. Plasmid DNA transformation 
 To introduce plasmid DNA or recombinant plasmid DNA into bacteria, 
the bacteria had to be made competent for this purpose. We used 
competent cells purchased from Invitrogen and Stratagene or we 
homemade competent cells according to the following protocols. 
 
2.2.7.1. Preparation of chemically competent cells – calcium 
chloride method 
 Bacteria were made competent for transformation according to a 
protocol provided by Sambrook et al (Sambrook et al., 1989). Working 
aseptically, DH10B cells (taken from a glycerol stock culture) were streaked 
out on a LB plate and incubated overnight at 37°C. The next day, one 
bacterial colony (2-3 mm in diameter) was picked and inoculated into 100 ml 
of LB medium in a 1-liter erlenmeyer, and the solution was incubated at 37°C 
in a rotatory shaker. Cell density was measured by a spectrophotometer at 
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OD600. When an OD600 of 0.18 to 0.22 was reached, the bacteria were 
transferred to a Falcon tube 2059 and incubated on ice for 10 min. 
The cells were spun down at 2,700 g for 10 min at 4ºC, the supernatant 
was discarded and the bacterial pellet was resuspended in 10 ml ice-cold 0.1 
M CaCl2 (from a 1M stock solution, the solution was filter sterilized through a 
filter of 0.45 µm pore size) and incubated on ice for 20 min. Centrifugation was 
performed again, and the cells were resuspended in 3.410 µl of 0.1 M CaCl2 
plus 590 µl of 87% glycerol. The cells were used immediately for transformation 
and/or distributed into several prechilled sterile microfuge tubes. The 
competent cells were frozen immediately by immersion of the microfuge 
tubes in liquid nitrogen and stored at – 80ºC in 50 µl aliquots. 
 
2.2.7.2. Preparation of electrocompetent cells - GYT method  
To prepare electrocompetent cells using the GYT method (Tung and 
Chow, 1995), a single bacteria colony was picked from a LB-agar plate and 
inoculated into 3 ml LB media and grown overnight in a shaker at 37ºC. The 
next day, the culture was diluted in 300 ml LB medium and incubated at 37ºC 
with vigorous shaking until the OD600 reached 0.6. The cells were then 
incubated on ice for 30 minutes and harvested at 4000 g for 15 min at 4ºC. 
The bacteria were washed twice with 25 ml ice-cold 10% glycerol and 
resuspended in a final volume of 0.6 ml ice-cold GYT. The cells were used 
immediately for transformation and/or distributed into several prechilled sterile 
microfuge tubes. Working quickly the competents cells were frozen 
immediately by immersion of the microfuge tubes in liquid nitrogen and the 
cells were stored at – 80ºC in 50 µl aliquots. 
 
GYT   
Glycerol 10 % 
Yeast extract 0.125 % 
Tryptone 0.25 % 
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2.2.8. Transformation of competent cells 
 Transformation is the term used to describe the introduction of plasmid 
DNA into bacteria. The experiment can be performed by an electrical or a 
chemical method. The electrical method, called electroporation (Andreason 
and Evans, 1988; Shigekawa and Dower, 1988; Tur-Kaspa et al., 1986) is a 
method which uses electric field pulses of high voltage (kV/cm) and short 
duration (microsecond range) to introduce foreign DNA into mammalian cells 
or bacteria. Electroporation is temperature-dependent and is best carried out 
at 0-4ºC. The efficiency of transformation drops as much as 100-fold when 
electroporation is carried out at room temperature (Sambrook and Russell, 
2001). 
The chemical method on its turn consists of a heat shock to introduce 
the DNA into the host. Routinely we used electroporation, but for some 
experiments the chemical method was applied.  
 
2.2.8.1. Electroporation 
In order to transform bacteria by electroporation we either used 
homemade electrocompetent cells (section 2.2.7.2) or the competent TOP10 
cells purchased from Invitrogen. The TOP10 cells were chosen because these 
cells have high transformation efficiency of 1 x 109 cfu/µg supercoiled DNA 
and contain the genotype φ80lacZ∆M15 which allows blue/white color 
screening of recombinant clones. The electrocompetent cells were stored at -
80ºC and were thawed on ice, and 20 µl of the cells were diluted once with 
sterile water and mixed with 1 to 2 µl (~25 ng DNA) of the ligation reaction (or 
10 ng of plasmid DNA) in a prechilled eppendorf tube and incubated for 1 
min. on ice. The reaction was transferred to a prechilled sterile cuvette (1 mm) 
and electroporated with an electrical pulse of 25 µF capacitance, 1.8 kV and 
200 ohm resistance. Immediately after electroporation 1 ml of pre-warmed LB 
media (without antibiotics) was added to the cells, followed by incubation for 
1 hour at 37ºC with gentle rotation to allow cells to recover. Up to 200 µl of the 
transformation reaction was plated onto 90-mm LB agar plates (containing 
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the required antibiotic according to the antibiotic resistance gene cassette 
presented on the plasmid DNA). The LB-agar plates were left open for a few 
minutes under the fume hood (sterile) until the liquid was absorbed, the plates 
were closed and incubated inverted overnight at 37ºC.   
 
2.2.8.2. Chemical transformation  
For transformation of mutated plasmid DNAs (section 2.2.21) we used 
the chemical transformation method as recommended by the manufacturer 
(Stratagene). XL2-Blue or XL10-Gold ultracompetent cells were thawed on ice, 
and 45 µl was placed in a prechilled falcon 2059 polypropylene tube, and 2 µl 
β-ME was added to the cells. The contents of the tube were swirled gently 
and incubated on ice for 10 minutes, every two minutes the tube was swirled, 
and 1.5 µl of the Dpn I-treated DNA (see section 2.2.21) was transferred to the 
tube containing the ultracompetent cells. The transformation reaction was 
swirled and incubated on ice for 30 minutes. The tube was heat-pulsed in a 
42ºC water bath for 30 seconds and incubated on ice for 2 minutes. 900 µl of 
preheated (42ºC) NZY+ broth media was added and incubated at 37ºC for 1 
hour in a shaker at 225-250 rpm. Different volumes were plated onto LB-agar 
plates (containing the antibiotic for selection) and incubated inverted 
overnight at 37ºC. 
 
2.2.9. Plasmid Preparation 
2.2.9.1. Small scale plasmid DNA preparation (mini-prep) 
Plasmid mini preparation was performed basically as described by 
Sheibani and Frazier, with small modifications (Sheibani and Frazier, 1997). A 
single bacterial colony was picked with a sterile inoculating loop and 
inoculated into 5 ml LB media (containing the required antibiotic for 
selection) into a 15 ml falcon tube, and grown overnight with vigorous shaking 
at 37ºC.  
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The following day, 1.5 ml of the culture was transferred to an eppendorf 
tube, and the bacteria were recovered by centrifugation for 3 min at 10,000 
g. Supernatant was removed and a second 1.5 ml bacterial culture was 
added and centrifuged. The supernatant was again discarded (the rest (2 ml) 
of the culture was kept at 4ºC). The bacterial pellet was resuspended by 
vortexing, and 300 µl ice-cold buffer P1 (Table 2.2) was added to the cells and 
mixed by inverting the tube 10 times. To lyse the cells, 300 µl (RT) buffer P2 was 
added, mixed by inverting the tube 6 times and incubated at RT for up to 5 
minutes. Lysis was stopped by addition of 300 µl ice-cold buffer P3. The mixture 
was centrifuged for 30 min at 10,000 x g and the supernatant was transferred 
to a new eppendorf tube. To precipitate the DNA, 600 µl isopropanol was 
added, and the DNA pellet was obtained by centrifugation for 30 min at 
10,000 x g. The supernatant was discarded and the DNA pellet was washed 
with 500 µl 70% ethanol. Finally DNA was dried at 65ºC and dissolved in 30 µl 
10T 0.1E buffer for 5 min at 65ºC at 800 rpm.  
 
Table 2.2. Buffers used for plasmid DNA mini preparation 
Buffer P1 Buffer P2 Buffer P3 
50 mM Tris/HCl, pH 8.0 200 mM NaOH 3 M K acetate, pH 5.5 
10 mM EDTA 1% SDS  
100 µg/ml Ribonuclease A* mix before use  
(Storage at 4ºC) (Storage at RT) (Storage at RT) 
* Ribonuclease A was made with 10 mg/ml RNase A, 15 mM NaCl and 10 mM Tris/HCl, pH 7.5. The 
solution was incubated at 90ºC for 30 min, cooled to room temperature and stored at -20ºC. 
 
2.2.9.2. Large scalle plasmid DNA preparation (maxi-prep) 
2.2.9.2.1. Ammonium Acetate Method 
 To obtain plasmid DNA on a large scale, we used the ammonium 
acetate protocol. The advantage of this method is the amount of DNA 
obtained compared to commercially available kits, e.g. the maximum yield 
using the QIAGEN®-tip 500 Column ranged from 250 to 600 µg of DNA per 100 
Materials & Methods 
 
 57
ml culture while the ammonium acetate protocol yielded between from 750 
to 5000 µg of DNA per 100 mL culture using high-copy-number plasmids. 
Besides this, the cost of this method is much less compared to that of 
commercial kits. The protocol described is from Saporiton-Irwin et al with small 
modifications (Saporito-Irwin et al., 1997). 
Plasmid DNA was usually prepared as follows: 50 µl mini-prep culture 
was inoculated in 500 ml LB media (containing the respective antibiotic for 
selection) in a 2 liter erlenmeyer, and grown overnight at 37ºC with vigorous 
shaking.  
The next day, the bacterial pellet was recovered by centrifugation in 
250 ml beakers (all the centrifugation steps were performed at 10,000 x g at 
4ºC, except as noted) and the bacterial pellet was resuspended with 
vigorously vortexing in 12 ml of freshly prepared Solution 1 (Table 2.3) and 
incubated at 37ºC for 30 min at 100 rpm to ensure even distribution. After 
incubation the cells were kept on ice for 20 min.  
To lyse the cells, 24 ml of freshly made Solution 2 (Table 2.3) was added 
and mixed by inverting the tube and directly incubated on ice for 10 min. 
Next, 18 ml ice-cold 7.5 M ammonium acetate (pH 7.6) was added and 
mixed by inversion and again incubated on ice for 10 min. Centrifugation was 
accomplished for 30 min. After centrifugation the solution was filtrated and 27 
ml of isopropanol was added followed by incubation for 10 min at RT. The 
solution was centrifuged once more for 10 min and the pellet containing the 
plasmid DNA was resuspended in 4 ml 2 M ammonium acetate (pH 7.4) and 
transferred to a falcon 2059 polypropylene tube and incubated either for 10 
min on ice or at 4ºC overnight. Next, the sample was centrifuged for 10 min, 
and the supernatant was placed into a new falcon 2059 polypropylene tube, 
and 4 ml isopropanol was added and mixed by inverting the tube. The 
sample was incubated for 10 min at RT and centrifuged for 10 min. The pellet 
obtained after centrifugation was resuspended in 2 ml distilled water and 10 
µl (5 mg/ml) RNase was added followed by incubation for 30 min at 37ºC. 
Optionally extraction with phenol:chloroform:isoamylalcohol was performed.  
Materials & Methods 
 
 58
Following RNase treatment, 1 ml of ice-cold ammonium acetate (pH 
7.6) was added, mixed by inversion and incubated for 5 minutes at RT, 
followed by a centrifugation step for 10 min. The supernatant was transferred 
to a falcon 2059 tube and 3 ml isopropanol was added and mixed by 
inverting the tube and incubated for 10 min at RT, followed by a 
centrifugation for 10 min at RT. Finally the obtained DNA pellet was washed 
with 70% ethanol, dried at 65ºC and resuspended in 300 – 500 µl TE buffer. 
 
            Table 2.3. Buffers used for plasmid DNA maxi preparation 
Solution 1 Solution 2 
25 mM Tris/HCl, pH 7.6 1% SDS 
10 mM EDTA pH 8.0 200 mM NaOH 
50 mM Glucose  
24 mg hen egg lysozyme  
 
2.2.9.2.2. Maxi-prep (Qiagen) 
The DNA Maxi preparation was performed using the Qiafilter Plasmid 
Maxi Prep Kit according to the suppliers protocols (Qiagen® Plasmid 
Handbook). The solutions used are shown in Table 2.4. Centrifugation steps 
were performed at ≥ 10,000 x g or, except as noted.  
 A single colony was picked from a LB plate and inoculated into 5 ml LB 
medium (containing the required antibiotic). The cells were grown for ∼8 hours 
(late logarithmic phase), and this miniculture was diluted 1:100 into 500 ml 
LB/Amp media and grown to saturation overnight at 37ºC under vigorous 
shaking. 
The next day bacteria were harvested by centrifugation at 3,800 x g for 
15 min at 4ºC. The supernatant was discarded and the bacterial pellet was 
resuspended in 10 ml of buffer P1. 
To lyse the cells, 10 ml of buffer P2 was added and the samples were 
gently mixed by inverting the tube 4-6 times and then incubated at room 
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temperature for 5 min. To stop lysis, 10 ml prechilled buffer P3 was added and 
the samples were mixed by inverting the tube 4-6 times, followed by an 
incubation on ice for 20 min. 
Samples were mixed again, and the clear supernatant obtained after 
centrifugation for 30 min at 4ºC was transferred to a new tube. The tube was 
recentrifuged for 15 min, and the supernatant was transferred to a new tube. 
The QIAGEN-tip 500 columns were equilibrated by applying 10 ml of 
buffer QBT, and the column was allowed to drain by gravity flow. The 
supernatant was applied to the column and allowed to enter the resin by 
gravity flow. The column was washed 2 times with 30 ml of buffer QC. 
For elution, 15 ml of buffer QF was added. DNA in the collected eluate 
was precipitated by adding 0.7 volumes (10.5 ml) of isopropanol, followed by 
centrifugation at 4ºC for 30 min. 
The DNA pellet was briefly washed with 5 ml of ice-cold 70% ethanol 
and again centrifuged for 15 min at 4ºC. DNA pellet was dried at 65ºC and 
then resuspended in 200-500 µl of sterile water or TE buffer.  
 
Table 2.4. Solutions for maxi preparation 
P1  P2 P3 
50 mM Glucose 0.2 M NaOH 3 M Potassium acetate 
25 mM Tris-HCl, pH 8.0 1% SDS 2 M Acetic acid 
10 mM EDTA, pH 8.0   
    
QBT QC QF 
750 mM NaCl 1 M NaCl 1.25 M NaCl 
50 mM MOPS 50 mM MOPS 50 mM Tris 
 
2.2.10. Determination of nucleic acid concentration 
Recovery, purity and concentration of nucleic acids were determined 
by spectrophotometric analysis. The ratio of absorbance at (A260-A320/A280-
A320) should be 1.8 to 2.0 for DNA and higher as 2.0 for RNA.  In presence of 
protein contamination the ratio is less. For the measurement we used a 
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spectrophotometer from Pharmacia Biotech. The DNA or RNA was diluted 
1:100 in distilled water and transferred to a quartz cuvette. The absorption was 
at wavelengths of 260 nm, 280 nm and 320 nm. An optical density (OD) of 260 
nm of 1.0 is equivalent to 50 µg/ml DNA, 40 µg/ml RNA or 20 µg/ml 
oligonucleotides. The spectrophotometer machine used provides us with the 
concentration and the ratio automatically. Nevertheless, the formula used to 
calculate the concentration (C) and molarity (M) were the following: 
 
C = OD 260nm x dilution factor x equivalent = x µg/ml 
 
M = Concentration (µg/ml) x 1,000/330 = x pmol/µl 
 
2.2.11. DNA cleavage with restriction endonucleases 
Restriction enzymes, also called restriction endonucleases are bacterial 
proteins which work as an immune system in bacteria. Their role is to destroy 
bacteriophages or other viruses which invade bacteria. Restriction 
endonucleases recognize a specific nucleotide sequence, and cut DNA 
wherever this specific sequence is found. Usually the palindromic restriction 
sites have a length of 4 to 8 base pairs. The purified restriction endonucleases 
are commercially available, and are predominantly used to generate DNA 
fragments for cloning experiments or Southern blot analysis. Therefore, 
restriction endonucleases are a major tool in recombinant DNA technology.  
Normally DNA was cleaved at 37ºC for 2 hours in a total volume 
reaction of 100 µl with 1 or 2 X buffer (supplied by the manufacturer) and 5-
fold enzyme units per microgram DNA. The enzyme Sma I was an exception 
and was incubated at 25ºC overnight. 
 
2.2.12. Dephosphorylation 
Calf intestinal phosphatase (CIP) or shrimp alkaline phosphatase (SAP) 
(Seeburg et al., 1977; Ullrich et al., 1977) are enzymes which can remove the 
DNA 5` phosphate group, and therefore suppress self-ligation and 
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recircularization of the plasmid DNA used for cloning. In this way the ligation 
(fragment-plasmid) efficiency is enhanced and background of transformed 
bacterial colonies that carry “empty” plasmids (plasmid without insert) is 
reduced. 
Desphophorylation was performed according to the protocol of 
Sambrook and Russel with small modification (Sambrook and Russell, 2001). 
Digested plasmid DNA was phenolized, ethanol precipitated and 
resuspended in 89 µl distilled water, and then the complete reaction was 
performed in three incubation steps:  
1) The 89 µl DNA solution was incubated for 30 min at 37ºC with 10 µl 
CIP-buffer (10 x) and 1 µl CIP (18 U);  
2) An additional microliter of CIP was added and incubation was 
proceeded for 30 min at 56ºC; 
3) The desphosphorylation reaction was stopped by adding 4 µl of 0.5 
M EDTA and incubation for 10 min at 68ºC.  
 
2.2.13. Ligation 
T4 DNA ligase is encoded by the gene 30 of bacteriophage T4 (Wilson 
and Murray, 1979). This enzyme can be used to ligate DNA restriction 
fragments. T4 DNA ligase has the capacity to catalyze in vitro the formation of 
a phosphodiester bond between adjacent nucleotides, one containing a 
terminal 5-phosphate group and one containing the hydroxyl terminus. A 
review of the ligation reaction can be seen in (Cherepanov and de Vries, 
2003; Madrid et al., 1998; Shuman, 1996). 
In my study, three types of ligation were performed: cohesive, blunt-end 
and recircularization, and they are briefly discussed below and schematically 
shown in table 2.5. 
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2.2.13.1. Ligation of cohesive ends 
Mostly restriction endonucleases create cohesive ends. When fragment 
DNA and plasmid DNA are digested with the same restriction endonuclease, 
complementary cohesive ends are generated that can easily be ligated. For 
such kind of ligation, incubation at 4 or 16ºC overnight was performed. 
Optionally incubation at room temperature was also performed; however, 
ligation rates are lower when compared to overnight incubation. 
 
Table 2.5. Ligation reactions and pipetting scheme 
Contents Cohesive end Blunt-end Recircularization 
Plasmid DNA ~ 50 ng ~ 200 ng ~ 50 ng 
Insert DNA ~  150 ng ~ 600 ng - 
50% PEG 4000 - 2 µl 5 µl 
10 x buffer 1 µl 2 µl 5 µl 
Ligase 1 U 5 U 5 U 
Total volume reaction 10 µl 20 µl 50 µl 
Incubation time 4ºC or 16ºC 
overnight 
22ºC for 1 hour 22ºC for 1 hour 
Phenolization and 
ethanol precipitation 
no yes no 
 
2.2.13.2. Blunt-end ligation 
PCR products originated from Pfu DNA polymerase are blunt-end. Some 
enzymes, e.g. Sma I also makes blunt end DNA. In contrast to cohesive ends, 
blunt-ends are difficult to ligate, and require high concentration of DNA and 
T4 DNA ligase. Blunt-end ligation is stimulated when using low amounts of 
polyethylene glycol (Rusche and Howard-Flanders, 1985; Zimmerman and 
Pheiffer, 1983), therefore, the blunt-end ligation was performed in the 
presence of PEG at a temperature of 22ºC for 1 hour. The enzyme was 
inactivated at 65ºC for 10 min, and the ligation reaction was phenolyzed and 
ethanol precipitated (section 2.2.16 and 2.2.17, respectively). 
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2.2.13.3. Recircularization 
 In some cases, it was only necessary to recirculize the plasmid DNA. For 
example when producing promoterless constructs, the promoter region was 
removed by restriction enzyme digestion, and the linearized gel purified 
plasmid DNA was religated. For this purpose, a large reaction volume was 
used to enhance the chance that plasmid DNA would self-religate in stead of 
ligation to an adjacent linearized plasmid DNA fragment. 
 
2.2.14. Agarose gel electrophoresis 
Agarose is a linear polymer composed of residues of D- and L- 
galactose and is used to separate fragments of DNA or RNA by size 
(Sambrook and Russell, 2001). Since deoxyribonucleic acids are negatively 
charged, they migrate through the agarose gel in a electrical field toward 
the positive anode. Molecules of double-stranded DNA migrate through gel 
matrices at rates that are inversely proportional to the log10 of the number of 
base pairs, therefore small molecules migrate faster than large ones (Helling 
et al., 1974). There is a linear relationship between the logarithm of the 
electrophoretic mobility of the DNA and the gel concentration (Bearden, 
1979; Calladine et al., 1991; Sambrook and Russell, 2001). 
Plasmid DNA or DNA fragments obtained after treatment with restriction 
enzymes were separated by electrophoresis through an agarose gel. The 
agarose concentration used varied from 0.6% to 2.0%. The RNA 
electrophoresis is discussed separately in section 2.2.25.2. 
 
2.2.14.1. Gel preparation 
To prepare an agarose gel, the required amount of agarose was 
dissolved in 50 or 100 ml (small and big gel, respectively) 1 x running buffer 
(Table 2.6). The agarose was solubilized in a microwave oven until the 
agarose was completely dissolved (during boiling the water volume 
decreases by evaporation, therefore the water volume was replenished). The 
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gel was cooled to ≤ 45ºC and ethidium bromide was added to an end 
concentration of 0.5 µg/ml and mixed through gentle swirling. The agarose 
gel was then poured into a horizontal gel tray, and a comb for forming the 
sample slots was placed into the gel. The gel was solidified for about 30 min 
and then placed into an electrophoresis tank, where the gel was covered by 
the same batch of running buffer used to make the gel.  
 
2.2.14.2. Sample preparation and running conditions 
The DNA was mixed with 1/5th of loading buffer (Table 2.6) and the 
sample was placed into a well on the agarose gel. As fragment size control, a 
DNA standard Gene RulerTM with either 100 bp or 1 Kb was used. 
Electrophoretic separation was achieved by constant current at 5 
V/gel cm for 60 to 90 minutes.  
 
Table 2.6. Runnning and loading buffer used for DNA electrophoresis 
1 x TBE 1 x TAE (modified)* Loading buffer 
90 mM Tris 40 mM Tris-acetate, pH 8.0 10 mM Tris/HCl, pH 7.5 
90 mM Boric acid   0.1 mM Na2EDTA 20% Ficoll 
2 mM EDTA  1 mg/ml Orange G 
* Modified TAE has 0.1 mM Na2EDTA while standard TAE has 1.0 mM. The lower concentration of 
EDTA in the modified TAE does not interfere with the magnesium concentration required for 
downstream enzymatic reaction (Montage). 
 
2.2.14.3. DNA visualization 
DNA within agarose gels is only visible when stained with ethidium 
bromide and can then be visualized under UV light. The gel was placed onto 
an UV ilumuminator that emits UV light at 302 nm and photographed with a 
CCD camera connected to a computer (Epi Chemi II). Image files were 
saved, printed and subsequently analyzed. The size of the DNA was 
determined by comparing their mobility with the fragments of the Gene Ruler. 
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2.2.15. Isolation of DNA fragments from agarose 
Isolation of DNA fragment from agarose gels was performed using the 
DNA Gel Extraction Kit or QIAquick Gel Extraction Kit as recommended by the 
manufacturers Montage and Qiagen, respectively: 
 
2.2.15.1. Montage DNA Gel extraction kit 
This kit contains a centrifugal filter device created to extract DNA 
fragments that range in size from 100 to 10,000 bp. When using this kit, the 
agarose gel and electrophoresis buffer was made with 1 x modified TAE 
buffer (Table 2.6). The agarose gel was placed above an UV table (Foto Prep 
I) and using a scalpel, a slice containing the desired DNA band was cut out 
from the agarose gel and placed into the Gel Nebulizer provided by the 
respective company. The Gel Nebulizer was connected to a sample filter 
cup, which was placed into a vial and centrifuged for 10 minutes at 5,000 x g. 
The centrifugation forces the agarose though the Gel Nebulizer, converting it 
into fine slurry that is captured by the Sample Filter Cup. The DNA passes 
through the microporous membrane in the sample filter cup and is collected 
in the vial. 
 
2.2.15.2. QIAquick® Gel Extraction Kit 
A slice containing the desired DNA band was excised from the gel. The 
gel slice was placed in a 1.5 ml eppendorf tube, and weighed. Three volumes 
of buffer QX1 were added to one volume of gel (e.g., 300 µl of buffer QX1 to 
each 100 mg of gel). 
The gel slice was incubated at 50ºC for 10 min to dissolve the agarose. 
To help gel dissolution the tubes were vortexed every 2 minutes. A QIAquick 
spin column was placed in a 2 ml collection tube. After the gel slice was 
dissolved completely, the solution was applied to the QIAquick column. This 
column was centrifuged for 1 min at 10,000 g. The DNA was bound to the 
column and the flow-through was discarded. 
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For washing, 750 µl of buffer PE was added to the column and 
centrifugation was performed for 1 min. The flow-through was discarded and 
centrifugation was repeated for an additional minute.  
The column was placed into a 1.5 ml eppendorf tube, and elution of 
DNA was performed by adding 50 µl of water or TE buffer to the center of the 
column and incubated for 1 min. Subsequently eppendorf tube with column 
was centrifuged for 1 min. This step was repeated once to remove residual 
DNA from the column. 
 
2.2.16. Phenol-chloroform extraction 
An equal volume of phenol/chloroform/isoamylalcohol (PCI) was 
added to a DNA solution in a 1.5 ml eppendorf tube and vigorously vortexed. 
Subsequently the solution was centrifuged at 10,000 g for 3 min at RT, and the 
aqueous upper phase was transferred to a new eppendorf tube for ethanol 
precipitation. 
 
2.2.17. Ethanol precipitation 
One tenth volume of 3 M sodium acetate (pH 5-7) and 2 ½ volumes of 
100% ethanol were added to the DNA solution and mixed. When having low 
DNA amounts, 1 µl glycogen (20 µg) was added additionally, followed by an 
incubation for 30 min at -80ºC or 2 hours at – 20ºC, and centrifugation for 30 
min at 10,000 x g. The supernatant was carefully removed, and the DNA pellet 
was washed with 1 volume of room-temperature 70% ethanol, followed by 
centrifugation at full speed for 10 min, the supernatant was carefully 
removed, and the DNA pellet was dried at 65ºC and dissolved into 10T 0.1E 
buffer at 65ºC for 5 min. 
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  2.2.18. Screening transformants for inserts by blue/white selection  
 Successful ligation of fragments cloned into the pGEM-T easy vector 
can be checked by color screening on indicator LB-agar plates. When a 
fragment is cloned into the pGEM-T easy vector, the fragment interrupts the 
coding sequence of the β-galactosidase gene and in turn the bacterial 
colonies will not turn blue. Therefore white colonies are picked for mini-prep 
and checked by restriction endonucleases.  
 Thirty minutes prior to plating the cells, 100 µl IPTG (100 mM), and 12.5 µl 
X-gal (80 mg/ml) were plated and incubated to allow the plates to absorb 
the liquid. The bacterial culture was plated onto a 90 cm plate and left open 
inside the fume hood until all the liquid was absorbed, then closed and 
incubated inverted at 37ºC overnight. 
 
2.2.19. DNA Sequencing 
The sequencing method  is based on the use of modified nucleotides, 
so called 2`, 3`-dideoxyl analogs (Sanger et al., 1977). These special 
nucleotides lack a hydroxyl residue at the 3`position of the deoxyribose. When 
DNA polymerase adds nucleotides into a DNA chain through its 5` 
triphosphate groups, the absence of a hydroxyl group on a dideoxyl analog 
avoids the formation of a phosphodiester bond with an adjacent nucleotide, 
leading to a stop in elongation. As the concentration of the analogs is very 
low, termination happens just occasionally. With four different analogous 
nucleotides in four separate reactions, numerous fragments corresponding to 
every base position will be synthesized. As fluorescently primers were used, 
newly synthesized DNA fragments are marked and the sequence can be 
detected by excitation with a laser and detection with photodiodes in a 
sequencing machine. We used the Li-cor machine, which has a dual laser, 
allowing the use of two labeled primers in a single tube reaction. 
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2.2.19.1. Gel preparation  
Before gel preparation, the sequence plates (66 cm) were rinsed twice 
with distilled water and 80% ethanol, and dried with a precision wipe tissue. 
Glass plates were put together with spacer between them and fixed with the 
rails. The 66 cm gel was made by adding the compounds depicted below 
into 100 ml beaker: 
 
Sequence gel    
Urea 25.2 g 
50% Acrylamide 5.6 ml 
10 x TBE 6.0 ml 
Distilled water, complete to  60.0 ml 
 
The contents were mixed thoroughly and filtered through a 0.45 µm 
pore size filter. To polymerize the gel, 400 µl of 10% ammonium persulfate (APS) 
and 40 µl of N,N,N,N-Tetramethylethylendiamin (TEMED) were added to the 
solution, briefly mixed and injected between the plates. 
 
2.2.19.2. DNA sequence reaction 
 
The sequence reaction was prepared in a sterile PCR tube using a 
Cycle Reader™Auto DNA sequencing Kit (MBI Fermentas), which provides the 
nucleotides, enzyme and buffer.  The nucleotide mixes were thawed on ice 
and 2 µl of each nucleotide mix (A, C, G and T) was added separately in 
each PCR tube. The following compounds were added in a eppendorf tube:  
 
Reaction sequence   
DNA ± 400 ng 
Buffer 2.5 µl 
Each label primer 2.0 pmol 
Polymerase 2.0 µl 
Water to 17 µl 
 
The compounds were mixed and briefly centrifuged and 4 µl of the 
reaction was added in each PCR tube containing the nucleotide mixes. The 
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sequence reactions were performed using a thermal cycler with the following 
program: 
                        
Segment Cycles Temperature Time 
1 1 94ºC 3 minutes 
2 40 94ºC 30 seconds 
  56ºC 30 seconds 
  72ºC 1 minutes 
 
After termination of the program, 3 µl stop solution was added, mixed 
and briefly centrifuged. 
 
2.2.19.3. DNA sequence electrophoresis 
Electrophoresis was performed using a 4200 and 4300 DNA Analyzer (Li-
cor) machine, which was connected to a computer. As running buffer, 0.8 x 
TBE buffer was used. Prior to sequencing, samples were heated to 90ºC for 3 
minutes and placed on ice, 1.5 µl was loaded and the gel was running for 
about 10 hours. The following day the results were analyzed with the DNA 
Sequencing and Analysis Software, version 3.0 (Li-cor). 
 
Running conditions 
Voltage 3000 V 
Current 30 mA 
Power 75 W 
Temperature 45 ºC 
Signal Filter 1  
Scann speed 3  
Frames 30  
 
10 x TBE buffer   
Tris Base 107.8 g 
Boric Acid  55.8 g 
EDTA 7.4 g 
Water to 1 L 
 
 
2.2.20. Gene transfer techniques (transfection of eukaryotic cells) 
The introduction of DNA or RNA molecules into target cells has been 
used to create cells expressing transiently or stable a gene of interest. 
Transfections are important to study cellular expression of proteins, for protein 
localization, to study transcription or translation, and for many other purposes. 
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Many techniques are available to introduce DNA of eukaryotic expression 
vectors containing the gene of interest into mammalian cells. These 
techniques can be basically divided into chemical, mechanical, electrical 
and viral methods. The transfection methods used in my study are briefly 
described below. 
 
2.2.20.1. Calcium phosphate precipitation method 
Calcium phosphate is a well known method to introduce DNA into 
mammalian cells, and is used preferably for transient expression of foreign 
DNA, but has also been used for stable expression. This method consists of 
encapsulation of DNA within a calcium phosphate precipitate which then 
enters the cells by endocytosis (Chen and Okayama, 1988; Graham and Eb, 
1973). One day prior to transfection, 3 x 106 cells were plated in a 10 cm plate. 
To perform the experiment, we used two eppendorf tubes: in the first one, 20 
µg plasmid DNA, 50 µl 2.5 M calcium chloride and water to 500 µl were 
added. In the second tube 500 µl BBS (pH 6.95) was added. The contents from 
the first tube (DNA/Ca2+/water) was added dropwise to the second tube 
containing BBS, and followed by incubation at 37ºC in a water bath for 15 
minutes. During this incubation time, when using HEK 293 cells, the medium 
was replaced with 12 ml of DMEM high glucose medium containing 
antibiotics and FCS. After incubation, the transfection mix was added 
dropwise onto the cells and rocked gently to ensure even distribution of the 
precipitate. The cells were incubated at 37ºC overnight with 3% CO2. The next 
day cell medium was gently replaced with 12 ml of HEK 293 cell medium, and 
CO2 was set to 5% again. 
 
2 X BBS buffer   
BES/HCl 50 mM 
NaCl 280 mM 
Na2HPO4 1.5 mM 
(pH 6.95)    
Storage at -20ºC   
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2.2.20.2. Transfection with GeneJuice 
 GeneJuice™ transfection reagent (Novagen) is a proprietary 
formulation of polyamines. One day prior to transfection the cells were 
trypsinized and 6 x 105 cells were plated in each well of a 6 well plate (the cell 
number and medium volume were adjusted according to the cell line and 
plate used, for example, please see Table 2.7). The following protocol was 
used for transfection in a 6 well plate.  
In a sterile eppendorf tube 100 µl serum-free medium plus 4 µl 
GeneJuice was mixed by vortexing and incubated for 5 minutes at room 
temperature. 2 µg DNA was added to the GeneJuice/serum-free medium 
mixture, gently mixed and incubated at room temperature for 15 minutes. The 
entire volume of DNA/GeneJuice was added dropwise to the cells in 
complete growth medium, the dish was gently rocked to guarantee even 
distribution, and the cells were incubated at 37ºC, 5% CO2 for 24-48 hours. 
 
Table 2.7. Plate size and recommended cell number for adherent cultures* 
Plate size Number of cells plated the day 
before transfection (x 105) 
Volume of growth 
medium (ml) 
24 well 1 0.5 
12 well  2 1.0 
6 well/35 mm dish  6 3.0 
60 mm dish 10 5.0 
100 mm dish 30 12.0 
* The cell number shown here was optimized in our laboratory for HEK 293 cells and differs 
from the GeneJuice™ Transfection Reagent protocol. 
 
2.2.20.3. Transfection with FUGENE 
Fugene transfection reagent (Roche), which is a proprietary of lipids 
and other components supplied in 80% ethanol, was also used to transfect 
eukaryotic cells. One day before transfection, 3 x 105 cells were plated per 
well in a 6 well plate. For transfection 97 µl DMEM was added into a sterile 
eppendorf tube and 3 µl FUGENE was directly pipetted into the medium (this 
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order is critical when using FUGENE reagent) and incubated at room 
temperature for 5 min. To the prediluted FUGENE reagent 1 µg DNA was 
added, mixed and incubated for 30 min at room temperature. The mixture 
FUGENE/medium/DNA was added dropwise onto the cells and the plates 
were rocked carefully to ensure even distribution and incubated according 
to standard procedures. 
 
 2.2.20.4. RNA Transfection (Qiagen) 
To transfect RNAs transcribed in vitro (section 2.2.22) into mammalian 
cells, TransMessenger™ Transfection Reagent (Qiagen) was used. The 
advantage in transfecting RNA is that it is delivered into the cell’s cytoplasm 
where it can be directly translated. By DNA transfection, the DNA transfected 
first has to enter the nucleus, be transcribed and then exported to the 
cytoplasm where it will be translated. 
The following protocol is based on the TransMessenger Transfection 
Reagent Handbook 10/2002. Twenty four hours before transfection HEK 293 
cells were plated at a density of 6 x 105 cells per well in a 6 well plate, 
containing 2 ml of complete medium. On the day of transfection, 4 µl 
Enhancer R was diluted in Buffer EC-R and mixed with 2 µg RNA (the final 
volume was 100 µl). The mixture Enhancer/buffer/RNA was incubated at room 
temperature for 5 minutes. Soon after that, 8 µl of TransMessenger Transfection 
Reagent was added, and mixed by pipetting up and down five times. To 
allow complex formation, the sample was incubated for 10 minutes at room 
temperature. Almost at the end of the incubation time, the complete cell 
growth medium was removed and the cells were gently washed with pre-
warmed PBS++. 900 µl serum-free medium (without antibiotics) was added to 
the transfection complexes and mixed by pipetting up and down twice. The 
transfection complexes were added onto the cells dropwise, and the plate 
was rocked to ensure even distribution. Cells were cultivated at 37ºC, 5% CO2 
for 3 hours, then the complex was removed from the cells, and washed once 
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gently with PBS++. Carefully 2 ml of complete growth medium was added and 
the cells were cultivated under standard conditions. 
 
2.2.21. Site-Directed Mutagenesis 
To make mutations in the myeov upstream AUGs (uAUGs), the 
QuikChange® Multi Site-Directed Mutagenesis Kit (Stratagene) was used. 
Myeov 5`UTR cloned into pGEM-T easy vector (Promega) was used as 
template. The method consists of PCR cycling (Table 2.8) using a mutagenic 
primer which anneals to denatured template DNA, and Pfu DNA polymerase 
to extend the mutagenic primer. This generates ds-DNA molecules, a 
template strand and a newly synthesized strand containing multiple mutations 
and nicks, which is sealed by components in the enzyme blend.  This PCR 
reaction creates copies of the template DNA containing one or more 
mutations. 
 
                           Table 2.8 Cycling parameters 
Segment Cycle(s) Temperature Time 
1 1 95ºC 1 minute 
2 30 95ºC 1 minute 
  55ºC 1 minute 
  65ºC    7 minutes* 
                 * 2 minutes/Kb of plasmid length 
 
After PCR, the reaction was digested with 1 µl of the restriction 
endonuclease Dpn I. This restriction enzyme targets the sequence 5`Gm6ATC-
3` which is specific for methylated and hemimethylated DNA (Nelson and 
McClelland, 1992) and therefore digests the parental template DNA, since 
almost all DNA isolated from E. coli strains is dam methylated, the newly 
synthesized and mutated DNA strand will not be digested.   
In the last step, the digested DNA was transformed into XL10-Gold® 
ultracompetent cells, where the mutated closed circle ss-DNA was converted 
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into a duplex form in vivo. The mutant plasmid was transformed by a 
chemical method as described in section 2.2.8.2. 
 
Mutagenesis reaction   
10 x reaction buffer 2.5 µl 
Water to a final volume of 25 µl 
ds-DNA template 50 ng 
Mutagenic primers each 50 ng 
dNTP mix 1 µl 
QuikChange® enzyme blend 1 µl 
 
2.2.22. RNA synthesis in vitro 
To produce in vitro capped RNA, we used the kit mMESSAGE 
mMACHINE™ from Ambion. The transcription using this system uses SP6, T3 or T7 
RNA polymerase. We have transcribed the plasmids pBSK, pBSK+UTR and 
pBSK+UTRmutated, which are under control of the T3 promoter. Prior to 
transcription, DNA was prepared as described below. 
 
2.2.22.1. DNA plasmid preparation prior to in vitro transcription 
The plasmids were first linearized using the restriction endonuclease Xho 
I. This restriction enzyme was used because the Xho I site was situated 
downstream of the sequence that we wanted to transcribe (myeov 5`-UTR 
and Firefly luciferase reporter gene). The restriction digestion was terminated 
by adding 1/20th volume of 0.5 M EDTA. DNA was then precipitated, washed 
with 70% ethanol and the DNA pellet was dried at 65ºC and resuspended in 
sterile water. As the template could be contaminated with RNase A from the 
mini-preparation (section 2.2.9.1), the linearized DNA was treated with 150 µg 
RNase-free proteinase K plus 0.5% SDS for 30 minutes at 50ºC. The plasmid 
DNA was then extracted with phenol/chloroform/isoamylalcohol, ethanol 
precipitated (section 2.2.16 and 2.2.17, respectively) and resuspended in 
DEPC-treated water in a concentration of 1 µg/µl. 
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2.2.22.2. In vitro RNA transcription reaction 
The transcription reaction was performed using RNase free filter tips and 
sterile eppendorf tubes. The reaction described below was incubated in a 
thermal block at 37ºC for 2 hours. The transcribed RNA was purified using the 
RNeasy MinElute Cleanup Kit (Qiagen). The quantity and purity was controlled 
using a spectrophotometer at A260, and the quality and size of the RNA 
transcribed was checked by formaldehyde agarose-gel electrophoresis. 
 
RNA transcription   
Linear template DNA 1 µg 
10 x reaction buffer 2 µl 
2 x NTP/cap 10 µl 
Enzyme mix 2 µl 
Nuclease-free water to 20 µl 
 
2.2.23. Luciferase assay 
 To measure the reporter genes Firefly luciferase (Photinus pyralis) and 
Renilla luciferase (Renilla reniformis) (de Wet et al., 1987; de Wet et al., 1985) in 
transfected cells or made in vitro, the Dual-Luciferase® Reporter (DLR™) Assay 
System (Promega) was used. To perform the assay in transfected cells, it was 
necessary first to obtain the cell lysate as described below. 
 
2.2.23.1. Procedure prior to the luciferase assay  
The medium of transfected cultured cells was removed, and the cells 
were briefly washed with pre-warmed PBS++. An appropriate amount of 
passive lysis buffer (table 2.9) was added onto the cells and incubated for 15 
min at room temperature with gently shaking. From this cell lysate only 20 µl 
was used for luciferase measurement and the rest was stored at -80ºC. 
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Table 2.9. Volume of passive lysis buffer 
Well Plate 1X PLB (µl) 
6 500 
12 250 
24 100 
48 65 
96 20 
 
2.2.23.2. Luciferase measurement 
To assay Firefly and Renilla luciferase, we used an automated 
luninometer (Rosys Anthos Lucy 2) with dual dispenser, one to inject the 
substrate to measure Firefly luciferase, and one to inject the substrate to 
measure Renilla luciferase. For this purpose, 20 µl of the cell lysate was placed 
in a special 96 well plate. The luminometer was connected to a computer, 
and the lucy software was used to process the assay. The parameters were 
set (table 2.10) and the luciferases were measured sequentially from a single 
sample in the same tube. At first, Firefly luciferase was measured the by 
adding 100 µl of the Luciferase Assay Reagent II (LAR II), which generates a 
“glow-type” luminescent signal. After quantifying the firefly luminescence, the 
reaction was quenched, and Renilla luciferase reaction was measured by 
adding 100 µl of Stop & Glo® reagent, which also produces a “glow type” 
signal. The lucysoft program is based on the Microsoft® Excell software and 
therefore the measurements are all collected automatically in an excel table.  
 
 Table 2.10. Parameters used to measure Firefly and Renilla luciferase 
 Parameters Time (seconds) 
 Waiting time 1 
 Lag time 2 
 Integration time 1 10 
 Lag time 2 
 Integration time 2 10 
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2.2.24. RNA preparation 
Total RNA was isolated from cultured cells using the High Pure RNA 
Isolation Kit from Roche. Total RNA was either used directly for Northern Blot 
analysis or used as starting material to make mRNA. mRNA was prepared from 
total RNA using the mRNA Isolation Kit (Roche). Alternatively, mRNA was 
prepared directly from cultured cells using the GenElute direct mRNA 
miniprep kit (Sigma). All procedures for RNA extraction were performed as 
suggested by the manufacturer. The cultured cells were washed with 
prewarmed PBS, typsinized and the trypsination was stopped by adding full 
growth medium. Cells were spun down for 5 min at 300 x g and washed twice 
with PBS, the cells were then used for total RNA or Poly(A) RNA isolation. After 
RNA isolation, the quantity and purity was controlled using a 
spectrophotometer (section 2.2.10) and the quality was checked by agarose-
gel electrophoresis and visualization on an UV-iluminator (section 2.2.14). 
 
2.2.24.1. Isolation of total RNA 
Cells resuspended in 200 µl PBS were mixed with 400 µl lysis/binding 
buffer. The lysate was pipetted into a filter tube combined with a collection 
tube and centrifuged for 15 s at 8000 x g and the flow through was discarded. 
DNase (90 µl DNase incubation buffer plus 10 µl DNase I) was added to the 
filter tube and incubated for 15 min at room temperature. To wash the RNA, 
500 µl wash buffer I was added into the filter, centrifuged for 15 s and the flow 
through was discarded. The wash procedure was repeated twice with 500 µl 
and 200 µl wash buffer II, respectively. In the second wash the centrifugation 
time was increased to 2 min to remove all residual washing buffer. The filter 
tube was transferred to a sterile eppendorf tube and 50-100 µl DEPC-treated 
water was added and centrifuged for 1 min at 8000 x g. The RNA was 
measured in a spectrophotometer, and 1 µg was loaded onto an agarose 
gel (control gel) and the rest was dried using a speed vac centrifuge and the 
Materials & Methods 
 
 78
pellet was resuspended in RNA sample buffer at a concentration of 0.5 µg/µl 
and stored at -80ºC.   
 
2.2.24.2. Isolation of mRNA 
To isolate polyadenylated mRNA, the GenElute™ Direct mRNA Miniprep 
Kit (Sigma) was used. All steps were carried out at room temperature and 
centrifugation steps were at maximum speed as recommended by the 
manufacturer. The cell pellet (up to 107 cells) was resuspended by vortexing in 
0.5 ml Lysis Solution (containing 1 mg/ml Proteinase K in 40% glycerol). The cell 
lysate was transferred into a GenElute filtration column and spun down for 2 
min and incubated for 10 min at 65ºC. While the solution was still warm, 32 µl 
of 5 M NaCl plus 25 µl of the oligo(dT) beads were added to the digested cell 
lysate, and mixed thoroughly by vortexing. The lysate was incubated for 10 
min to allow binding of the oligo(dT) beads to the mRNA. The complex was 
centrifuged for 5 min and the pellet was resuspended in 350 µl wash solution 
and transferred into a GenElute spin filter-collection tube, spun down for 2 min 
and washed twice with 350 µl Low Salt Wash Solution. The spin filter was 
transferred into a fresh collection tube and 50 µl Elution Solution pre-heated to 
65ºC was added into the spin filter, incubated for 5 min at 65ºC and spun 
down for 2 min. The same elution step was repeated once. The mRNA was 
precipitated by adding 15 µl 2 M NaAc, 250 µl of ice-cold 100% ethanol and 1 
µl glycogen (20 µg) and incubated overnight at -20ºC. The next day the 
solution was centrifuged at full speed in a refrigerated centrifuge at 4ºC for 30 
minutes, the pellet was washed with 200 µl 70% ethanol and the pellet was 
dried at 65ºC and resuspended in 20 µl RNA sample buffer. 
 
RNA sample buffer   
Running buffer  1 x 
Deionised formamide 50 % 
Water 20 % 
Formaldehyde 20 % 
(sterile filtration)   
 
Materials & Methods 
 
 79
2.2.25. Preparation of formaldehyde gel   
Agarose (1.0 to 1.5 g) was mixed with 10 ml 10 x running buffer (1 x final 
concentration) and DEPC treated water to 80 ml. The agarose solution was 
incubated in a microwave until it was completely dissolved (during boiling the 
water volume decreases by evaporation, therefore DEPC-water was added 
to readjust the original volume of 80 ml). In a fume hood, the agarose was 
cooled down and 20 ml of 37% formaldehyde was added (formaldehyde 
vapor is toxic). The gel solution was poured immediately into a clean gel tray 
(the gel tray and comb were incubated overnight with 10% H2O2, and rinsed 
with DEPC treated water prior to use) and allowed to solidify for at least 30 
minutes. 
 
10 x running buffer   
HEPES 500 mM 
EDTA . 2 H20  10 mM 
Sodium acetate trihydrate 50 mM 
(pH adjusted with NaOH to 7.0)   
(autoclaved)    
 
2.2.25.1. Sample preparation for electrophoresis 
Before loading samples on a formaldehyde gel, 20 µl (10 µg) of RNA in 
sample buffer was incubated for 10 min at 68ºC and chilled on ice, briefly 
centrifuged and 2 µl ethidium bromide (0.5 µg/ml) was added and mixed by 
pipetting up and down, followed by addition of 5.5 µl 5 x loading buffer. 
 
5 x loading buffer   
Bromophenolblue & xylene cyanol FF 0.4 % 
Glycerol 50 % 
NaH2PO4 0.01 M 
 
2.2.25.2. RNA electrophoresis 
The RNA samples were loaded onto a formaldehyde gel and run for 
about 3-4 hours at 80 V until the bromophenol blue marker almost reached 
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the end of the gel. The gel was observed under UV light and photographed. 
The gel was washed twice for 20 min with DEPC treated 20 x SSC buffer. In the 
second wash, the nitrocellulose membrane was briefly wetted in DEPC-H2O 
and incubated together with the gel in 20 x SSC buffer. 
 
20 x SSC   
NaCl 3 M 
Tri-Sodium citrate dihydrate 0.3 M 
DEPC 0.1 % 
pH 7.0   
 
2.2.25.3. RNA blotting 
To avoid contamination of the blotting apparatus, one whatman paper 
(larger than the gel) wetted in 20 x SSC was placed on the apparatus before 
making the transfer “sandwich”. The “sandwich” was made by placing the 
gel on top of the large whatman paper. Used x-ray films were placed 
alongside the gel to guarantee that 20 X SSC pass through the gel only. The 
nylon membrane was placed onto the gel and all possible bubbles were 
removed. Carefully two whatman papers wetted in 20 x SSC, two dry 
whatman papers and tissue papers (the contents of a full box) were placed 
on top of the membrane and the sandwich was weighted with a one liter 
bottle of water.  
The blot was performed until all tissues were wetted with buffer, usually 
an overnight incubation was enough. The next day, transfer quality was 
checked by UV illumination and the slots were marked on the membrane. The 
membrane, with the RNA facing upwards was UV-crosslinked for 12 seconds 
(auto crosslink setting, 254 nm, Stratagene, Stratalinker). The membrane was 
then placed inside a whatman paper and baked for 2 hours at 80ºC.  
 
2.2.25.4. Hybridization 
The DNA insert to be labeled (50 to 100 ng) was diluted in a total 
volume of 22 µl water and incubated at 95ºC for 5 min and chilled on ice for 2 
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min. To avoid DNA precipitation, the following solutions were warmed at 37ºC 
for 2 min, and added to the DNA (which was also warmed at 37ºC).  
 
HexaLabel™ DNA Labelling Kit (MBI Fermentas) 
Hexanucleotide in 5 x buffer 10 µl 
Spermidin (10 mM) 3 µl 
Mix minus C 3 µl 
32P -dCTP  4 µl 
Polymerase klenow 1 µl 
 
The reaction was incubated at 37ºC for 10 min, 4 µl dNTPs were added 
and incubation was proceeded at 37ºC for 5 min. The reaction was stopped 
by adding 1 µl 0.5 M EDTA.  
The reaction was applied to a Sephadex G50 column and then 80 µl of 
TE buffer was added dropwise, followed by the addition of 130 µl of TE buffer 
twice. The flow through was collected in one eppendorf tube. This was 
followed by a successive application of 130 µl TE buffer (not dropwise any 
more)  of which each flow through was collected in a single eppendorf tube. 
The radioactivity was measured and the reaction containing the 
radiolabelled DNA probe was taken for further experiments. To this solution, 20 
µl salmon sperm DNA was added, followed by incubation for 10 min at 95ºC 
and cooled on ice. The solution was finally added to the hybridization mix, 
swirled 10 times before the membrane was added and incubated overnight 
at 63ºC.  
 
Hybridization mix   
Denhardt´s 10 x 
Dextransulfat 10 % 
SDS 0.1 % 
Salmon sperm  DNA 50 mg/l 
 
100 x Denhardt´s   
Ficoll type 400 2 % 
BSA fraction V 2 % 
Polyvinylpyrolidon type 360 2 % 
 
 
2.2.25.5. Washing and membrane exposure 
On the following day, the membrane was washed with 3 x wash buffer 
for 20 min at 63ºC. When necessary the membrane was washed more 
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stringently (1 x, 0.3 x or 0.1 x wash buffer) and/or the temperature was 
increased up to 73ºC. The membrane was placed in a MS-cassete with 
intensifying screen containing MS-film and kept at -80ºC and developed the 
following day. 
 
2.2.26. Electrophoresis of proteins on SDS-polyacrylamide gels  
To separate proteins by size, sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed in a vertical gel chamber 
according to a described method (Towbin et al., 1979). This method is based 
on a two gel layer system (Laemmli, 1970): a stacking gel and a separating 
gel.  
            
Solution for preparing 12% separating gels 
Water 5.15 ml 
40% Acrylamide:bisacrylamide 29:1 3.60 ml 
1.5 M Tris/HCl, pH 8.8 3.00 ml 
20% SDS 60 µl 
              
Solution for preparing 5% stacking gels 
Water 4.66 ml 
40% Acrylamide:bisacrylamide 29:1 780 µl 
1.0 M Tris/HCl, pH 6.8 800 µl 
20% SDS 32 µl 
 
2.2.26.1. Gel preparation 
 The amounts depicted above are sufficient to make 2 mini gels in a 
cassette from Invitrogen. The contents were mixed and in order to polymerize 
the separating gel, 10% ammonium persulphate (120 µl) plus TEMED (7.2 µl) 
was added. Working quickly, the solution was applied into the gel cassette up 
to ± 6.5 cm, and the last ± 2.5 cm of the cassette was filled with distilled water.  
The gel was polymerized for at least 30 min, and the water was carefully 
removed. To prepare the stacking gel, 64 µl APS and 6.4 µl TEMED were 
added to the stacking gel solution and the solution was directly poured into 
the gel cassette, and the gel comb was placed to form the slots. The stacking 
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gel was polymerized for at least 30 min, and used on the same day or stored 
at 4ºC in a sealed bag containing 1 x running buffer. 
 
2.2.26.2. Sample preparation 
The samples containing proteins were resuspended in 1 x sample buffer 
(with 10% DTT). DTT is prepared in 0.01 M Na-acetate pH 5.2 and added at a 
final concentration of 10% to the sample just prior to use. The samples were 
denaturated for 5 min at 95ºC and loaded immediately on the SDS PAGE gel.  
 
4 x Sample buffer   
Tris/HCl pH 6.8 0.2 M 
SDS 8 % 
Bromophenol 0.02 % 
Glycerol 40 % 
DTT 0.1 M 
 
2.2.26.3. Electrophoreris 
Electrophoresis was carried out in Tris-glycine electrophoresis buffer 
using a Novex apparatus. The electrophoresis was divided in two steps. During 
the first step the proteins run in the stacking gel for 15 min at 150 V, 250 mA, 25 
W. In the second step, the proteins were separated by size running through 
the pores of the separating gel for 105 min at 100 V, 250 mA, 25 W. As 
molecular weight marker SeeBlue®Plus2 from Invitrogen was used, containing 
marker proteins of 4, 6, 16, 30, 36, 50, 64, 98 and 250 KDa, respectively. The 
protein gel was ready for blotting and subsequent immunodetection (sections 
2.2.26.4 and 2.2.26.5, respectively). 
 
2.2.26.4. Transfer of proteins from gels to nitrocellulose membrane 
 For immunological detection of the proteins of interest, the proteins 
from the gels were transferred after electrophoretic separation onto a 
nitrocellulose membrane. For this purpose, a transfer set (depicted below) 
Materials & Methods 
 
 84
was prepared using: 2 sponges, the gel from SDS-PAGE, nitrocellulose 
membrane, and 4 whatman papers (cut according to the gel size).  
 
 
 
All contents were soaked in transfer buffer. To prepare the transfer set, 
the first sponge and two whatman papers were placed inside the transfer 
plate (cathode side), and the gel was carefully placed on top of the 
whatman paper. The nitrocellulose membrane was then placed on the gel, 
which was covered with the last two whatman papers and the sponges, and 
finally closed with the transfer plate (anode side). The transfer set was placed 
inside the transfer apparatus immersed with transfer buffer, and the electric 
field was applied (25 V, 125 mA, 17 W, for 90 min). After transfer, the gel was 
stained to check for blotting efficiency and the nitrocellulose membrane was 
used for immunodetection (section 2.2.26.5).   
 
Transfer buffer   
Tris Base 12 mM 
Glycine 96 mM 
Methanol 20 % 
(pH 8.3 prior addition of methanol) 
 
2.2.26.5. Immunodetection of blotted proteins 
Immunodetection of specific proteins blotted onto nitrocellulose 
membrane was performed according to Gershoni, JM (Gershoni and Palade, 
1983). Nitrocellulose membrane with immobilized proteins were first stained 
with Ponceau Red (0.1% v/v Ponceau S in 1% v/v acetic acid) to control the 
amount of proteins present on the membrane, and to mark the molecular 
weight markers. The membrane was washed with distilled water, and it was 
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subsequently blocked for 1 hour at RT in blocking solution (10% dry milk in TBS-
T) to block free binding sites on the membrane. The membrane was then 
incubated overnight at 4ºC with the appropriate antibody (diluted in blocking 
solution) which recognizes and binds to the protein of interest. Next day, 
unbound antibodies were washed off (5 x 6 min) with 1 x TBS-T buffer, and the 
membrane was then incubated with the secondary antibody (goat IgG 
against rabbit IgG or mouse IgG conjugated with horseradish peroxidase) for 
1 hour at room temperature. After washing off unbound secondary antibody 
conjugates (5 x 6 min) with 1 x TBS-T buffer, positive bands were detected 
using the chemiluminescence reaction (section 2.2.26.6). 
 
Antibody Type Company Dilution 
Anti-GAL4 BD mouse monoclonal Santa Cruz 1 : 10,000 
Anti-MYEOV rabbit polyclonal Homemade 1 : 1,000 
Goat anti-mouse IgG-HRP conjugated BioRad 1 : 5,000 
Goat anti- rabbit IgG-HRP conjugated BioRad 1 : 20,000 
 
2.2.26.6. Cheminulescence reaction 
To visualize the proteins, an ECL kit was used as recommend by the 
manufacturer (Amersham). An equal volume of detection solution 1 (oxidizing 
reagent) was mixed with detection solution 2 (enhancer reagent), and used 
to cover the nitrocellulose membrane for 1 min. Subsequently, the membrane 
was placed in the film cassette. The lights were switched off and a sheet of 
autoradiography film (X-OMAT AR, Kodak) was placed on top of the 
membrane. The cassette was closed and the membrane was exposed to a 
film for 1 min. The film was developed immediately in a film developer 
(Epichemi II darkroom, UVP). On the basis of the appearance of various 
bands it was estimated how long the exposure of the second film had to be 
continued. Second exposures varied from 20 sec to 5 hours, depending on 
the amount of the target protein on the membrane. 
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3. Results 
3.1. Translation of myeov open reading frame 
 The myeov gene codes for a transcript of 2300 nucleotides and exhibits 
a long 5`UTR of 445 nucleotides and a 3`UTR of 800 nucleotides. The myeov 
mRNA contains two open reading frames coding for two proteins, one long 
one with 313 amino acids and one short one with 255 amino acids. Both 
proteins share the same stop codon (Figure 3.1).  
 
 
Figure 3.1. The amino acid sequence of myeov. 
The possible two open reading frames of myeov are shown, the arrows indicate the 
start codon of both proteins, that share the same stop codon. The six transmembrane 
domains are shown in blue, and the ribonucleoprotein-1 motive is marked red. The 
leucine and isoleucine tail is underlined.   
 
The long open reading frame has a start codon in a suboptimal context 
(CTCAUGG) and the second open reading frame has an imperfect start 
codon (CTCAUGT) (for details of Kozak’s start codon, please see the 
introduction section 1.4).  
 
3.2. The complete myeov mRNA is not translated 
Several constructs containing either the full myeov cDNA or only the 
long or short open reading frame were cloned into the eukaryotic expression 
vector pMT2SM (Figure 3.2a). The eukaryotic expression vector pMT2SM 
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containing myeov constructs were transfected into several eukaryotic cell 
lines to transiently express MYEOV. Three days after transfection of the 
constructs  shown on Figure 3.2a, proteins were isolated from the transfected 
cells and were resolved by 10% SDS-PAGE and blotted onto nitrocellulose 
membrane by standard procedures. The nitrocellulose membrane was 
blocked, and incubated with our MYEOV specific antibodies and developed 
using a luminescence reaction (Figure 3.2b).  
The protein detected with our MYEOV antibody in lane 1 (Figure 3.2b) 
corresponds to transfection of DNA of construct number 1, where the myeov 
short open reading frame was modified to have a perfect Kozak’s start codon 
(shown with a green arrowhead). The second lane shows the protein 
corresponding to construct number 2. In this construct the start codon of the 
long open reading frame was modified to a perfect Kozak’s start codon. 
Proteins shown in lanes three and four correspond basically to the constructs 
one and two, however, these constructs lack the leucine tail (see Figure 3.1, 
underlined amino acid sequence). Lanes five and six show transfections with 
constructs of the myeov short and long ORF containing its own start codon, 
again protein could be detected using our MYEOV specific antibody. In the 
lanes 1 to 6, we can see that the transfected constructs produce enough 
myeov proteins detectable by MYEOV antibody. However, in lanes 7 and 8 
no-protein could be detected. These lanes correspond to constructs 
exhibiting the complete myeov cDNAs coding for the short and the long ORF, 
respectively. The absence of MYEOV protein after transfection with constructs 
containing the full myeov cDNA draws our attention. We wondered why 
transfection of the full myeov cDNA did not produce detectable MYEOV 
proteins. During standard ribosome scanning, the 40S ribosomal subunit, with 
associated initiation factors bind in the vicinity of the cap structure in the 
5`UTR and scans the mRNA in the 3`direction until an initiation codon in a 
favorable context is reached, and protein translation is initiated (Kozak, 1999). 
In line with this knowledge, our experiments suggested that the myeov 5`UTR 
was responsible for the lack of MYEOV protein translation. 
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Figure 3.2.  Translation efficiency of myeov cDNA constructs.  
(A) Different myeov open reading frame (ORF) cDNA fragments (constructs 1-6) 
were inserted using the indicated restriction sites into the eukaryotic expression 
vector pMT2SM (construct 9). The green arrowhead indicates a start codon in a 
perfect Kozak context. An open arrow indicates the start codon of the original first or 
second ORF, respectively. The constructs number 7 and 8 contain the entire myeov 
cDNA. B) The constructs were transiently transfected into HEK 293 cells, and 48 hours 
after transfection the cells were lysed and Western immunoblotting was performed. 
Specific MYEOV polyclonal antibodies were used. Note that no MYEOV protein could 
be detected in cells transfected with DNA constructs containing the full myeov 
cDNA. 
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3.3. Structural features of the myeov 5`UTR 
 The myeov 5`UTR exhibits an unusual long length of 445 nucleotides, 
containing four AUG codons, which code for four possible open reading 
frames of respective 22, 59, 11 and 7 amino acids. These upstream AUGs 
(uAUGs) are located upstream of the translation start site of the open reading 
frame. Concerning the relevance of nucleotides at the position -3 and +4 in 
the Kozak’s consensus sequence for optimal ribosome recognition of a start 
codon, the first three uAUGs in myeov 5`UTR show only one of the two Kozak’s 
features. The fourth uAUG shows both features, however the ORF initiated 
from this AUG codes for a very small peptide of only 7 amino acids (Figure 
3.3).  
 
 
 
Figure 3.3. The myeov 5`UTR cDNA sequence.  
The myeov 5`UTR contains four upstream AUG codons that are indicated in the order 
of its appearance from number 1 to 4. The start codon of the main myeov open 
reading frame is also indicated (AUG number 5). The first 18 amino acids of the 
myeov protein are shown in one letter code.  
 
Analyzing the myeov 5`UTR sequence to structure prediction using the 
software mfold 3.1 algorithm (Zuker, 2003), we found that myeov 5`UTR was 
predicted to have a very complex secondary structure with several stable 
hairpins and a Gibbs free energy of ∆G of -153,1 kcal/mol for the most stable 
configuration (Figure 3.4).  
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Figure 3.4. Predicted myeov secondary structure.  
The mRNA of the myeov 5`UTR was submitted to the software mfold 3.1 and 
predicted to have a stable secondary structure containing several hairpins. The most 
stable configuration with a free energy of -153.1 kcal/mol. 
 
It has been described that mRNAs containing a secondary structure 
with a folding free energy of ≤50 kcal/mole can effectively reduce ribosome 
scanning or even promotes complete inhibition of the scanning mechanism.  
Our data suggest that myeov mRNA translation is strictly regulated and 
MYEOV protein overproduction is repressed. However, it is possible that when 
MYEOV proteins are required, translation might occur by a cap-independent 
mechanism, e.g., internal ribosome entry. 
 
3.4. Effect of myeov 5`UTR on translation of a downstream reporter 
gene 
 In order to verify the effect of the myeov 5`UTR on translation of a 
reporter gene, we amplified myeov 5`UTR and added the restriction sites 
EcoRI and NcoI using the primers myeovEcoRI and myeovNcoI. This PCR 
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fragment was cloned into pGEM-T easy vector, the cloned fragment was 
checked by sequencing and subcloned between EcoRI/NcoI sites located 
upstream of the reporter gene Firefly luciferase in the monocistronic plasmid 
pGL3 (Promega), and thus creating the vector pGL3+UTR (Figure 3.5a). The 
Firefly luciferase present in the vector pGL3 has a perfect start codon. 
However, in order to mimic the normal situation as found in myeov cDNA, we 
introduced the same suboptimal start codon as found in the myeov long 
open reading frame. For that, the perfect start codon was modified to an 
suboptimal start codon after cloning of myeov 5`UTR into the vector pGL3. 
Considering the possibility that modification of the Kozak’s start codon might 
result in poor translation of the Firefly luciferase, we designed another set of 
primers to amplify myeov 5`UTR exhibiting a perfect start codon. For that the 
myeov 5`UTR was amplified using myeovEcoRI and myeovNcoI-K 
oligonucleotides primers, cloned into pGEM-T easy vector, checked by 
sequencing and subcloned into the correct open reading frame of the Firefly 
luciferase cistron in the plasmid pGL3, creating pGL3+UTR(K) (Figure 3.5a). 
These vectors were transfected into HEK 293 cells, and 48 hours after 
transfection, cells were lysed with lysis buffer provided with the Dual luciferase 
Kit (Promega). The Firefly luciferase light units were measured using an 
automated luminometer (Anthos) machine (Figure 3.5b). As we can see in 
Figure 3.5b, the presence of the myeov 5`UTR in both constructs (pGL3+UTR 
and pGL3+UTR(K) strongly represses translation of the reporter gene Firefly 
luciferase activity by 93% and 96%, respectively (Table 3.1). This result was in 
accordance with the results obtained after transfection of a complete myeov 
cDNA construct in a eukaryotic expression vector into HEK 293 cells (Figure 
3.2b, lanes 7 and 8).  
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Figure 3.5. The myeov 5`UTR reduces translation initiation efficiency of a downstream 
reporter gene.  
(A) The myeov 5`UTR was inserted in the indicated restriction sites into the 
monocistronic vector pGL3, creating the constructs pGL3+UTR and pGL3+UTR(K). In 
the construct pGL3+UTR the start codon of the Firefly luciferase was modified to a 
suboptimal context to mimic the myeov start codon, whereas the start codon of the 
Firefly luciferase in the construct pGL3+UTR(K) contains an optimal Kozak context. (B) 
These DNA constructs were transfected into HEK 293 cells and the relative activity of 
Firefly luciferase was measured.  
 
Our results clearly show that the presence of the myeov 5` 
UTR blocks protein translation of the reporter gene, implicating that myeov 
5`UTR may control protein translation. In analogy to that what has been 
described for other genes, it may pass that myeov might be translated under 
specific situations (e.g. heat shock, apoptosis, etc). In this situation, the 
ribosomes would escape the strong secondary structure found in myeov 
5`UTR mRNA (Figure 3.4) and jump directly at or near the AUG of the main 
ORF. This cap-independent translation mechanism has been called Internal 
Ribosome Entry Site mediated translation (IRES). To test this possibility, an 
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inverted sequence (hairpin) with -55 kcal/mole was introduced downstream 
of the promoter region in the vector pGL3 to create the vector phpL. The 
same was performed in the vector pGL3+UTR and pGL3+UTR(K), creating the 
vectors phpL+UTR and phpL+UTR (K), respectively (Figure 3.6a).  
 
 
Figure 3.6.  Myeov 5`UTR directs internal ribosome entry in the presence of a stable 
hairpin.  
(A) A palindromic  sequence that when transcribed creates a stable hairpin with a 
free energy of -55 kcal/mol and blocks ribosomal scanning was inserted at the 
indicated site in the DNA constructs depicted in Figure 3.5, creating phpL, phpL+UTR 
and phpL+UTR(K). (B) The monocistronic DNA constructs were transiently transfected 
into HEK 293 cells and Firefly luciferase activity was measured.  
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The presence of a stable hairpin blocks the ribosome scanning and 
therefore the translation of the Firefly luciferase reporter gene should be 
severely impaired. In case the myeov 5`UTR contains, for example an Internal 
Ribosome Entry Site, the ribosome can bind to the IRES, and Firefly luciferase 
will be translated. The DNA constructs depicted in Figure 3.6a were transiently 
transfected into HEK 293 cells and luciferase was measured 48 hours after 
transfection (Figure 3.6b). Our results show that the presence of a hairpin 
inhibits translation of the reporter gene by ~99% and emphasizes its 
effectiveness in blocking ribosome scanning. However, after transfection of 
phpL+UTR and phpL+UTR(K), Firefly luciferase activity was 38 and 48-fold 
higher as compared to the empty vector phpL. These data suggest that the 
Firefly luciferase produced was translated by a cap independent manner. 
e.g. IRES-mediated translation. 
 
3.5. Does the myeov 5`UTR harbors an Internal Ribosome Entry Site? 
 To answer this question, myeov 5`UTR was inserted into the bicistronic 
vector pRF between the Renilla luciferase (Rluc) and Firefly luciferase (Fluc) 
reporter genes. The first cistron (Renilla) is under control of a simian virus (SV40) 
promoter and is translated via a cap dependent mechanism. The Renilla 
luciferase is used to correct for transfection variation. The second cistron 
(Firefly luciferase) is translated independent of the cap structure, e.g. by 
internal ribosome entry site.  Myeov 5`UTR fragment was obtained from the 
vector pGEM-T+UTR and pGEM-T+UTR (K) and cloned upstream of the Firefly 
luciferase cistron originating pRF+UTR and pRF+UTR(K), respectively (Figure 
3.7a). These vectors were transiently transfected into HEK 293 cells and 48 
hours after transfection, activities of both luciferases were measured using the 
Dual Luciferase Kit from Promega in an automated luminometer with dual 
dispenser. Figure 3.7b demonstrates that the Firefly luciferase activity was 
increased 6- and 9-fold in pRF+UTR and pRF+UTR(K), respectively, when 
compared to the empty vector pRF.  
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This result suggests the possibility that the myeov 5`UTR may contain an 
IRES. However, one has to consider other possible mechanisms that may lead 
to the production of Firefly luciferase activity after transfection of bicistronic 
constructs. For example, the Firefly luciferase activity observed using the 
bicistronic assay may be due to ribosome shunting. In this situation, the 
ribosome goes to a downstream site by intramolecular shunting, bypassing 
the RNA structure, and resumes scanning until the next appropriate start 
codon is reached (Hellen and Sarnow, 2001).  
 
 
Figure 3.7. Myeov 5`UTR supports translation of the 3`cistron in a bicistronic vector.  
(A) The bicistronic expression cassette of the vector pRF. The myeov 5`UTR sequence 
was inserted into pRF using the indicated restriction sites to create the construct 
pRF+UTR and pRF+UTR(K). In the construct pRF+UTR the start codon of the Firefly 
luciferase was modified to a suboptimal Kozak context to mimic the myeov start 
codon. The Firefly luciferase start codon in the construct pRF+UTR(K) contains the 
optimal Kozak start codon. (B) HEK 293 cells were transfected with these DNA 
constructs and the activities of both luciferases were measured and normalized to 
internal control Renilla luciferase levels.   
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To eliminate this possibility and in order to demonstrate that the 
observed Firefly luciferase was indeed due to IRES activity, an inverted 
repeated sequence (hairpin) was placed upstream of the Renilla luciferase 
open reading frame of the vectors pRF, pRF+UTR and pRF+UTR(K), thus 
creating the constructs phpRF, phpRF+UTR and phpRF+UTR(K), respectively 
(Figure 3.8a).  
 
 
Figure 3.8. A stable hairpin appended to 5`end of bicistronic mRNA does not block 
translation of the 3`cistron. 
(A) A palindromic sequence that when transcribed generates a stable hairpin with 
free energy of -55 kcal/mol was inserted upstream of the Renilla luciferase cistron in 
the constructs depicted in Figure 3.7: pRF, pRF+UTR and pRF+UTR(K), creating phpRF, 
phpRF+UTR and phpRF+UTR(K). (B) HEK 293 cells were transiently transfected with 
these DNA constructs and both reporter gene activities were measured. Firefly 
luciferase activities were normalized to control Renilla luciferase levels.  
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These constructs were transiently transfected into HEK 293 cells and 48 
hours after transfection cells were lysed and luciferase activities were 
measured (Figure 3.8b). As expected, insertion of a hairpin effectively blocks 
ribosome scanning, and Renilla luciferase activity produced from these 
constructs was reduced to 90-100% of that of wild type (pRF). Again 
introduction of the myeov 5`UTR stimulated Firefly luciferase activity. This result 
suggests that translation of Firefly luciferase in the bicistronic constructs were 
independent of ribosome scanning from the 5`end of the bicistronic mRNA, 
and may probably occur by a cap independent mechanism (e.g. IRES). 
 
3.6. In vitro Coupled Transcription and Translation  
 In order to confirm that myeov 5`UTR has an Internal Ribosome Entry 
Site, we performed an additional control experiment. In this experiment, 
transcription starts from a T7 promoter and translation is performed in vitro in a 
rabbit reticulocyte lysate. In addition to the SV40 promoter, the bicistronic 
vector also contains a T7 promoter located downstream of the SV40 promoter 
(Figure 3.9a). In this assay translation of Renilla luciferase still occurs via cap-
dependent scanning, whereas translation of Firefly luciferase still depends on 
the presence of an IRES in the intercistronic region. Firefly luciferase activity 
should be expected when an IRES is present. Both constructs pRF and 
pRF+UTR were transcribed and translated in vitro using a Coupled 
Transcription and Translation Kit (Promega). The in vitro reaction was 
performed in a total volume of 50 µl and every 10 minutes a sample of 5 µl 
was taken from the reaction and mixed with 2 x Passive Lyses Buffer 
(Promega), and reporter activity of Renilla and Firefly luciferase was 
measured (Figure 3.9b). The Renilla luciferase (used as internal control) activity 
was high showing that the reactions worked properly. However, to our surprise 
the results demonstrated basically no difference between the Firefly luciferase 
activity of the empty bicistronic vector and the bicistronic construct 
comprising the myeov 5`UTR  (Figure 3.9b). 
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Figure 3.9. Effect of the myeov 5`UTR on reporter gene expression in vitro.  
(A) Bicistronic constructs pRF and pRF+UTR. The arrow indicates the position of the T7 
promoter. (B) These constructs were transcribed and translated in vitro using T7 
polymerase for transcription of the RNA and a nuclease-treated rabbit reticulocyte 
lysates to translate the transcribed RNA. Every 10 minutes 5 µl of the sample was 
mixed with lysis buffer and used to measure both luciferases activities. The Renilla 
luciferase activity is used as internal control and the Firefly luciferase activity is used 
to measure the putative IRES activity. R.luc = Renilla luciferase, F.luc = Firefly 
luciferase. 
 
 We also used the known IRES sequence of the encephalomyocarditis 
virus (EMCV) cloned into the vector pRF upstream of the Firefly luciferase 
cistron as a positive control (pRF+EMCV, Figure 3.10). In this construct the 
Renilla luciferase is translated via a cap-dependent mechanism and the 
Firefly luciferase is translated via the IRES of EMCV. We used pRF, pRF+UTR and 
pRF+EMCV in a coupled in vitro transcription and translation assay. Every 10 
minutes one tenth of the sample was mixed with 2 x Passive Lysis Buffer, and 
luciferases activity were measured (Figure 3.10b and c).  
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Figure 3.10.  Effect of the myeov and EMCV 5`UTRs on reporter gene expression in 
vitro.  
(A) Schematic diagram of the bicistronic constructs. The construct pRF+EMCV 
contains the IRES of the encephalomyocarditis virus and was used as a positive 
control for IRES activity. (B) The constructs were transcribed and translated in vitro 
using T7 polymerase for transcription and a nuclease-treated rabbit reticulocyte 
lysate to translate the transcribed RNA. The Renilla and Firefly luciferase activities 
were determined after 80 minutes incubation. Firefly luciferase activities were 
normalized to Renilla luciferase levels. (C) Every 10 minutes 5 µl of the reaction was 
used to measure the control Renilla luciferase activity.  
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Again we did not observed any induction of the Firefly luciferase with 
the construct containing the myeov 5`UTR. In contrast, the construct 
containing the IRES of EMCV showed 10-fold induction over background pRF 
vector (Figure 3.10b). Cap dependent translation of the Renilla luciferase 
cistron (used as internal control) was positive for all three constructs tested in 
this in vitro assay (Figure 3.10c). 
In this in vitro assay, we failed to proof IRES activity in myeov 5`UTR. One 
possible explanation could be that certain specific IRES-Trans-Activation 
Factors (ITAFs) required for IRES-dependent translation were not present in the 
rabbit reticulocyte lysate and therefore may explain our failure to show IRES 
activity of the myeov 5`UTR in this in vitro assay (Holcik et al., 2003; Kullmann et 
al., 2002; Millard et al., 2000; Stoneley et al., 2000).  
 
3.7. IRES activity of the myeov 5`UTR during apoptosis 
 Several mRNAs whose proteins products are involved in apoptosis are 
translated by the alternative mechanism of internal ribosome entry (Hellen 
and Sarnow, 2001). Staurosporin is a strong inhibitor of protein kinase C and 
therefore this antibiotic has a potent toxic effect on several tumor cell lines, 
which in turn will drive these cells into apoptosis. 
In order to verify whether the myeov putative IRES would be activated 
during apoptosis, we transiently transfected the DNAs from the constructs 
pGL3, pGL3+UTR, pRF and pRF+UTR into HEK 293 cells. Twenty four hours after 
transfection, 1 µM Staurosporin was added to the transfected cells, and 
twenty four hours after treatment with Staurosporin, cells were lysed and 
luciferase activities were measured (Figure 3.11a and b). Figure 3.11 shows the 
Firefly luciferase measured from cells transfected with the mono- and 
bicistronic constructs. Staurosporin drove about 30% of the cells into 
apoptosis, but no increase in Firefly luciferase activity could be demonstrated 
during treatment with Staurosporin. 
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Figure 3.11. The myeov putative IRES is not active during apoptosis.  
(A) HEK 293 cells were transfected with DNA of the monocistronic constructs 
pGL3+UTR and (B) with DNA of the bicistronic constructs pRF+UTR. Twenty four hours 
after transfection Staurosporin was added directly to the cells medium. Forty eight 
hours after transfection the cells were lysed and the activities of both reporter genes 
were measured. The empty vector pGL3 and pRF showed similar luciferases activities 
and are not depicted. 
 
In addition to Staurosporin treatment, we also transfected cells with 
FADD (Fas-associated death domain containing molecule also called 
MORT1), and deprived cells of serum. FADD drives the activation of caspase 
8, and this in turn leads to the cleavage of procaspase 3 and the triggering of 
the caspases cascade, ending in apoptosis (Zou et al., 1999). Deprivation of 
serum in the medium of cells also leads to apoptosis. Again we transfected 
293 cells with pGL3, pGL3+UTR, pRF and pRF+UTR. In this experiment, we have 
divided the cells basically into four groups:  
a) cells without treatment; 
b) cells treated with Staurosporin; 
c) cells transfected with FADD; 
d) cells deprived of serum. 
The cells in the first group (a) were lysed after 48 hours. The cells in 
second group (b) were treated with Staurosporin 24 hours after transfection of 
the luciferase reporter constructs, and lysed 24 hours after treatment. The cells 
in the third group (c) were transfected with FADD 24 hours after transfection 
of the luciferase reporter vectors, and lysed 12 and 24 hours after that. The 
cells in the fourth group (d) were deprived of serum 24 hours after transfection 
of the luciferase reporter constructs, and lysed 24 and 48 hours after that. The 
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luciferase measurements of the monocistronic and bicistronic constructs are 
shown in Figure 3.12a and b, respectively. Our analyses did not reveal IRES 
dependent activation by the myeov 5`UTR during apoptosis. 
 
 
Figure 3.12. No indication of myeov IRES activity during specific cell stress. 
(A) HEK 293 cells were transfected with DNA of the monocistronic construct 
pGL3+UTR and (B) with DNA of the bicistronic constructs pRF+UTR. Twenty four hours 
after transfection cells were stressed using different methods, such as: 1) the addition 
of Staurosporin to the cell’s medium; 2) transfection with DNA of the adaptor 
molecule FADD (Fas-associated death domain-containing molecule) that induces 
apoptosis and 3) deprivation of the cells with serum for 24 and 48 hours. 72 hours 
after transfection the activities of both reporter genes were measured. The empty 
vector pGL3 and pRF showed similar luciferases activities and are not depicted. 
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3.8. Does myeov 5`UTR has a cryptic promoter? 
 In order to ensure that the Firefly luciferase activity observed in our 
bicistronic constructs was not due to the presence of a cryptic promoter in 
the myeov 5`UTR, we created a promoterless construct. For this purpose, we 
simply removed the SV40 promoter and the intron of the bicistronic plasmid 
vectors pRF, pRF+UTR and pRF+EMCV and religated the plasmid DNA, 
creating the vectors pRF-P, pRF-P+UTR and pRF-P+EMCV, respectively (Figure 
3.13a). In this experiment no promoter is present in the constructs, and 
therefore no RNA transcription can occur and translation will be abrogated, 
and consequently no Firefly luciferase should be measured. The DNAs from 
the promoterless constructs were transiently co-transfected with the control 
plasmid pCMV-LacZ into 293 cells and luciferase activity was measured 48 
hours after transfection. Firefly luciferase activity was normalized in pRF-P+UTR 
to the β-Gal activity. We observed a 10-fold higher luciferase activity 
compared to background (pRF-P). Surprisingly pRF-P+EMCV also showed 10-
fold induction, suggesting a promoter activity in EMCV 5`UTR. (Figure 3.13b).  
Despite the fact that we detected a 10-fold induction with both the 
myeov and EMCV 5`UTR constructs, the Firefly luciferase activity measured 
was rather lower. To ensure whether myeov 5`UTR harbors a cryptic promoter, 
we transfected again cells using the same set of constructs. These cells were 
lysed 48 hours after transfection, and mRNA was isolated, subjected to 
formaldehyde gel electrophoresis, transferred onto nitrocellulose membrane, 
and then hybridized with a 32P-labelled Firefly luciferase probe (Figure 3.13c). 
Our Northern Blot analysis showed a clear transcript and suggests the 
presence of a cryptic promoter in the myeov 5`UTR. We also observed a very 
faint band in RNA of cells transfected with pRF-P+EMCV, which may indicate 
the presence of promoter activity in the EMCV 5`UTR. 
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Figure 3.13. Cryptic promoter activity of the myeov 5`UTR.  
(A) Schematic diagram of the promoterless bicistronic constructs pRF-P, pRF-P+UTR 
and pRF-P+EMCV. The sequence of the promoter and the chimeric intron were 
removed from the parenteral vector. (B) HEK 293 cells were transfected with DNAs of 
the promoterless constructs in combination with pCMV-LacZ, and 48 hours after 
transfection the activities of both reporter genes were measured. Firefly luciferase 
activity was normalized to β-galactosidase activity. The relative values of Firefly 
luciferase activities were calculated and normalized to that of the empty vector 
(pRF-P), where pRF-P was set to 1. (C) Northern Blot analysis of poly(A+) mRNAs 
derived from transfected cells. The RNAs were electrophoresed in the presence of 
formaldehyde, transferred to nitrocellulose and then probed with a 32P-labelled 
Firefly luciferase fragment.  
 
In order to check these data, we also removed the promoter of the 
monocistronic vectors pGL3+UTR and pGL3+EMCV, creating the constructs 
pGL3-P+UTR and pGL3-P+EMCV, respectively (Figure 3.14a). All these plasmid 
DNAs were transiently transfected into HEK 293 cells and 48 hours after 
transfection, one tenth of the cells were lysed and Firefly luciferase activity 
was measured (Figure 3.14b). The rest of the lysate was used to isolate mRNA. 
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Poly(A+) RNA was subjected to formaldehyde agarose gel electrophoresis, 
blotted onto nitrocellulose membrane, and hybridized with a 32P-labelled 
Firefly luciferase probe (Figure 3.14c). 
 
 
Figure 3.14. Promoter activity of myeov 5`UTR in the promoterless monocistronic 
constructs.  
(A) Schematic diagram of the monocistronic constructs pGL3-P+UTR, pGL3-P+EMCV, 
pGL3 and pGL3+UTR. The promoter sequences were removed in the constructs 
pGL3-P+UTR (myeov 5`UTR) and pGL3-P+EMCV (EMCV 5`UTR). (B) HEK 293 cells were 
transfected with these constructs in combination with pCMV-LacZ, and 48 hours after 
transfection the activities of Firefly luciferase was measured. Firefly luciferase activity 
was normalized to β-galactosidase activity. (C) Northern Blot analysis of transfected 
cells using a 32P-labelled Firefly luciferase fragment.   
 
The presence of a strong transcript in cells transfected with pGL3-P+UTR 
confirms the promoter activity of the myeov 5`UTR as observed in the 
bicistronic promoterless constructs. These data and the data from the 
previous experiment suggest the presence of a cryptic promoter in the myeov 
5`UTR and no IRES. To confirm this result, we again transfected HEK 293 cells 
with DNAs of the following constructs: pRF, pRF+UTR (Figure 3.15a) and phpRF 
and phpRF+UTR (Figure 3.16a).  
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Figure 3.15. Presence of promoter activity in the myeov 5`UTR.  
(A) Schematic diagram of the bicistronic constructs. Myeov 5`UTR was inserted using 
the indicated restriction sites into the intercistronic region. (B) HEK 293 cells were 
transfected with the described constructs and both luciferases activities were 
measured. Firefly luciferase was normalized to the internal control Renilla luciferase. 
(C) Northern Blot analysis of the mRNAs isolated from transfected cells, hybridized 
with a 32P-radiolabelled Firefly luciferase fragment. The asterisk indicates the 
bicistronic RNA that initiates at the SV40 promoter. The arrowhead indicates the 
position of the Firefly luciferase transcript that initiates in the myeov 5`UTR.   
 
Forty eight hours after transfection, one tenth of the sample was used to 
measure the luciferases activity (Figure 3.15b and 3.16b). The rest of the lysate 
was used for mRNA extraction followed by formaldehyde gel electrophoresis, 
blotting and hybridization with a 32P-labelled Firefly luciferase probe (Figure 
3.15c and 3.16c). If the observed Firefly luciferase was due to the presence of 
an IRES, one should be able to see only one transcript. However, if a promoter 
is present one should be able to see two transcripts. One transcript 
corresponding to the bicistronic RNA and one transcript corresponding to the 
monocistronic RNA produced by the myeov 5`UTR cryptic promoter. Figure 
3.15c and 3.16c clearly show two transcripts: one long transcript 
corresponding to a bicistronic mRNA which is produced under the control of 
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the SV40 promoter, and one short mRNA corresponding to the promoter 
present in the myeov 5`UTR. This result was confirmed by hybridization of the 
same samples with a 32P-labelled Renilla luciferase probe, where only the long 
transcript was observed (data not shown).  
 
 
Figure 3.16. Presence of promoter activity in the myeov 5`UTR using the bicistronic 
construct with a stable hairpin.  
(A) Schematic diagram of the bicistronic constructs. A stable hairpin (-55 kcal/mol) 
was inserted in the indicated restriction site upstream of the Renilla luciferase cistron. 
(B) HEK 293 cells were transfected with these constructs and the luciferases activities 
were measured. (C) Northern Blot analysis of the RNAs isolated from transfected cells, 
hybridized with a 32P-labelled Firefly luciferase fragment. The asterisk indicates the 
bicistronic RNA that initiates at the SV40 promoter. The arrowhead indicates the 
position of the Firefly luciferase transcript that initiates in the myeov 5`UTR.   
 
3.9. Mapping the myeov 5`UTR promoter 
 In order to determine the precise location of myeov promoter activity in 
its 5`UTR, we generated several promoter deletions constructs as shown in 
Figure 3.17a. The advantage to use the bicistronic vectors containing the 
SV40 promoter is that the bicistronic mRNA is transcribed and the Renilla 
luciferase activity (translated via a cap-dependent mechanism) can be used 
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to measure transfection efficiency. The constructs were transfected into 
HEK293 cells and 48 hours after transfection the cells were used to measure 
luciferase activity (Figure 3.17b).  
 
 
Figure 3.17. Deletion mapping of the myeov cryptic promoter.  
(A) Deletions of the myeov 5`UTR were created by PCR, and the deletion products 
were introduced into the bicistronic vector pRF, creating the constructs pRF+UTRdel1, 
pRF+UTRdel2 and pRF+UTRdel3. (B) HEK 293 cells were transiently transfected with 
these constructs and both luciferases activities were measured.  
 
As demonstrated by the Firefly luciferase activity (Figure 3. 17b) we 
could see the higher Firefly luciferase levels in cells transfected with the first 
two constructs (myeov 5`UTR wild type and the construct in which 112 
nucleotides from the 5`end were removed “deletion 1”). In cells transfected 
with DNA from the last two constructs (deletion 2 and 3, in which 222 and 336 
nucleotides from the 5` end of the myeov 5`UTR were removed) the level of 
the Firefly luciferase was reduced. This suggests that the myeov promoter 
region is located between nucleotides 113 and 223 (Figure 3.18).   
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The results obtained so far clearly demonstrated the presence of a 
cryptic promoter in the myeov 5`UTR. The intensity of the transcript originating 
from the myeov 5`UTR promoter was similar to that of the one produced by 
the SV40 promoter (see Figure 3.15c and 3.16c, please compare the upper 
band (bicistronic RNA) and the lower band (monocistronic) RNA). This result 
implies that the myeov 5`UTR promoter is a very efficient promoter almost 
comparable to the strong SV40 promoter.  
Despite high transcription levels, translation of Firefly luciferase was 
strongly impaired in the monocistronic as well as the bicistronic constructs 
when compared to the Renilla luciferase activity translated from the transcript 
originating from the SV40 promoter. In order to clarify this discrepancy, we 
decided to investigate whether the uAUGs present in the myeov 5`UTR could 
be responsible for the reduced protein level produced by our luciferase 
reporter plasmids. 
 
                                                1 
 1  CGGACCGCGA ACCCACAUCC CUACAAAGCA GGAAAGUAUG CUUGGGAGAG  
 
      51  GCCAAGUGAG UGGGGAAUCA GCCCAAAGCC AGGCGUCCAG GGUCUCCCUC  
                                                          2    
     101  ACCUGAAGCU GACUUUUUCC CCACCUUGGA CAGAGGGCGG GAGAUGCCAU  
 
     151  CCCCACUGAA CCCAGUGCUU UCACCAGCCA UAUUAGCUCC CACUCACCCC  
                                                             3  3     
     201  CCGUCGUGGA AGCCUCGGCC GUCACACCUG CAGGGCCGGG GCGUGCAUGG  
                   4 
     251  CCUCAGGGAU GGCCUGUUCA GCUGCUGGGU GACUCGGGUC CAGGUGCCUC  
 
     301  ACCACCUGCU GAGCUCUGUG UGAUUUCUGG ACGCUUCUGC UCGUUGCCUU  
 
     351  UGGGCUCAGU GAAGAGUCUG GAGUUUAUCU GGAGUGAGGU GGCCGGUUCU  
                                                            5 
401 UGGUGGGAUC UGAGCAGGAC AGCGUCUGGC UCCUUCCCUC GGCUCAUGGC 
 
 
Figure 3.18. Mapping of myeov 5`UTR promoter activity.  
The possible myeov sequence responsible for its cryptic promoter activity is shown in 
green. The expected transcript from the myeov cryptic promoter encompasses two 
or three upstream open reading frames. The start codons present in the myeov 5`UTR 
are underlined. The AUG number 5 indicates the myeov start codon that codes for 
the MYEOV protein.  
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3.10. Regulation of translation efficiency by the myeov 5`UTR 
Despite strong promoter activity found in the myeov 5`UTR, translation 
of the Firefly luciferase cistron was much lower than that of the Renilla 
luciferase cistron, when using the bicistronic construct. These results suggest 
that, albeit strong Firefly luciferase transcription from the cryptic promoter in 
the myeov 5`UTR, translation of this transcript was severely blocked. For this 
reason, we decided to evaluate the effect of the four uAUGs present in the 
myeov 5`UTR on translation of the reporter gene.  We therefore mutated the 
uAUGs of the myeov 5`UTR to AAG using the mutagenesis kit from Stratagene.  
For this purpose, myeov 5`UTR DNA was amplified using the primers 
myeovUTRHindIIIfor and myeovEcoRVrev, containing HindIII and EcoRV 
restriction sites. The PCR fragment was cloned into pGEM-T easy vector, 
creating the vector pGEM-T+myeov5`UTRHindIIIEcoRV, checked by restriction 
digestion and sequencing. Subsequently this construct was used as a 
template for mutagenesis. Mutagenesis was performed using four primers 
(myeovATG1, myeovATG2, myeov ATG3, and myeovATG4). Each primer was 
designed to make a mutation of the uracil nucleotide in the start codon of 
the uORF, where U was replaced to A. In this way the AUG start codon was 
replaced by the codon AAG, which codes for leucine. The mutated fragment 
was checked by sequencing and subcloned upstream of Renilla luciferase 
cistron into the plasmid vector pRF+EMCV, thus creating the vector 
pRF+EMCV+myeov1,2,3,4mut. The wild type myeov 5`UTR fragment without 
mutations was also cloned into pRF+ECMV to create the vector 
pRF+EMCV+myeov without mutation (Figure 3.19a). In these constructs the fist 
cistron is translated via a cap dependent mechanism and the second cistron 
is cap-independently translated via the IRES of EMCV. The Firefly luciferase 
activity produced is used as an internal control to normalize for transfection 
variations. The DNA constructs were transfected into HEK 293 cells, and 48 
hours after transfection cells were lysed and luciferase activities were 
measured (Figure 3.19b). The corrected Renilla luciferase activity was high in 
the empty vector (pRF+EMCV), where Renilla luciferase was translated via a 
cap-dependent mechanism. In the construct containing the myeov 5`UTR 
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lacking any mutation (pRF+EMCV+myeov without mutation). Renilla luciferase 
activity was strongly reduced (96%). This result was in agreement with previous 
observations, where the myeov 5`UTR has been shown to block protein 
translation. Transfection of pRF+EMCV+myeov1,2,3,4mut in which all uAUGs 
were removed, almost completely restored the level of Renilla luciferase. 
These results clearly show that upstream AUG triplets in the myeov 5`UTR 
transcript can regulate the expression on the level of translation.   
 
 
 
Figure 3.19. Effect of myeov 5`UTR wt or mutated on translation of reporter gene. 
(A) Schematic diagram of the bicistronic reporter vector pRF+EMCV. In these 
constructs the translation of the Firefly luciferase cistron is mediated by the EMCV 
internal ribosome entry site (or cryptic promoter). The myeov 5`UTR wild type or the 
mutated form, where the four AUG start codon of the myeov 5`UTR was mutated to 
AAG, were inserted upstream of the first Renilla cistron (pRF+EMCV+5`UTR without 
mutation and pRF+EMCV+5`UTR 1,2,3,4 mutated, respectively). (B) HEK 293 cells were 
transfected with these constructs and both luciferases activities were measured. The 
Renilla luciferase activity was normalized to the internal control Firefly luciferase.   
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In order to evaluate the contribution of individual uAUGs to the 
repression of translation of the reporter gene constructs several constructs 
with single and/or combinations of AUG-AAG mutations were designed. For 
this purpose we used pGEM-T+myeov5`UTRHindIIIEcoRV as a template and 
the mutagenic primers myeovATG1, myeovATG2, myeovATG3 and 
myeovATG4 and the mutagenesis kit. Several mutational combinations were 
constructed. The mutated plasmid DNAs were transformed into bacteria, mini-
preparation was performed, and DNAs were sequenced. After having 
sequenced many miniprep DNAs we finally ended up with a complete set of 
constructs representing all possible mutational combinations (in total 16 
constructs containing various mutations, and one wild type). The myeov 5`UTR 
cloned into T-vector was subcloned into the vector pRF-EMCV upstream of 
the Renilla luciferase reporter gene, creating pRF+EMCV+UTRmutated (Figure 
3.20a). All constructs were transiently transfected into HEK 293 cells and the 
luciferase activities were measured 48 hours after transfection (Figure 3.20b).  
As depicted in Figure 3.20b, all mutations had some effect on the translation 
efficiency, but a clear preference could not be observed. 
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Figure 3.20. Effect of different myeov 5`UTR upstream start codon mutation on 
translation of the reporter gene. 
(A) Schematic diagram of the bicistronic vector pRF+EMCV. The myeov 5`UTR wild 
type was inserted upstream of the Renilla luciferase cistron. The myeov AUGs were 
mutated to AAG. The respective mutations are indicated by an “X” in the constructs 
3 to 17. (B) HEK 293 cells were transfected with the wild type or the mutant constructs 
and luciferases activities were measured. Renilla luciferase was normalized to the 
internal control Firefly luciferase. The translation of the Firefly luciferase reporter gene 
is mediated by an IRES of the encephalomyocarditis virus.  
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3.11. RNA transfection 
 In order to analyze the effect of uAUGs in the myeov 5`UTR directly, 
without the interference of possible transcriptional effects due to, for 
example, promoter competition for transcription factors, we transiently 
transfected in vitro transcribed RNAs into HEK 293 cells. For this experiment, we 
used the bluescript based vector containing a T3 promoter upstream of the 
Firefly luciferase reporter gene. Myeov 5`UTR wild type or the mutated myeov 
5`UTR, in which all four uAUGs were mutated to AAG were amplified by PCR 
and SpeI and NcoI restriction sites were added. The purified PCR fragments 
were cloned into pGEM-T easy vector, originating the vector pGEM-
T+myeovSpeINcoI and pGEM-T+myeovSpeINcoI1,2,3,4mut, respectively. 
Clones were verified by sequencing and the myeov 5`UTR fragments were 
subcloned into pBSK, creating the vectors pBSK+UTR and pBSK+UTR1,2,3,4mut 
(Figure 3.21a). The T3 promoter present in these vectors was used for in vitro 
transcription using T3 polymerase. Prior to in vitro transcription the constructs 
were linearized with the restriction enzyme XhoI, that is located downstream 
of the Firefly luciferase reporter cistron. In this way we obtained one transcript 
of the myeov 5`UTR (wild type and mutated) and the reporter gene Firefly 
luciferase. The DNA fragment was purified and synthetic mRNA was 
generated using the mMESSAGE mMachine™ reaction system (Ambion) as 
described in Materials and Methods. The transcribed mRNA was purified and 
quantitated by spectrophotometer analysis and agarose gel electrophoresis. 
RNAs were transfected into HEK 293 cells. Twenty four hours after transfection, 
cells were lysed and part of the lysate was used to measure the Firefly 
luciferase activity (Figure 3.21b), and the rest of the lysate was used to extract 
mRNA. The RNAs were applied to a formaldehyde agarose gel, blotted and 
hybridized with a 32P-labelled Firefly luciferase probe and quantitated by 
phosphoimager (Figure 3.21c). As we can see in Figure 3.21b, the high Firefly 
luciferase activity in pBSK was abolished when myeov 5`UTR wild type was 
placed upstream of the Firefly luciferase cistron. Firefly luciferase activity levels 
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were restored to a normal level when we replaced the myeov 5`UTR for a 
mutated form of the myeov 5`UTR. 
 
 
Figure 3.21. Effect of the myeov upstream open reading frame on translation of the 
reporter gene by RNA transfection.  
(A) Schematic diagram of the DNA constructs pBSK, pBSK+UTR (wild type) and 
pBSK+UTRmutated, in which all four uAUGs were mutated to AAG. The DNA 
constructs were linearized and transcribed in vitro using the T3 promoter. (B) HEK 293 
cells were transiently transfected with the purified RNAs transcribed in vitro, and 24 
hours after transfection the Firefly luciferase activities were measured. (C) Poly(A+) 
RNAs were isolated from the transfected cells, electrophoresed in the presence of 
formaldehyde, transferred to nitrocellulose membrane and then probed with a 32P-
radiolabelled Firefly luciferase fragment.  
 
This result was in agreement with our DNA transfection data and shows 
once more that the myeov uAUGs are responsible for the control of protein 
translation of the reporter gene. 
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3.12. Is the myeov upstream open reading frame responsible for 
MYEOV protein translation control? 
 Our previously mentioned data strongly suggest that myeov uAUGs are 
responsible for protein translation control, since the wild type myeov 5`UTR 
can drastically abolish protein translation, and a mutated form of the myeov 
5`UTR restores normal protein levels as shown in our DNA and RNA transfection 
experiments. Although these results clearly show that uAUGs can control 
protein translation of reporter genes, we were interested to check whether 
the same effect could be observed using the complete myeov cDNA 
sequence. Therefore, we cloned the complete wild type myeov cDNA 
sequence, and a cDNA sequence in which all uAUGs in the 5`UTR were 
mutated and sequences that were missing either the 5`UTR, the 3`UTR or both 
into the eukaryotic expression vector pMT2SM (Fig. 3.22a). Constructs were 
transiently transfected into HEK 293 cells and 48 hours after transfection RNAs 
and proteins were isolated. The RNAs were submitted to formaldehyde 
agarose electrophoresis, blotted and probed with 32P-labelled myeov (Figure 
3.22b). Proteins were subjected to 10% SDS-PAGE, blotted and incubated with 
MYEOV specific antibodies (Figure 3.22c). Northern blot analysis showed 
specific transcripts of the expected sizes. The first lane of the SDS-PAGE gel 
shows proteins derived from transfection of the construct in which the start 
codon of the main myeov ORF was altered into an optimal Kozak start codon. 
Only one MYEOV specific protein band corresponding to the large MYEOV 
protein of 313 amino acids could be seen. Lane two shows the results after 
transfection with the myeov ORF with its own AUG. Two bands could be 
observed by Western Immunoblotting analysis. The two proteins are probably 
deduced from the long ORF of 313 amino acids and a protein product that 
starts at the second AUG in the same open reading frame, resulting in a 
protein with a length of 255 amino acids. Lanes three and four in the Northern 
Blot analysis show a very strong transcript, which corresponds to the complete 
myeov cDNA, however no protein could be detected (compare lanes three 
and four of the Northern Blot with the Western blot). 
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Figure 3.22. Effect of the myeov 5`and 3`UTR on MYEOV protein translation.  
(A) Schematic diagram of the different myeov constructs in the eukaryotic 
expression vector pMT2SM (vector, number 8). Different combinations of fragments 
or mutated fragments of the complete myeov cDNA were inserted downstream of 
the adenovirus promoter of the pMT2SM vector. Filled green and open arrowheads 
indicate the positions of a translation initiation site in a perfect Kozak context or in its 
own suboptimal Kozak context, respectively. The shorter open reading frame is 
derived from a differently spliced myeov cDNA clone (B) HEK 293 cells were 
transfected with these cDNA constructs and 48 hours after transfection cells were 
harvested for RNA and protein extraction. RNAs were analyzed by Northern Blot 
analysis using a specific 5`myeov (position 1-894) probe and (C) proteins were 
analyzed by Western blotting using MYEOV-specific antibody. Positions of MYEOV 
proteins derived from the short (S) and long (L) open reading frame.  
 
Lane five shows that mutation of the uAUGs in the myeov 5`UTR restores 
translation of MYEOV in the construct containing the complete myeov cDNA. 
Lane 6 shows the results of the transfection with the construct lacking the 
myeov 3`UTR. Although a transcript can be detected, no MYEOV protein 
could be seen, demonstrating that the myeov 3`UTR had no obvious inhibitory 
effect on MYEOV protein translation. Different results were obtained when the 
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5`UTR was removed (lane 7). Although the level of myeov RNA expression was 
rather low, clear MYEOV proteins could be observed on the Western blot. In 
summary these results strongly suggest that myeov uAUGs can regulate 
MYEOV biosynthesis on the level of translation and myeov uAUGs are 
responsible for a strong reduction of MYEOV protein translation.  
 
3.1.3. Can MYEOV function as a transcription factor? 
To answer this question, we have performed one experiment based on 
the knowledge that a transcription factor consists of two domains: a binding 
domain (BD) and an activating domain (AD). Two plasmid vectors were used 
to perform this experiment, namely pBIND and pG5luc. The vector pBIND has 
two cistrons: the first cistron contains GAL4-BD under the control of a CMV 
promoter, and in the second cistron the reporter gene Renilla luciferase is 
under the control of a SV40 promoter, and is used as transfection control. The 
monocistronic vector pG5luc has the reporter gene Firefly luciferase under 
the control of the adenovirus promoter, which is located downstream of five 
GAL4- DNA binding site. This implies that in order to start transcription, a GAL4- 
transcription factor (containing BD and AD) should bind to the GAL4- DNA 
binding sites, recruit the transcriptional machinery and drive transcription and 
translation of the Firefly luciferase reporter gene. In a situation where the AD 
of the transcription factor has been removed, the transcription factor is still 
able to bind to the binding sites in the DNA. However, as the AD is missing, 
transcription can not start.   
  To verify whether MYEOV codes for a transcription factor, we amplified 
the myeov ORF (coding for a long protein of 313 amino acids) and the AD of 
the transcription factor VP16 as a control. BamHI and XbaI restriction sites 
were added by PCR, and the purified fragments were cloned into the vector 
pGEM-T, creating pGEM-T+myeovORFBamXbaI and pGEM-T+VP16BamXbaI, 
respectively. The fragments were checked by sequencing and subcloned 
into pBIND in frame with the Gal4-Binding Domain (GAL4-BD), creating the 
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constructs pBIND+myeov and pBIND+VP16. Three different transient 
transfections into HEK 293 cells were performed (Figure 3.23):  
 
a) pBIND and pG5luc (negative control); 
b) pBIND+VP16 and pG5luc (positive control); 
c) pBIND+myeov and pG5luc  
 
 
Figure 3.23. Transcription factor constructs.  
(A) The plasmid pBIND contains the GAL4-BD under control of a CMV promoter. The 
Renilla luciferase is under control of the SV40 promoter and is used as internal control. 
The reporter plasmid pG5luc contains five GAL4-DNA binding sites. The Firefly 
luciferase reporter gene is used to measure transcriptional activation. (B) The 
activation domain of the transcription factor VP16 was inserted in frame with GAL4-
BD. In this situation, a reconstituted transcription factor consisting of the GAL4 binding 
domain and the activation domain of VP16 binds to the GAL4-DNA binding sites and 
recruits the transcriptional machinery, resulting in transcription and translation of the 
reporter Firefly luciferase. (C) The myeov long open reading frame was inserted in 
frame with the GAL4-BD.  However this fusion protein was not able to activate 
transcription of the reporter construct. 
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Forty eight hours after transfection the Luciferases activities were 
measured (Figure 3.24a). In the first transfection the GAL4-BD vector lacks the 
AD. GAL4-BD can bind to the GAL4 DNA binding sites in pG5luc, but 
transcription is not activated and as consequence no translation of the 
reporter gene Firefly luciferase occurs. In the second transfection the pBIND 
vector contains the AD of VP16 fused in frame with the GAL4-BD. The GAL4-
BD/VP16AD fusion protein can bind to the GAL4 binding sites on the DNA and 
activate transcription. In the third transfection we did not detect any Firefly 
luciferase activity, suggesting that MYEOV is not able to activate transcription. 
In all transfections the Renilla luciferase activity of the pBIND vector was used 
as a transfection control. In addition we also decided to perform a Western 
Immunoblot analysis with GAL4-BD and MYEOV specific antibodies to check 
for proper expression of the transfected DNAs (Figure 3.24b). Proteins of 
expected sized were detected.  
 
 
Figure 3.24. Myeov is not a transcription factor.  
(A) The DNA constructs depicted in Figure 3.23 were transiently transfected 
into HEK 293 cells and forty-eight hours after transfection the activity of both 
reporter genes were measured. (B) Proteins from transfected cells were 
isolated and submitted to Western immunoblotting and incubated with either 
MYEOV specific antibody or GAL4-BD antibody. Fragments of expected size 
were detected. Co-transfections: A = pBIND and pG5-luc; B = pBIND-VP16AD 
and pG5luc; C = pBIND+myeov and pG5luc; D = untransfected cells.  
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The same set of plasmid DNAs were also transfected into another cell 
line, Met-5A. Met-5A expresses a SV40 large T antigen, which promotes 
replication from the SV40 origin found in the pBIND vector. The combination of 
large T antigen and SV40 origin may result in a higher copy number of this 
vector in the cells, and therefore increase expression of the reporter gene. As 
expected, the Renilla luciferase measured in the lysate extracted from Met-
5A cells was about 10-fold higher compared to lysates from HEK 293 cells 
(Figure 3.25). However also in these cells Firefly luciferase was not activated 
when pBIND-myeov was used, implying that MYEOV could not activate 
transcription in Met-5A cells as well as in 293 cells. In conclusion these data 
show that MYEOV does not act as a transcription factor. 
 
 
Figure 3.25. Myeov does not act as a transcription factor in Met-5A cells.  
The DNA constructs depicted in Figure 3.23 were transfected into Met-5A cells. Forty-
eight hours after transfection the activities of both reporter genes were measured. 
Co-transfections: A = pBIND and pG5-luc; B = pBIND-VP16AD and pG5luc; C = 
pBIND+myeov and pG5luc.  
 
3.1.4. MYEOV protein in adenocarcinoma cell lines 
In a previous study we reported high RNA levels of myeov in different 
esophageal squamous cell carcinoma cell lines (Janssen et al., 2002).  Next 
we wanted to find out whether MYEOV protein is expressed in human 
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carcinoma cell lines, and if yes, whether those cells possibly contain 
alternative transcripts in which myeov uAUGs might be not present. Thirty 
samples from patients suffering of esophageal squamous cell carcinomas 
were donated by Dr. Yutaka Shimada (Department of Surgery & Surgical 
Basic Science, Kyoto University Hospital, Japan) and were analyzed by 
Western Immunoblotting. Unfortunately we failed to detect any MYEOV 
protein in all samples tested (data not shown). In previous studies, we have 
seen anomalous myeov transcripts in pancreas tissue and we therefore 
decided to check whether pancreas adenocarcinoma cell lines might 
express MYEOV protein. We used the pancreas cell lines Capan 1 and Dan-G. 
In addition, other cell lines were used: Met-5A, Hep-G2, HEK-293 and COS-7. 
Cells were cultivated as described in Materials and Methods and mRNA and 
proteins were isolated for Northern and Western Immunoblotting analysis, 
respectively (Figure 3.26a and b). The results of the Western blot analysis 
revealed endogenous MYEOV protein in Dan-G and COS-7 cells. We know 
from a previous study that KMS-12 show high myeov RNA levels that are not 
translated. Our Northern blot analysis shows high myeov transcript levels in 
Capan-1 also express myeov, but no MYEOV protein could be detected in 
the Western blot. This point has to be clarified further.  
 
 
Figure 3.26. Northern and Western blot analysis of adenocarcinoma cell lines 
(A) Northern blot analysis of RNA isolated from the indicated cells. The RNAs 
were submitted to a formaldehyde gel and blotted with a 32P-labelled myeov 
fragment. (B) Western blot analysis of proteins extracted from different cell 
lines with MYEOV specific polyclonal antibody. 
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4. Discussion 
4.1. Identification of the myeov gene 
The myeov gene was identified in a tumorigenicity assay with DNA from 
a patient suffering from a gastric carcinoma. FISH analysis mapped the 
myeov gene to chromosome 11q13 (Janssen et al., 1999; Janssen et al., 2000). 
The myeov gene was also shown to be involved in cases of multiple myeloma 
(MM) harboring the t(11;14)(q13;q32). Further, FISH analysis revealed that 
myeov is activated in these MM patients through the juxtaposition of the Eµ 
enhancer of the immunoglobulin heavy chain to the myeov gene (Janssen et 
al., 2000). Myeov expression is tightly regulated. At first, it has been shown in 
cell lines of patients with esophageal squamous cell carcinomas that myeov 
transcription is repressed by gene methylation (Janssen et al., 2002). Secondly, 
our study demonstrated that MYEOV biosynthesis is also controlled by the 
presence of upstream AUG codons (uAUGs) present in the myeov 5`UTR.  
Similar mechanisms have also been described for other important 
genes in which potent protein overproduction is repressed by the presence of 
uAUGs in the transcribed mRNAs. Along this line it may be suggested that the 
function of the MYEOV protein might be very important.  
 
4.2. Protein-protein interaction 
In order to clarify the function of the MYEOV protein and its possible role 
in carcinogenesis, we looked for proteins that may interact with the MYEOV 
protein. Unfortunately we failed to find any interaction partner in the yeast as 
well in the bacterial two hybrid system. Therefore, we cloned the myeov 
coding region in frame with GST and myc tags in order to perform 
coimmunoprecipitation analysis and to detect and isolate possible interaction 
partners biochemically. These experiments were also negative and did not 
allow us to find any interaction partner of the MYEOV protein.   
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4.3. MYEOV does not code for a transcription factor 
As the MYEOV protein does not contain any known motifs or domains 
and we were unable to detect any interaction partner, its biological function 
remains enigmatic. A sequence homologous to the myeov cDNA sequence 
reported similarity to the transcription factor forkhead box D2. In order to test 
whether the MYEOV protein might function as a transcription factor, we used 
a two-hybrid like system. The myeov coding region failed to demonstrate any 
activation of the Firefly luciferase reporter gene in this assay. The very strong 
activity of Firefly luciferase measured in the lysate from cells transfected with 
control DNA confirmed that the system worked properly.  
Data base analysis as well DNA analysis by Southern Blot (Zoo blot) of 
different species revealed the presence of the myeov gene in humans and 
monkeys only. The absence of the myeov gene in cat, rat, mouse, sheep and 
mice suggests that the myeov gene may play an important role in higher 
mammals. 
 
4.4. Characterization of the myeov 5`UTR 
 The 5`UTR of most eukaryotic mRNAs has a length in the range between 
100 and 300 nucleotides, which is compatible with the ribosome-scanning 
model (Kozak, 1999). In contrast, about 10% of the eukaryotic mRNAs have a 
longer atypical 5`UTR which may also contain upstream AUGs codons 
(uAUGs) and, in some cases, associated upstream open reading frames 
(uORFs) (Morris and Geballe, 2000). Interestingly, uAUGs are extremely 
common in certain class of genes, including two-thirds of oncogenes and 
other genes involved in the control of cellular growth and differentiation 
(Kozak, 1987a; Kozak, 1991a; Morris, 1995). These mRNAs are poorly translated 
by a cap-dependent translation mechanism (Willis, 1999). Translation initiation 
of almost all eukaryotic mRNAs proceeds by a cap-dependent mechanism 
whereby the AUG nearest the 5`UTR-end is utilized as initiation codon (Kozak, 
2000; Pestova et al., 2001; Sedman et al., 1990). The control of mRNA 
translation is an important step in order to regulate gene expression, and most 
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of the translational regulation occurs at the level of initiation, which is usually 
the rate-limiting step in protein synthesis (Donahue, 2000; Hershey, 1991; 
Kozak, 1991c; Mathews et al., 2000; Sonenberg, 1994). 
The myeov 5`UTR has several features which seem to be incompatible 
with an efficient ribosome scanning of protein synthesis initiation. 1) The 
myeov 5`UTR contains an unusual length of 445 nucleotides, 2) its 5`UTR has 
four upstream start codons (uAUGs), associated with four upstream open 
reading frames (uORFs) of 22, 59, 11 and 7 amino acids, respectively and 3) it 
has a high G+C content and can potentially form complex secondary 
structures. These features are common among mRNAs regulated by their 
5`UTR and suggest that MYEOV protein synthesis might be regulated at a 
posttranscriptional level. These findings prompted us to investigate the 
possible role of the myeov 5`UTR in controlling its protein level.  
 Using the mfold 3.1 algorithm (Zuker, 2003) the myeov 5`UTR sequence 
was predicted to be able to form a very stable secondary structure with a 
Gibbs free energy of ∆G of -153,1 kcal/mol for the most stable configuration. It 
has been described that secondary structures caused by the high G+C 
content of vertebrate leader sequences attenuate ribosome scanning 
(Kozak, 1991a; Kozak, 1992). However, G+C rich elements can also serve as 
internal promoters for transcription (Kozak, 1991a; Macleod et al., 1998). In this 
situation the effect depends on the position of the hairpin structure to the 
AUG start codon. It was reported that an AUG codon in a suboptimal context 
was recognized better when a hairpin structure was positioned 13 to 15 
nucleotides downstream of the AUG start codon (Kozak, 1990). This data fits 
with mapping experiments  in which the leading edge of the ribosome was 
shown to extent about 15 nucleotides beyond the AUG codon (Kozak, 1977). 
A hairpin positioned at +15 would therefore be expected to pause the 40S 
ribosomal subunit with its AUG-recognition-center right over the AUG codon 
(Kozak, 1990). As the myeov 5`UTR structure is incompatible with the ribosome-
scanning model, it is suggested that the myeov 5`UTR RNA secondary 
structure may block ribosome scanning, and consequently reduce or 
completely abrogate MYEOV protein translation. In such a case, MYEOV 
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protein synthesis would be regulated at a translational level, and/or might 
occur by a cap-independent mechanism (e.g. internal ribosome entry).  
 
4.5. Myeov does not cotain an IRES 
Some viral RNAs use an internal ribosome entry site (IRES) to initiate 
translation in a cap-independent manner. The RNA of these viruses is usually 
uncapped therefore utilizing an IRES sequence to recruit the ribosome to the 
vicinity of the initiation codon and facilitate translation. IRESes were also 
identified in mammalian mRNAs containing a cap-structure, e.g. BiP, the 
gene that codes for the immunoglobulin heavy chain binding protein, 
fibroblast growth factor 2 (FGF2), the X-chromosome linked inhibitor of 
apoptosis (XIAP), and c-myc (Holcik and Korneluk, 2000; Macejak and 
Sarnow, 1991; Nanbru et al., 1997; Vagner et al., 1995; Yang and Sarnow, 
1997). The IRESes found in these genes are located in their 5`UTRs near the 
start codon of the main open reading frame. In these examples, the ribosome 
circumvents the stable secondary structure or the uAUGs that may block 
ribosome-scanning by jumping on the RNA at the IRES directly or near to the 
AUG start codon, and initiate protein synthesis.  
Transfection of DNA constructs containing the full myeov cDNA did not 
yield sufficient MYEOV protein to be detected by specific antibodies in 
Western blot analyses. When we inserted the myeov 5`UTR cDNA sequence 
into a monocistronic reporter construct (pGL3) upstream of the Firefly 
luciferase cistron, a strong reduction of the reporter gene activity was 
observed, suggesting that the stable secondary structure of its 5`UTR may 
have an attenuating effect on protein synthesis. Presence of a stable hairpin 
upstream the Firefly luciferase cistron in the monocistronic constructs (phpL) 
abrogated the translation of the reporter gene. In contrast, insertion of the 
myeov 5`UTR 3`of a stable hairpin stimulated the reporter activity 38 to 48 fold 
(Figure 3.6), suggesting that the secondary structure present in the myeov 
5`UTR initiates MYEOV translation by internal ribosome entry or represents an 
internal promoter. To investigate if myeov contains IRES elements, the 5`UTR 
Discussion 
 
 127
was first inserted into the intercistronic region of the bicistronic vector pRF. The 
insertion of the myeov 5`UTR in the bicistronic construct also stimulated Firefly 
luciferase activity.  
However, recent publications have shown that results from the 
bicistronic assay alone are not enough to prove that a sequence under 
scrutiny encompasses an IRES. Another possibility, for example, could be 
ribosomal readthrough enhanced by signals in the myeov 5`UTR. To examine 
the possibility of ribosomal readthrough from the first cistron, a stable hairpin 
was inserted upstream of the 3`cistron (Renilla luciferase) into the bicistronic 
vector pRF, creating phpRF. The presence of a hairpin abrogated luciferases 
activity. However, insertion of the myeov 5`UTR upstream of Firefly luciferase in 
the vector phpRF promoted strong induction of Firefly luciferase activity. These 
data suggested the presence of an IRES in the myeov 5`UTR. However, still 
other possibilities could explain the increased activity of the Firefly luciferase 
(Figure 4.1), like for example:    
 
A) The possibility of RNA nuclease cleavage within the intercistronic 
region, creating two monocistronic mRNAs rather than the 
expected bicistronic mRNA (Figure 4.1a) (Jackson et al., 1995; 
Kozak, 2001b).  
 
B) Another potent artifact reported using the bicistronic vector is the 
possibility that the putative IRES element contains a cryptic promoter 
which could result in the production of two capped monocistronic 
mRNAs (Figure 4.1b) (Jackson et al., 1995; Kozak, 2001b). 
 
C) A third possibility is the presence of a splice acceptor site in the 
putative IRES sequence, resulting in this way in a form of mRNA that 
could be translated by a normal cap-dependent mechanism, 
and/or leaky scanning and/or ribosome reinitiation (Figure 4.1c) 
(Kozak, 2002b). 
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Figure 4.1. Alternative mechanisms that may also increase the activity of the second 
cistron using the bicistronic assay to test sequences for IRES activity (see text). SD = 
splice donor and SA = splice aceptor. 
 
To distinguish between these possibilities, we performed additional 
control experiments, namely 1) in vitro transcription and translation of the 
bicistronic construct harboring the myeov 5`UTR; 2) deletion of the promoter in 
the mono and bicistronic constructs, creating promoterless constructs; 3) 
Northern blot analysis of RNAs from cells transfected with these constructs. 
The results from the in vitro assay did not demonstrate the presence of 
an IRES in the myeov 5`UTR, since no increase in Firefly luciferase activity was 
detectable when compared to the empty vector pRF. Although the failure to 
demonstrate IRES activity in the myeov 5`UTR by this method argues against 
the presence of an IRES, this result might be explained by the requirement of 
IRES trans-activating factors (ITAFs) absent in this in vitro system. Some other 
Discussion 
 
 129
cellular IRESes were also inactive in this in vitro assay, suggesting the 
requirement of ITAFs for some internal ribosomal entry events (Holcik et al., 
2003; Holcik and Korneluk, 2000; Kullmann et al., 2002; Millard et al., 2000; 
Pilipenko et al., 2000). For example, poliovirus and rhinovirus IRESes are not 
active in the rabbit reticulocyte lysate unless the lysate is supplemented by a 
HeLa cell extracts (Borman et al., 1993; Brown and Ehrenfeld, 1979; Dorner et 
al., 1984). Another explanation is that some cellular IRESes need a “nuclear 
event” to work properly (Iizuka et al., 1995; Stoneley et al., 2000). This is the 
case for the IRES of the antiapoptotic XIAP, which needs two nuclear 
ribonucleoproteins for proper IRES function (Holcik et al., 2003). 
 
4.6. Analysis of the putative myeov IRES activity during cellular 
stress situations 
 Cap independent mechanisms mediated by an IRES are usually 
activated under situations where cap dependent mechanisms are reduced 
or completely blocked. For example, cap-dependent protein translation in 
cells infected by poliovirus is strongly impaired, but the viral mRNAs are still 
translated by a cap-independent translation mechanism that is mediated by 
an IRES (Macejak and Sarnow, 1991; Sarnow, 1989; Yang and Sarnow, 1997). 
The same is true for mRNAs that are translated in specific situations, e.g. during 
hypoxia, apoptosis, heat shock, etc. Also, during mitosis cap-dependent 
translation is impaired, suggesting a cap independent mechanism of 
translation for mRNAs expressed during this stage of the cell cycle (Hernandez 
et al., 2004; Pyronnet et al., 2000; Qin and Sarnow, 2004; Subkhankulova et al., 
2001). Translation of ornithine decarboxylase (ODC), the rate-limiting enzyme 
in the biosynthesis of polyamines, peaks twice during the cell cycle, at the 
G1/S transition and at G2/M (Pyronnet et al., 2000). It has been described that 
an IRES in the ODC mRNA that functions exclusively at G2/M is present to 
ensure elevated levels of polyamines, which are necessary for mitotic spindle 
formation and chromatin condensation (Pyronnet et al., 2000). The c-myc 
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mRNA also contains an IRES that functions specifically during mitosis 
(Subkhankulova et al., 2001). 
 To check whether the putative myeov IRES is activated during such 
stress situations, we investigated the effect of the myeov 5`UTR during cell 
starvation and apoptosis. Cells transfected with the DNAs from the bicistronic 
constructs containing the myeov 5`UTR were treated with Staurosporin, which 
is a strong inhibitor of protein kinase C and consequently has a potent toxic 
effect in cells, leading to apoptosis. Analysis of luciferase activities in these 
cells did not show increased Firefly luciferase activity when compared to 
untreated cells (Figure 3.11). This result was confirmed in cells transfected with 
the bicistronic constructs containing the myeov 5`UTR that were co-
transfected with FADD, a death domain-containing protein that interacts with 
the death domain of Fas and initiates apoptosis. In the group of cells 
transfected with DNAs of the reporter gene, which were deprived of serum, 
we also did not see any induction of Firefly luciferase activity (Figure 3.12). 
Together these data suggested that either the myeov putative IRES is not 
active during cellular stress situations or the myeov 5`UTR does not contain an 
IRES.  
 
4.7. Myeov 5`UTR harbours a cryptic promoter 
 We next investigated the possibility whether the myeov 5`UTR contains 
a cryptic promoter by removing the SV40 promoter of the mono- and 
bicistronic constructs. The activity of the Firefly luciferase in transfected cells 
with DNA of the promoterless constructs, suggested the presence of a cryptic 
promoter in the myeov 5`UTR. This result was confirmed by Northern blot 
analysis of RNAs from transfected cells, using a Firefly luciferase fragment as a 
probe. In these Northern Blot analyses we detected a transcript the size of 
which suggests a transcriptional start site within the myeov 5`UTR. This data 
was also confirmed using the bicistronic construct (pRF+UTR) that contains the 
myeov 5`UTR and the SV40 promoter. In this case, two transcripts were 
observed. The first transcript initiated at the SV40 promoter, and the second 
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one initiated within the intercistronic region, and therefore presumably in the 
myeov 5`UTR. Hybridization of the Northern Blot with a 5` Renilla luciferase 
probe showed only one transcript starting from the SV40 promoter. The 
absence of a second and smaller transcript confirmed our findings that the 
second transcript originated in the myeov 5`UTR. Surprisingly, these analyses 
also revealed the presence of promoter activity in the 5`UTR of EMCV that 
was confirmed by transfection of promoterless constructs. The 5`UTR of EMCV 
harbors an IRES (Jang et al., 1988), as published in numerous studies (Aminev 
et al., 2003; Davies and Kaufman, 1992; Dove et al., 2004; Kolupaeva et al., 
2003; Urwin et al., 2000; Witherell and Wimmer, 1994). Even our DNA 
transfections experiments using the bicistronic reporter construct, as well as 
the in vitro transcription and translation experiments also suggested the 
presence of an IRES in the 5`UTR of EMCV.  
There is an ongoing debate whether cellular mRNAs really contain 
IRESes. In a recent review Kozak  discussed 26 publications of cellular mRNAs 
that were reported to contain an IRES (Kozak, 2001b). She criticized the design 
of different experiments performed to identify the putative IRES in those 
mRNAs. According to this report only one of the 26 reported putative IRESes 
may contain an IRES, while in all the other cases the mRNAs were probably 
translated by an alternative transcript derived from splicing that would 
remove part of their 5`UTR or the presence of a cryptic promoter in their 5`UTR. 
Our results are in agreement with her criticism and similar observations were 
also described by other investigators, e.g. for the translation of the eIF4G  that 
originally was reported to be mediated by an IRES located in its 5`UTR (Gan et 
al., 1998; Johannes and Sarnow, 1998). Experiments using promoterless 
constructs ruled out the presence of an IRES in the 5`UTR of eIF4G, but rather 
revealed the presence of cryptic promoter activity (Han and Zhang, 2002). 
Although RNA analysis performed by Northern blot were usually conducted to 
rule out the existence of monocistronic transcript originating from the second 
cistron, monocistronic transcripts that represent less than 5% of the bicistronic 
mRNA level may not be detected by Northern blotting analysis (Kozak, 
2001b). Therefore, inadequate RNA analysis may explain the inflation of 
Discussion 
 
 132
reports on cellular mRNAs containing putative IRESes. Consequently, some of 
the reported cellular IRESes might be erroneously identified. For example, the 
mRNAs of ornithine decarboxylase (Pyronnet et al., 2000), connexin-32 
(Hudder and Werner, 2000) and Gtx (Chappell et al., 2000) have been 
reported to contain an IRES, since their 5`UTR supported translation of the 3` 
cistron of the bicistronic reporter construct 2.5, 5 and 7 fold, respectively, 
when compared to the empty vector. This marginal induction of reporter 
gene activity might also be explained by “contaminated” monocistronic RNA 
that is not detectable by Northern blot analysis. In agreement with that, the 
human Sno and mouse Bad mRNAs were described to contain an IRES in their 
5`UTR, and Northern blot analysis of their mRNA did not reveal the presence of 
a monocistronic transcript and thus supported this view. Unfortunately, the 
promoterless assay revealed the presence of a cryptic promoter in both 
5`UTR`s (Han and Zhang, 2002). The different results obtained using 
promoterless constructs, support the view that it is of outmost importance to 
use this system when analyzing putative IRES sequences to rule out the 
presence of a cryptic promoter in the sequence under scrutiny. Our results 
impressively support this argument, since we detected promoter activity in the 
myeov 5`UTR using the promoterless constructs.   
Deletions of the myeov 5` UTR suggested that the cryptic promoter 
drives transcription of a mRNA that still encompasses two or even three AUGs 
upstream of the myeov main ORF. Presently, we are mapping the precise 
transcription start site of this myeov cryptic promoter by primer extension 
analysis. 
 
4.8. Myeov uAUGs reduce translation of the reporter gene 
Despite the strong promoter activity detected in the myeov 5`UTR, the 
reporter gene activity was rather low due to the presence of four upstream 
AUGs (uAUGs) within the myeov 5`UTR. This was confirmed by mutation 
analysis. Transfection of wild type myeov 5`UTR, strongly reduced reporter 
gene activity. In contrast, in a mutated form, in which all four uAUGs were 
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removed, the protein level was almost restored to the level of the control 
construct pRF+EMCV (Figure 3.19). This result was also confirmed by directly 
transfecting RNAs into cells. The biggest advantage of this method is that it 
bypasses the complex issue of transcriptional regulation, and the effects are 
directly measured after the cytoplasmic delivery of the transcripts (Han and 
Zhang, 2002). These results suggested that the absence of upstream start 
codons allowed the ribosome to reach the reporter gene start codon. In 
order to investigate if this translational control can be assigned to a specific 
uAUG, we have created 16 mutational combinations. Specific analysis of the 
reporter gene activity in transfected cells revealed that all four myeov uAUGs 
had some effect on protein translation control, but a preferable uAUG could 
not be clearly observed.  
Attenuation of translation efficiency by the presence of uORFs is well 
known for genes having a critical proliferation or survival function, including 
oncogenes, cytokines, signal transduction proteins, transcription factors, and 
other potent proteins (Hernandez-Sanchez et al., 2003; Morris and Geballe, 
2000). In the case of cellular mRNAs, uORFs might be used as a device for 
limiting the translation of potent proteins that would be harmful if 
overproduced (Kozak, 2001a). When the protein of the major ORF would be 
required, the inhibitory effect of the uORF will be eliminated by switching to 
an alternative promoter or splice site (Arrick et al., 1994; Phelps et al., 1998).  
The most well described example concerning uORFs is the yeast GCN4 
gene. This gene encodes a transcription factor that is responsible for the 
activation of the expression of approximately 50 genes of the amino acid 
biosynthesis (Grant et al., 1995). During amino acid deprivation, protein 
synthesis is blocked and in turn translation of the GCN4 mRNA is enhanced 
(Hinnebusch, 1996). The GCN4 mRNA contains four uORFs that are necessary 
for GCN4 protein translation control in response to amino acid limitation 
(Hinnebusch, 1996; Hinnebusch, 1997). The uORF1 is always translated 
efficiently, after which ribosomes resume scanning and reinitiate, usually at 
uORF4. uORF4 is unusual in that its translation precludes further reinitiation 
events, thus, when uORF4 is translated, GCN4 is not. This is the situation in 
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which yeast cultures contain adequate nutrients. In contrast, amino acid 
starvation causes some ribosomes to bypass the inhibitory uORF4 and to 
reinitiate instead farther downstream. This occurs because starvation creates 
a pool of uncharged tRNAs which activate a protein kinase that 
phosphorylates, and thus partially inactivates, eIF2. When eIF2 levels fall, it 
takes longer for ribosomes to reacquire Met-tRNAi and thus become 
competent to reinitiate. The slower acquisition of competence means that 
some ribosomes, scanning in the reinitiation mode, will bypass the nearby 
uORF4 and can thus reach the downstream GCN4 start site (Hinnebusch, 
1996; Hinnebusch, 1997; Kozak, 2002b).   
A second example is the proinsulin that is expressed prior to 
development of the pancreas and promotes cell survival. The embryonic 
proinsulin mRNA shares the coding region with the pancreatic form, but 
presents a 32 nucleotides extension in its 5`UTR. This extension contains two 
uAUGs which are responsible for the reduced level of insulin protein. The 
presence of these uAUGs is necessary to ensure a low insulin level, since the 
addition of exogenous proinsulin to embryos in ovo decreases apoptosis and 
in turn generates abnormal developmental traits. This data shows the 
significance of uAUGs as a tight regulator of protein levels important for 
developmental signal pathways (Hernandez-Sanchez et al., 2003).  
There are several other examples where uAUGs are responsible for the 
inhibition of protein translation. Thrombopoietin protein production is strongly 
impaired by the presence of uAUGs, resulting in very low thrombopoietin a 
level that is normally found in serum. Mutation or splicing events that remove 
the uAUGs can lead to overproduction of this potent cytokine, resulting in 
thrombocythaemia (Ghilardi et al., 1998). This was confirmed in a study 
performed in a Dutch family. This family comprised eleven individuals with 
thrombocythaemia (Wiestner et al., 1998). The thrombopoietin (TPO) long 
transcript contains seven uAUG codons upstream the TPO ORF. The uAUG1 
through uAUG6 create small upstream open reading frames which terminate 
before the main TPO start codon, while the uAUG7 produces a small open 
reading frame that overlaps with the TPO start codon. All uAUGs contribute to 
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translation control of TPO protein synthesis. The thrombopoietin gene of the 
affected individuals in the described Dutch family contains a mutation which 
leads to shortened 5` UTR removing specific uAUG codons, which leads to 
overproduction of the thrombopoietin protein. The absence of the uAUG 
codon was considered the responsible factor to cause this 
thrombocythaemia (Kozak, 2002a; Wiestner et al., 1998). In conclusion, 
hereditary thrombocythaemia result from mutations that restructure the 5` 
leader sequence in a manner that promotes elevated level of this potent 
cytokine (Ghilardi et al., 1998; Kondo et al., 1998; Wiestner et al., 1998). 
Additional examples of the involvement of uORFs in translation control in 
human diseases are described in the review of Kozak 2002 (Kozak, 2002a).  
 
4.9. Myeov uAUGs control MYEOV biosynthesis  
Our data clearly showed that the uAUGs located in the myeov 5`UTR 
strongly impaired the translation of the reporter gene. Next, we wanted to 
find out the effect of the uAUGs on the translation of the myeov ORF. Analysis 
of RNAs and proteins from transfected cells using the complete myeov cDNA 
wild type or the mutated form, where all four uAUGs were mutated, 
confirmed our previous results where we used the mono- and bicistronic 
reporter constructs. It has also been demonstrated that the 3`UTR can also 
participate in controlling protein translation initiation (Gallie, 1996; Gebauer et 
al., 1999; Jacobson, 1996; Michel et al., 2000; Valcarcel and Gebauer, 1997). 
This is in part due to the interaction between the Poly(A) tail with the PAB 
protein, which again interacts with the initiation factor eIF4G. The cap-binding 
initiation factor, eIF4E on its turn interacts with the factor eIF4G. In this way, 
both mRNA ends bind to the eIF4G through interaction of the eIF4E and PAB 
protein. Contacts between the eIF4G and the poly A tail bound to PAB seem 
to enhance translation efficiency but are not absolutely required for ribosome 
recruitment (von der Haar et al., 2004). To clarify whether the myeov 3`UTR 
collaborates in MYEOV protein translation control, a myeov cDNA construct in 
the eukaryotic expression vector pMT2SM lacking its 3`UTR was used. Absence 
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of the myeov 3`UTR did not alter the protein levels as no protein could be 
detected by Western Immunoblotting analysis. This was confirmed with the 
construct lacking the myeov 5`UTR, but still containing the myeov ORF and its 
3`UTR. In cells transfected with DNA from this construct, MYEOV protein could 
be detected by Western Immunoblotting using MYEOV specific antibodies.  
Our results clearly demonstrated that MYEOV protein translation is 
strongly impaired by the presence of uAUGs or by the small uORFs.  In 
situations where efficient translation of MYEOV protein is required, the 
inhibitory effect of uAUGs or uORFs may be eliminated by switching to an 
alternative promoter or splice site (Phelps et al., 1998). There are several 
examples in which a specific gene creates transcripts with different 5`UTRs. In 
mice, the cyclin-dependent kinase inhibitor p18INK4c is excessively transcribed 
but not translated because the mRNA contains a long 5`UTR with 1115 
nucleotides and five uAUGs. During differentiation, a downstream promoter 
produces a second transcript with a smaller mRNA that can be translated 
efficiently (Phelps et al., 1998). The human MET gene ORF encodes a tryrosine 
kinase receptor that binds the human growth factor (HGF) and is implicated 
in oncogenesis. The mRNA of the MET gene is present in all cell types, but it 
has been demonstrated to lack the exon that contains the start codon (Lin et 
al., 1998). The inability to translate this transcript is a way to adjust the quantity 
of functional mRNA for this important protein (Lin et al., 1998). The mouse 
cerebroside sulfotransferase gene is transcribed in many tissues and is also not 
translated because of the presence of uAUGs (Hirahara et al., 2000). These 
examples show that it is important to verify whether alternative transcripts 
removing uAUGs from a mRNA exist. However, detection of such alternative 
transcripts is complicated by 1) competition for a common probe that can 
cause minor transcripts to be missed (Chen et al., 1999), 2) even abundant 
transcripts can be missed just because the probe was located too far 
upstream (Cortner and Farnham, 1990) or within an intron (Frost et al., 2000) or 
3) because hybridization conditions favored detection of a minor GC-rich 
5`UTR over an alternative AU-rich 5`UTR (Sazer and Schimke, 1986). 
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4.10. Expression of MYEOV protein in carcinoma cell lines 
 We have also analyzed several carcinoma cell lines by Western blot 
analysis using MYEOV specific antibodies. We found that some pancreas 
carcinoma cells expressed MYEOV protein, albeit of an abnormal size. This 
difference may be explained by the presence of anomalous transcripts that 
are produced in pancreas tissue. In fact, in a previous study we reported the 
presence of alternative myeov transcripts in pancreas tissue. These pancreas 
specific mRNAs may differ in their 5`UTR sequences and regulate MYEOV 
biosynthesis in a tissue specific manner. The regulation of MYEOV biosynthesis 
and its biological function, as well as the presence of specific MYEOV protein 
products in human pancreas deserves further attention and hopefully will be 
clarified in future studies. 
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5. Summary 
The myeov gene was identified using the tumorigenicity assay with DNA 
from a patient suffering a gastric carcinoma. The Myeov gene is localized at 
chromosome band 11q13, a frequent site for chromosomal rearrangements in 
various carcinomas and B-cell neoplasms. The gene was shown to be 
involved in cases of multiple myeloma harboring the t(11;14)(q13;q32). In 
addition, myeov is coamplified with cyclin D1 and overexpressed in 
carcinomas of the breast, lung, bladder, esophageal squamous cell 
carcinomas and oral squamous cell carcinomas. Myeov DNA amplification 
and overexpression was detected in several carcinoma cell lines, however, 
hardly any MYEOV protein could be detected using specific antibodies in 
Western blot analysis. The 5` untranslated region (5`UTR) of the myeov gene is 
long, encompasses four upstream AUG codons (uAUGs) and is predicted to 
fold in a strong secondary structure. These features are common among 
mRNAs regulated by their 5`UTR and suggest that MYEOV protein synthesis 
might be regulated at a posttranscriptional level. These findings prompted us 
to investigate the possible role of the myeov 5`UTR in controlling its protein 
level, and the possibility of MYEOV protein synthesis to be mediated by an 
internal ribosome entry site (IRES). Here we show that initial experiments using 
mono- and bicistronic reporter constructs supported this view. However, 
further examination by in vitro transcription/translation assays, Northern blot 
analysis and the application of promoterless constructs revealed promoter 
activity in the myeov 5`UTR. Despite this strong promoter activity, we did not 
find any translation products. Our experiments showed that this was due to 
the presence of uAUGs codons present in the myeov 5`UTR. DNA and RNA 
transfection of the wild type and mutated 5`UTR, where the uAUGs were 
mutated to AAG, confirmed that these uAUGs abrogate translation of the 
reporter gene as well as the myeov gene. Alternative splicing mechanisms in 
specific cell types and/or developmental stages may be a way to evade this 
translation control.  
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6. Zusammenfassung 
Das Myeov Gen wurde mittels eines Tumorigenizitätsassays aus der DNA eines 
Patienten mit einem Magentumor isoliert. Das Gen ist auf der Chromosomenbande 
11q13 lokalisiert worden, einem häufig betroffenen Abschnitt für chromosomale 
Rekombinationen in verschiedenen Karzinomen und B-Zell-Neoplasien. Es ist 
nachweislich an Fällen multipler Myelome beteiligt, die eine t(11;14)(q13;q32) zeigen. 
Auch findet man Myeov zusammen mit Cyclin D1 koamplifiziert und überexprimiert in 
Karzinomen der Brust, der Lunge, der Blase, sowie in Epithelzellkarzinomen des 
Ösophagus und der Mundhöhle. Amplifikation und Überexpression von MYEOV 
wurden zwar in mehreren Karzinom-Zelllinien gezeigt, jedoch konnte in der Western-
Blot-Analyse mit myeov-spezifischen Antikörpern kein Protein nachgewiesen werden. 
Die 5` nichttranslatierte Region (5`UTR) des Myeov-Gens ist relativ lang, sie enthält 
vier vorgeschaltete AUG Kodons (uAUGs) und ist laut Prognose eines 
Computerprogramms in der Lage, eine starke Sekundärstruktur zu bilden. Diese 
Eigenschaften kommen häufig bei mRNAs vor, die durch ihre 5`UTR reguliert werden 
und deuteten auch in unserem Fall darauf hin, daß die MYEOV-Proteinsynthese auf 
postranskriptionaler Ebene gesteuert sein könnte. Diese Entdeckungen veranlassten 
uns dazu, einerseits die mögliche Rolle der Myeov-5`UTR bei der Regulation der 
Proteinexpression näher zu untersuchen, sowie andererseits zunächst die Möglichkeit 
zu überprüfen, ob die Proteinsynthese durch eine „internal ribosome entry site“ (IRES) 
ermöglicht werden könnte. Erste Experimente mit mono- und bicistronischen 
Reporterkonstrukten schienen diese Ansicht zu stützen. Jedoch wies die weitere 
Prüfung durch in vitro-transcription/translation assays, Northern-Blot-Analyse und die 
Verwendung promotorloser Konstrukte auf eine Promotorfunktion der Myeov 5`UTR 
hin. Doch trotz deutlicher Promotoraktivität fanden wir keine translatierten Produkte. 
Unsere Experimente zeigten schließlich, daß die Ursache in den uAUG Kodons der 
Myeov 5`UTR zu suchen war. Die Transfektion verschiedener DNA- und RNA- 
Luciferase- Reporterkonstrukte mit Myeov 5`UTR und parallel dazu einer mutierten 
Form, bei der die uAUGs zu AAG verändert worden waren, bestätigte, daß diese 
uAUGs die Translation des Reportergens sowie des Myeov-Gens verhindern. 
Alternatives Splicing in bestimmten Zell-Arten und/oder Entwicklungsstadien könnten 
eine Möglichkeit sein, diese Translationskontrolle zu umgehen. 
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